TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-1280215	Cytokine Signaling in Immune system	5.04212097056981e-27	-60.551970689785	756	108	0.223140495867769	484	10287	5698,1844,8503,6351,3669,1839,26281,3976,54739,149233,3553,10125,3552,3627,6352,941,3593,960,2920,2635,3586,3162,2633,5699,3575,4982,1326,11213,51561,3429,595,970,9235,3684,330,3687,8995,8767,4318,3576,6363,3589,3559,4067,2537,3455,4939,4312,1435,6708,64127,1847,5292,2668,8638,5721,4314,7133,3604,23529,3592,10148,8809,9636,115362,3055,1440,146433,4940,23586,29949,3659,4790,115361,50604,4843,3557,1848,3383,3561,6364,1437,90865,6348,3934,4791,3460,27189,3394,3569,1850,6288,56300,943,5971,6347,2634,91543,27177,2247,11009,5743,3601,4938,2069,2919,3656,4233	PSMB9,DUSP2,PIK3R3,CCL4,ISG20,HBEGF,FGF20,LIF,XAF1,IL23R,IL1B,RASGRP1,IL1A,CXCL10,CCL5,CD80,IL12B,CD44,CXCL2,GBP3,IL10,HMOX1,GBP1,PSMB10,IL7R,TNFRSF11B,MAP3K8,IRAK3,IL23A,IFI27,CCND1,CD70,IL32,ITGAM,BIRC3,ITGAX,TNFSF18,RIPK2,MMP9,CXCL8,CCL19,IL11,IL2RA,LYN,IFI6,IFNAR2,OAS2,MMP1,CSF1,SPTA1,NOD2,DUSP5,PIM1,GDNF,OASL,PSME2,MMP3,TNFRSF1B,TNFRSF9,CLCF1,IL12A,EBI3,IL18R1,ISG15,GBP5,HCK,CSF3,IL34,OAS3,DDX58,IL19,IRF1,NFKB1,GBP4,IL20,NOS2,IL1RN,DUSP6,ICAM1,IL2RG,CCL20,CSF2,IL33,CCL3,LCN2,NFKB2,IFNGR2,IL17C,IRF8,IL6,DUSP8,SAA1,IL36G,TNFRSF8,RELB,CCL2,GBP2,RSAD2,IL36B,FGF2,IL24,PTGS2,IL15RA,OAS1,EREG,CXCL1,IRAK2,MET
R-HSA-449147	Signaling by Interleukins	1.16908852284992e-21	-48.1980625479741	525	80	0.165289256198347	484	10287	146433,1440,29949,10148,3592,8809,3055,90865,6348,1437,3934,4791,4790,50604,1848,3557,4843,3561,6364,3383,2247,27177,11009,5743,27189,1850,3569,6288,6347,56300,2069,2919,4233,3656,3601,3552,10125,3553,3627,6352,8503,1844,5698,6351,3976,26281,1839,149233,3162,5699,3575,3593,941,2920,3586,3576,4318,6363,4067,3559,3589,51561,11213,1326,595,3687,8767,3684,9235,2668,5292,5721,4314,23529,7133,4312,1435,6708,1847,64127	IL34,CSF3,IL19,EBI3,IL12A,IL18R1,HCK,IL33,CCL3,CSF2,LCN2,NFKB2,NFKB1,IL20,DUSP6,IL1RN,NOS2,IL2RG,CCL20,ICAM1,FGF2,IL36B,IL24,PTGS2,IL17C,DUSP8,IL6,SAA1,CCL2,IL36G,EREG,CXCL1,MET,IRAK2,IL15RA,IL1A,RASGRP1,IL1B,CXCL10,CCL5,PIK3R3,DUSP2,PSMB9,CCL4,LIF,FGF20,HBEGF,IL23R,HMOX1,PSMB10,IL7R,IL12B,CD80,CXCL2,IL10,CXCL8,MMP9,CCL19,LYN,IL2RA,IL11,IL23A,IRAK3,MAP3K8,CCND1,ITGAX,RIPK2,ITGAM,IL32,GDNF,PIM1,PSME2,MMP3,CLCF1,TNFRSF1B,MMP1,CSF1,SPTA1,DUSP5,NOD2
R-HSA-6783783	Interleukin-10 signaling	7.85520596840042e-21	-46.2931104601998	49	25	0.0516528925619835	484	10287	2919,7133,1437,6348,941,3593,3383,3586,6364,2920,3557,1435,6363,3627,3553,1440,3552,3576,5743,6352,3569,3592,6351,6347,3976	CXCL1,TNFRSF1B,CSF2,CCL3,CD80,IL12B,ICAM1,IL10,CCL20,CXCL2,IL1RN,CSF1,CCL19,CXCL10,IL1B,CSF3,IL1A,CXCL8,PTGS2,CCL5,IL6,IL12A,CCL4,CCL2,LIF
R-HSA-168256	Immune System	6.58708296960516e-17	-37.258835975357	2101	176	0.363636363636364	484	10287	4790,7498,50604,115361,3557,4688,7130,3383,6364,3561,90865,221687,4791,3592,10148,6280,115362,9636,8809,3055,114770,57823,1440,4940,3659,3725,4586,2069,3394,3569,629,5329,6288,54210,6347,718,91543,6616,7097,11009,5743,3593,5317,941,960,2920,3162,5068,2633,64135,8503,1844,5698,26253,6351,3669,1839,26281,3976,7128,255488,3552,3710,10125,1118,10517,1520,6352,6891,7295,4939,5292,6317,8638,5721,23327,3604,7133,23529,719,1326,3429,53831,970,8995,2495,3576,3589,3455,10584,5005,4843,1848,3937,92369,1437,6348,4794,3934,285852,5806,6890,146433,23586,79930,29949,3601,4033,4938,11119,55521,2919,3656,4233,3460,154664,27189,1850,943,5971,56300,23308,2634,27177,2247,3386,1540,2635,6279,1604,3586,84676,29126,5699,55008,3575,4982,4792,54739,149233,3553,245973,10071,3627,2268,644150,4312,6278,342510,117157,6708,1435,64127,1847,2668,50617,4314,127544,8876,51561,11213,595,2207,3684,9235,330,3687,8767,4318,5004,6363,3559,2537,4067,5266,272	NFKB1,XDH,IL20,GBP4,IL1RN,NCF2,TNFAIP6,ICAM1,CCL20,IL2RG,IL33,RNF182,NFKB2,IL12A,EBI3,S100A9,GBP5,ISG15,IL18R1,HCK,PGLYRP2,SLAMF7,CSF3,OAS3,IRF1,JUN,MUC5AC,EREG,IRF8,IL6,CFB,PLAUR,SAA1,TREM1,CCL2,C3,RSAD2,SNAP25,TLR2,IL24,PTGS2,IL12B,PKP1,CD80,CD44,CXCL2,HMOX1,REG3A,GBP1,IFIH1,PIK3R3,DUSP2,PSMB9,CLEC4E,CCL4,ISG20,HBEGF,FGF20,LIF,TNFAIP3,RNF144B,IL1A,ITPR3,RASGRP1,CHIT1,FBXW10,CTSS,CCL5,TAP2,TXN,OAS2,PIM1,SERPINB3,OASL,PSME2,NEDD4L,TNFRSF9,TNFRSF1B,CLCF1,C3AR1,MAP3K8,IFI27,GPR84,CD70,TNFSF18,FTH1,CXCL8,IL11,IFNAR2,COLEC10,ORM2,NOS2,DUSP6,LCP2,SPSB4,CSF2,CCL3,NFKBIE,LCN2,TREML4,PTX3,TAP1,IL34,DDX58,DOK3,IL19,IL15RA,LRMP,OAS1,BTN3A1,TRIM36,CXCL1,IRAK2,MET,IFNGR2,ABCA13,IL17C,DUSP8,TNFRSF8,RELB,IL36G,ICOSLG,GBP2,IL36B,FGF2,ICAM4,CYLD,GBP3,S100A8,CD55,IL10,TRIM63,CD274,PSMB10,HERC6,IL7R,TNFRSF11B,NFKBIA,XAF1,IL23R,IL1B,ATP6V1C2,MUC12,CXCL10,FGR,WIPF3,MMP1,S100A7,CD300E,SH2D1B,SPTA1,CSF1,NOD2,DUSP5,GDNF,ATP6V0A4,MMP3,RNF19B,VNN1,IL23A,IRAK3,CCND1,FCER1G,ITGAM,IL32,BIRC3,ITGAX,RIPK2,MMP9,ORM1,CCL19,IL2RA,IFI6,LYN,PI3,AMPD3
R-HSA-380108	Chemokine receptors bind chemokines	1.37719177380276e-13	-29.6135597295901	48	19	0.0392561983471074	484	10287	6346,6372,7852,2920,6364,1236,2919,57007,6373,643,4283,9034,3576,6376,3627,6374,6363,2921,6352	CCL1,CXCL6,CXCR4,CXCL2,CCL20,CCR7,CXCL1,ACKR3,CXCL11,CXCR5,CXCL9,CCRL2,CXCL8,CX3CL1,CXCL10,CXCL5,CCL19,CXCL3,CCL5
R-HSA-6785807	Interleukin-4 and 13 signaling	8.67389255797904e-13	-27.7732885502614	111	27	0.0557851239669422	484	10287	51561,3592,3569,595,6288,3976,3684,149233,6347,3687,4318,3553,3576,3552,2247,5743,3593,4312,4843,3383,3561,3586,5292,3162,4314,7133,3934	IL23A,IL12A,IL6,CCND1,SAA1,LIF,ITGAM,IL23R,CCL2,ITGAX,MMP9,IL1B,CXCL8,IL1A,FGF2,PTGS2,IL12B,MMP1,NOS2,ICAM1,IL2RG,IL10,PIM1,HMOX1,MMP3,TNFRSF1B,LCN2
R-HSA-375276	Peptide ligand-binding receptors	3.3271118110956e-09	-19.5211612332925	188	30	0.0619834710743802	484	10287	2921,6352,1910,3576,718,6376,3627,2847,9283,6363,6374,6288,2151,643,9034,4283,623,719,6373,57007,10887,1236,2919,7852,6372,2920,6752,6364,6346,5021	CXCL3,CCL5,EDNRB,CXCL8,C3,CX3CL1,CXCL10,MCHR1,GPR37L1,CCL19,CXCL5,SAA1,F2RL2,CXCR5,CCRL2,CXCL9,BDKRB1,C3AR1,CXCL11,ACKR3,PROKR1,CCR7,CXCL1,CXCR4,CXCL6,CXCL2,SSTR2,CCL20,CCL1,OXTR
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	1.12162521278212e-06	-13.7007318416194	322	36	0.0743801652892562	484	10287	10887,2919,6752,6372,6346,2863,2847,6363,9283,3576,6376,718,4283,9034,2151,6288,6373,719,57007,1236,6364,7852,2920,5021,150,6352,135,1910,147,2921,3627,6374,643,134864,623,8111	PROKR1,CXCL1,SSTR2,CXCL6,CCL1,GPR39,MCHR1,CCL19,GPR37L1,CXCL8,CX3CL1,C3,CXCL9,CCRL2,F2RL2,SAA1,CXCL11,C3AR1,ACKR3,CCR7,CCL20,CXCR4,CXCL2,OXTR,ADRA2A,CCL5,ADORA2A,EDNRB,ADRA1B,CXCL3,CXCL10,CXCL5,CXCR5,TAAR1,BDKRB1,GPR68
R-HSA-909733	Interferon alpha/beta signaling	3.07430810227236e-06	-12.6924306894149	69	14	0.0289256198347107	484	10287	8638,2634,91543,4940,3455,3659,2537,3669,9636,4939,3429,3394,4938,54739	OASL,GBP2,RSAD2,OAS3,IFNAR2,IRF1,IFI6,ISG20,ISG15,OAS2,IFI27,IRF8,OAS1,XAF1
R-HSA-418594	G alpha (i) signalling events	3.21496414293873e-06	-12.6476943533886	242	29	0.0599173553719008	484	10287	623,719,5999,6373,6288,2914,643,4283,3576,718,3627,2847,9628,6374,6363,2921,6352,6004,150,5996,6372,7852,2920,6752,6364,2918,1236,2919,57007	BDKRB1,C3AR1,RGS4,CXCL11,SAA1,GRM4,CXCR5,CXCL9,CXCL8,C3,CXCL10,MCHR1,RGS6,CXCL5,CCL19,CXCL3,CCL5,RGS16,ADRA2A,RGS1,CXCL6,CXCR4,CXCL2,SSTR2,CCL20,GRM8,CCR7,CXCL1,ACKR3
R-HSA-500792	GPCR ligand binding	3.43754336131723e-06	-12.5807534808498	453	44	0.0909090909090909	484	10287	6752,6372,2863,6346,10887,2919,9034,4283,2151,6288,6373,719,11211,9283,6363,2847,6376,718,3576,1604,2918,6364,7474,2920,7852,5021,150,57007,1236,643,2914,2642,8111,623,134864,147,135,1910,6352,2921,9340,6374,90226,3627	SSTR2,CXCL6,GPR39,CCL1,PROKR1,CXCL1,CCRL2,CXCL9,F2RL2,SAA1,CXCL11,C3AR1,FZD10,GPR37L1,CCL19,MCHR1,CX3CL1,C3,CXCL8,CD55,GRM8,CCL20,WNT5A,CXCL2,CXCR4,OXTR,ADRA2A,ACKR3,CCR7,CXCR5,GRM4,GCGR,GPR68,BDKRB1,TAAR1,ADRA1B,ADORA2A,EDNRB,CCL5,CXCL3,GLP2R,CXCL5,UCN2,CXCL10
R-HSA-168249	Innate Immune System	1.76823749321783e-05	-10.942942181033	1285	92	0.190082644628099	484	10287	3659,79930,23586,114770,6280,5806,9636,3055,1437,3934,4791,4843,1848,7130,4688,3937,3561,10584,4790,5005,1540,718,6616,7097,2247,6288,5329,5971,54210,154664,629,1850,3656,4233,2069,2919,4586,4033,3725,1118,2268,1520,3553,245973,10125,3710,10071,4792,1839,26281,7128,1844,26253,8503,5698,64135,5068,5699,1604,6279,941,5317,960,3559,4067,5266,272,2495,4318,5004,2207,3684,330,3687,8767,11213,719,1326,53831,7133,8876,6317,2668,50617,5721,6708,64127,1847,644150,7295,342510,6278	IRF1,DOK3,DDX58,PGLYRP2,S100A9,PTX3,ISG15,HCK,CSF2,LCN2,NFKB2,NOS2,DUSP6,TNFAIP6,NCF2,LCP2,IL2RG,COLEC10,NFKB1,ORM2,CYLD,C3,SNAP25,TLR2,FGF2,SAA1,PLAUR,RELB,TREM1,ABCA13,CFB,DUSP8,IRAK2,MET,EREG,CXCL1,MUC5AC,LRMP,JUN,CHIT1,FGR,CTSS,IL1B,ATP6V1C2,RASGRP1,ITPR3,MUC12,NFKBIA,HBEGF,FGF20,TNFAIP3,DUSP2,CLEC4E,PIK3R3,PSMB9,IFIH1,REG3A,PSMB10,CD55,S100A8,CD80,PKP1,CD44,IL2RA,LYN,PI3,AMPD3,FTH1,MMP9,ORM1,FCER1G,ITGAM,BIRC3,ITGAX,RIPK2,IRAK3,C3AR1,MAP3K8,GPR84,TNFRSF1B,VNN1,SERPINB3,GDNF,ATP6V0A4,PSME2,SPTA1,NOD2,DUSP5,WIPF3,TXN,CD300E,S100A7
R-HSA-109582	Hemostasis	5.02744748749641e-05	-9.89801306741304	632	52	0.107438016528926	484	10287	2886,5004,4067,3559,5329,2151,2207,5327,10938,3687,3684,7273,54210,6385,9162,2152,5341,5552,5880,8140,2888,857,4312,5270,23764,10125,3710,4602,23657,5152,11343,3659,83953,9056,2268,5197,8503,3779,5055,490,3053,6547,1437,150,9732,5005,960,55619,6401,3937,4843,3561	GRB7,ORM1,LYN,IL2RA,PLAUR,F2RL2,FCER1G,PLAT,EHD1,ITGAX,ITGAM,TTN,TREM1,SDC4,DGKI,F3,PLEK,SRGN,RAC2,SLC7A5,GRB14,CAV1,MMP1,SERPINE2,MAFF,RASGRP1,ITPR3,MYB,SLC7A11,PDE9A,MGLL,IRF1,FCAMR,SLC7A7,FGR,PF4V1,PIK3R3,KCNMB1,SERPINB2,ATP2B1,SERPIND1,SLC8A3,CSF2,ADRA2A,DOCK4,ORM2,CD44,DOCK10,SELE,LCP2,NOS2,IL2RG
R-HSA-6799990	Metal sequestration by antimicrobial proteins	6.7319843318076e-05	-9.60605551606452	6	4	0.00826446280991736	484	10287	6279,3934,6280,6278	S100A8,LCN2,S100A9,S100A7
R-HSA-877300	Interferon gamma signaling	0.000117707409686732	-9.04730859167165	94	14	0.0289256198347107	484	10287	3394,960,4939,3460,115362,115361,2635,4938,3383,4940,2634,2633,8638,3659	IRF8,CD44,OAS2,IFNGR2,GBP5,GBP4,GBP3,OAS1,ICAM1,OAS3,GBP2,GBP1,OASL,IRF1
R-HSA-448706	Interleukin-1 processing	0.000151231882341077	-8.79669625440296	7	4	0.00826446280991736	484	10287	3552,3553,4790,4791	IL1A,IL1B,NFKB1,NFKB2
R-HSA-913531	Interferon Signaling	0.000191204920357796	-8.5621648235892	201	22	0.0454545454545455	484	10287	8638,2633,4938,3383,2635,115361,960,4939,3455,3659,2537,23586,4940,91543,2634,54739,9636,115362,3669,3394,3429,3460	OASL,GBP1,OAS1,ICAM1,GBP3,GBP4,CD44,OAS2,IFNAR2,IRF1,IFI6,DDX58,OAS3,RSAD2,GBP2,XAF1,ISG15,GBP5,ISG20,IRF8,IFI27,IFNGR2
R-HSA-202733	Cell surface interactions at the vascular wall	0.000210788477921134	-8.46465540160907	136	17	0.0351239669421488	484	10287	8140,6385,6401,4312,2888,960,857,5197,83953,4067,9056,2886,23657,3687,54210,3684,2207	SLC7A5,SDC4,SELE,MMP1,GRB14,CD44,CAV1,PF4V1,FCAMR,LYN,SLC7A7,GRB7,SLC7A11,ITGAX,TREM1,ITGAM,FCER1G
R-HSA-71240	Tryptophan catabolism	0.000212202083909203	-8.45797151133684	13	5	0.0103305785123967	484	10287	3620,8942,6999,8564,8140	IDO1,KYNU,TDO2,KMO,SLC7A5
R-HSA-446652	Interleukin-1 signaling	0.000243394474152068	-8.32082708041273	46	9	0.0185950413223141	484	10287	11213,1326,4790,64127,8767,3557,3553,3552,3656	IRAK3,MAP3K8,NFKB1,NOD2,RIPK2,IL1RN,IL1B,IL1A,IRAK2
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.000308902174125765	-8.08248591978103	29	7	0.0144628099173554	484	10287	4790,4791,8767,64127,6288,3656,4792	NFKB1,NFKB2,RIPK2,NOD2,SAA1,IRAK2,NFKBIA
R-HSA-1474244	Extracellular matrix organization	0.000332326580458506	-8.00939239646022	296	28	0.0578512396694215	484	10287	4319,3386,56999,1520,169044,4318,4321,375790,2247,10516,9378,3684,3687,3914,3918,1294,63923,1305,4314,4316,6385,4322,27302,650,3383,9507,960,4312	MMP10,ICAM4,ADAMTS9,CTSS,COL22A1,MMP9,MMP12,AGRN,FGF2,FBLN5,NRXN1,ITGAM,ITGAX,LAMB3,LAMC2,COL7A1,TNN,COL13A1,MMP3,MMP7,SDC4,MMP13,BMP10,BMP2,ICAM1,ADAMTS4,CD44,MMP1
R-HSA-1442490	Collagen degradation	0.000459946806322076	-7.68439971359804	40	8	0.0165289256198347	484	10287	4322,4321,4318,4316,1305,4319,4314,4312	MMP13,MMP12,MMP9,MMP7,COL13A1,MMP10,MMP3,MMP1
R-HSA-1474228	Degradation of the extracellular matrix	0.000683649501836234	-7.28806519589191	111	14	0.0289256198347107	484	10287	9507,4312,3918,960,3914,4316,56999,1520,4319,4314,1305,4322,4318,4321	ADAMTS4,MMP1,LAMC2,CD44,LAMB3,MMP7,ADAMTS9,CTSS,MMP10,MMP3,COL13A1,MMP13,MMP9,MMP12
R-HSA-168898	Toll-Like Receptors Cascades	0.000843084888270825	-7.07844290720194	153	17	0.0351239669421488	484	10287	7097,1520,6280,1326,11213,6288,4792,8767,330,3684,3656,4791,4790,3725,1848,64127,6279	TLR2,CTSS,S100A9,MAP3K8,IRAK3,SAA1,NFKBIA,RIPK2,BIRC3,ITGAM,IRAK2,NFKB2,NFKB1,JUN,DUSP6,NOD2,S100A8
R-HSA-933542	TRAF6 mediated NF-kB activation	0.000866242654523815	-7.0513454871223	25	6	0.012396694214876	484	10287	23586,4790,4791,64135,4792,6288	DDX58,NFKB1,NFKB2,IFIH1,NFKBIA,SAA1
R-HSA-6783589	Interleukin-6 family signaling	0.00133659487901368	-6.61763003424757	27	6	0.012396694214876	484	10287	23529,3976,3589,3569,10148,3592	CLCF1,LIF,IL11,IL6,EBI3,IL12A
R-HSA-5689896	Ovarian tumor domain proteases	0.00147085453454693	-6.52191173107188	37	7	0.0144628099173554	484	10287	23586,10318,8767,7128,64127,79931,64135	DDX58,TNIP1,RIPK2,TNFAIP3,NOD2,TNIP3,IFIH1
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.00159994710189452	-6.43778471159887	95	12	0.0247933884297521	484	10287	6288,1848,4792,8767,64127,1326,11213,4790,3725,3656,4791,7097	SAA1,DUSP6,NFKBIA,RIPK2,NOD2,MAP3K8,IRAK3,NFKB1,JUN,IRAK2,NFKB2,TLR2
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.00159994710189452	-6.43778471159887	95	12	0.0247933884297521	484	10287	4791,3656,7097,8767,64127,1848,6288,4792,3725,4790,11213,1326	NFKB2,IRAK2,TLR2,RIPK2,NOD2,DUSP6,SAA1,NFKBIA,JUN,NFKB1,IRAK3,MAP3K8
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.00159994710189452	-6.43778471159887	95	12	0.0247933884297521	484	10287	7097,4791,3656,3725,11213,4790,1326,8767,64127,6288,1848,4792	TLR2,NFKB2,IRAK2,JUN,IRAK3,NFKB1,MAP3K8,RIPK2,NOD2,SAA1,DUSP6,NFKBIA
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.00159994710189452	-6.43778471159887	95	12	0.0247933884297521	484	10287	1848,6288,4792,8767,64127,4790,11213,1326,3725,3656,4791,7097	DUSP6,SAA1,NFKBIA,RIPK2,NOD2,NFKB1,IRAK3,MAP3K8,JUN,IRAK2,NFKB2,TLR2
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	0.0019442766823842	-6.242865256742	20	5	0.0103305785123967	484	10287	10148,3592,23529,3976,3589	EBI3,IL12A,CLCF1,LIF,IL11
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.00235777925990305	-6.05003509452162	126	14	0.0289256198347107	484	10287	4792,6288,1848,330,3684,64127,8767,11213,4790,1326,3725,3656,4791,7097	NFKBIA,SAA1,DUSP6,BIRC3,ITGAM,NOD2,RIPK2,IRAK3,NFKB1,MAP3K8,JUN,IRAK2,NFKB2,TLR2
R-HSA-5669034	TNFs bind their physiological receptors	0.00237875609624047	-6.04117757656562	30	6	0.012396694214876	484	10287	943,7133,3604,4982,8995,970	TNFRSF8,TNFRSF1B,TNFRSF9,TNFRSF11B,TNFSF18,CD70
R-HSA-75205	Dissolution of Fibrin Clot	0.00246367660745491	-6.00610048889897	13	4	0.00826446280991736	484	10287	5055,5270,5329,5327	SERPINB2,SERPINE2,PLAUR,PLAT
R-HSA-166054	Activated TLR4 signalling	0.0028610067433262	-5.8565817079347	115	13	0.0268595041322314	484	10287	3725,11213,4790,1326,64127,330,8767,4792,6288,1848,7097,4791,3656	JUN,IRAK3,NFKB1,MAP3K8,NOD2,BIRC3,RIPK2,NFKBIA,SAA1,DUSP6,TLR2,NFKB2,IRAK2
R-HSA-5603029	IkBA variant leads to EDA-ID	0.00314310603877715	-5.76254378365846	7	3	0.00619834710743802	484	10287	4791,4792,4790	NFKB2,NFKBIA,NFKB1
R-HSA-168638	NOD1/2 Signaling Pathway	0.00335266618815651	-5.69799937262573	32	6	0.012396694214876	484	10287	3656,8767,7128,64127,330,1540	IRAK2,RIPK2,TNFAIP3,NOD2,BIRC3,CYLD
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.00335266618815651	-5.69799937262573	32	6	0.012396694214876	484	10287	4312,4322,4318,4316,4314,4319	MMP1,MMP13,MMP9,MMP7,MMP3,MMP10
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.00345646760427594	-5.66750813502966	104	12	0.0247933884297521	484	10287	5698,970,943,330,5971,8995,5721,5699,3604,7133,4791,4982	PSMB9,CD70,TNFRSF8,BIRC3,RELB,TNFSF18,PSME2,PSMB10,TNFRSF9,TNFRSF1B,NFKB2,TNFRSF11B
R-HSA-114604	GPVI-mediated activation cascade	0.00349739370009592	-5.65573724499705	54	8	0.0165289256198347	484	10287	3937,2207,3561,8503,5880,1437,3559,4067	LCP2,FCER1G,IL2RG,PIK3R3,RAC2,CSF2,IL2RA,LYN
R-HSA-112409	RAF-independent MAPK1/3 activation	0.00375546093891562	-5.58454424792662	23	5	0.0103305785123967	484	10287	1847,1848,1850,3569,1844	DUSP5,DUSP6,DUSP8,IL6,DUSP2
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.00436379196231419	-5.43441388347801	15	4	0.00826446280991736	484	10287	9420,1645,1581,1646	CYP7B1,AKR1C1,CYP7A1,AKR1C2
R-HSA-425407	SLC-mediated transmembrane transport	0.00448456074485417	-5.40711472698471	287	24	0.0495867768595041	484	10287	115019,51296,51458,6506,84102,6580,124935,8140,64849,6513,64116,6547,3099,64078,11182,28232,6542,80736,6534,23657,8671,28231,23382,9056	SLC26A9,SLC15A3,RHCG,SLC1A2,SLC41A2,SLC22A1,SLC43A2,SLC7A5,SLC13A3,SLC2A1,SLC39A8,SLC8A3,HK2,SLC28A3,SLC2A6,SLCO3A1,SLC7A2,SLC44A4,SLC6A7,SLC7A11,SLC4A4,SLCO4A1,AHCYL2,SLC7A7
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.00485423686701	-5.32790337455559	8	3	0.00619834710743802	484	10287	4792,4791,4790	NFKBIA,NFKB2,NFKB1
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.00587236639530103	-5.13749759259661	84	10	0.0206611570247934	484	10287	4790,1326,3725,6288,1848,4792,8767,64127,3656,4791	NFKB1,MAP3K8,JUN,SAA1,DUSP6,NFKBIA,RIPK2,NOD2,IRAK2,NFKB2
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.00587236639530103	-5.13749759259661	84	10	0.0206611570247934	484	10287	23586,4791,1540,3659,64135,9636,4790,7128,6288,4792	DDX58,NFKB2,CYLD,IRF1,IFIH1,ISG15,NFKB1,TNFAIP3,SAA1,NFKBIA
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.00587236639530103	-5.13749759259661	84	10	0.0206611570247934	484	10287	64127,8767,4792,1848,6288,3725,1326,4790,4791,3656	NOD2,RIPK2,NFKBIA,DUSP6,SAA1,JUN,MAP3K8,NFKB1,NFKB2,IRAK2
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.00587236639530103	-5.13749759259661	84	10	0.0206611570247934	484	10287	4791,3656,3725,4790,1326,64127,8767,4792,1848,6288	NFKB2,IRAK2,JUN,NFKB1,MAP3K8,NOD2,RIPK2,NFKBIA,DUSP6,SAA1
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.00590164431963458	-5.13252426865645	443	33	0.0681818181818182	484	10287	1910,147,11343,3710,10125,1839,2642,26281,8111,8503,1844,5698,623,1437,5699,3561,1848,5021,3559,2247,2847,6288,2151,1850,10887,4314,4233,5721,2069,9162,2668,1847,6708	EDNRB,ADRA1B,MGLL,ITPR3,RASGRP1,HBEGF,GCGR,FGF20,GPR68,PIK3R3,DUSP2,PSMB9,BDKRB1,CSF2,PSMB10,IL2RG,DUSP6,OXTR,IL2RA,FGF2,MCHR1,SAA1,F2RL2,DUSP8,PROKR1,MMP3,MET,PSME2,EREG,DGKI,GDNF,DUSP5,SPTA1
R-HSA-351200	Interconversion of polyamines	0.00642086266713261	-5.04820279847984	3	2	0.00413223140495868	484	10287	54498,6303	SMOX,SAT1
R-HSA-210991	Basigin interactions	0.00653669475939635	-5.03032362973633	26	5	0.0103305785123967	484	10287	9056,8140,23657,857,4312	SLC7A7,SLC7A5,SLC7A11,CAV1,MMP1
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.00667417798461366	-5.00950923065169	99	11	0.0227272727272727	484	10287	4790,1326,3725,6288,1848,4792,8767,330,64127,3656,4791	NFKB1,MAP3K8,JUN,SAA1,DUSP6,NFKBIA,RIPK2,BIRC3,NOD2,IRAK2,NFKB2
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.00667417798461366	-5.00950923065169	99	11	0.0227272727272727	484	10287	4791,3656,3725,4790,1326,8767,64127,330,1848,6288,4792	NFKB2,IRAK2,JUN,NFKB1,MAP3K8,RIPK2,NOD2,BIRC3,DUSP6,SAA1,NFKBIA
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.00667417798461366	-5.00950923065169	99	11	0.0227272727272727	484	10287	3656,4791,4790,1326,3725,6288,1848,4792,8767,64127,330	IRAK2,NFKB2,NFKB1,MAP3K8,JUN,SAA1,DUSP6,NFKBIA,RIPK2,NOD2,BIRC3
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.00672971750294731	-5.00122211199443	60	8	0.0165289256198347	484	10287	3918,1294,3914,1520,4316,4314,4322,4318	LAMC2,COL7A1,LAMB3,CTSS,MMP7,MMP3,MMP13,MMP9
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.00674201314979157	-4.99939671174328	48	7	0.0144628099173554	484	10287	7128,8767,1540,64127,330,3656,7295	TNFAIP3,RIPK2,CYLD,NOD2,BIRC3,IRAK2,TXN
R-HSA-2214320	Anchoring fibril formation	0.00702898277072308	-4.9577132819618	9	3	0.00619834710743802	484	10287	3918,1294,3914	LAMC2,COL7A1,LAMB3
R-HSA-8854691	Interleukin-19, 20, 22, 24	0.00702898277072308	-4.9577132819618	9	3	0.00619834710743802	484	10287	11009,29949,50604	IL24,IL19,IL20
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.00702898277072308	-4.9577132819618	9	3	0.00619834710743802	484	10287	27113,637,5366	BBC3,BID,PMAIP1
R-HSA-193639	p75NTR signals via NF-kB	0.00706114436010348	-4.95314814994604	17	4	0.00826446280991736	484	10287	8767,4803,4792,4790	RIPK2,NGF,NFKBIA,NFKB1
R-HSA-5621481	C-type lectin receptors (CLRs)	0.007822912566383	-4.85069834282343	144	14	0.0289256198347107	484	10287	26253,5698,4790,4586,2207,4792,5971,3710,10071,3553,5699,5721,4067,4791	CLEC4E,PSMB9,NFKB1,MUC5AC,FCER1G,NFKBIA,RELB,ITPR3,MUC12,IL1B,PSMB10,PSME2,LYN,NFKB2
R-HSA-5621480	Dectin-2 family	0.00904114269685982	-4.70596970804654	28	5	0.0103305785123967	484	10287	4067,4586,2207,10071,26253	LYN,MUC5AC,FCER1G,MUC12,CLEC4E
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.0102204957625482	-4.58336018632751	91	10	0.0206611570247934	484	10287	3656,4791,4792,6288,1848,64127,8767,1326,4790,3725	IRAK2,NFKB2,NFKBIA,SAA1,DUSP6,NOD2,RIPK2,MAP3K8,NFKB1,JUN
R-HSA-913709	O-linked glycosylation of mucins	0.010830244564569	-4.52541263608488	65	8	0.0165289256198347	484	10287	6482,4586,10071,51301,50614,79623,6484,10164	ST3GAL1,MUC5AC,MUC12,GCNT4,GALNT9,GALNT14,ST3GAL4,CHST4
R-HSA-382551	Transmembrane transport of small molecules	0.0113443045209479	-4.47903946532242	677	45	0.0929752066115702	484	10287	26154,23382,2495,6534,64078,11182,6542,8140,1080,23327,6506,50617,366,5721,124935,4645,115019,28231,8671,9056,6338,23657,266675,245973,8714,28232,80736,5698,4363,64849,6513,3934,64116,6547,6446,3099,84102,6580,5699,3162,490,24,8989,51458,51296	ABCA12,AHCYL2,FTH1,SLC6A7,SLC28A3,SLC2A6,SLC7A2,SLC7A5,CFTR,NEDD4L,SLC1A2,ATP6V0A4,AQP9,PSME2,SLC43A2,MYO5B,SLC26A9,SLCO4A1,SLC4A4,SLC7A7,SCNN1B,SLC7A11,BEST4,ATP6V1C2,ABCC3,SLCO3A1,SLC44A4,PSMB9,ABCC1,SLC13A3,SLC2A1,LCN2,SLC39A8,SLC8A3,SGK1,HK2,SLC41A2,SLC22A1,PSMB10,HMOX1,ATP2B1,ABCA4,TRPA1,RHCG,SLC15A3
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.0117434049819435	-4.44446347409998	107	11	0.0227272727272727	484	10287	8140,8671,23382,9056,6547,6506,23657,124935,115019,6542,51296	SLC7A5,SLC4A4,AHCYL2,SLC7A7,SLC8A3,SLC1A2,SLC7A11,SLC43A2,SLC26A9,SLC7A2,SLC15A3
R-HSA-1474290	Collagen formation	0.0118266816969361	-4.43739713933007	93	10	0.0206611570247934	484	10287	1520,169044,4316,4314,1305,4322,4318,1294,3918,3914	CTSS,COL22A1,MMP7,MMP3,COL13A1,MMP13,MMP9,COL7A1,LAMC2,LAMB3
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.0118266816969361	-4.43739713933007	93	10	0.0206611570247934	484	10287	3656,4791,1326,4790,3725,4792,6288,1848,64127,8767	IRAK2,NFKB2,MAP3K8,NFKB1,JUN,NFKBIA,SAA1,DUSP6,NOD2,RIPK2
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.0118266816969361	-4.43739713933007	93	10	0.0206611570247934	484	10287	1848,6288,4792,8767,64127,1326,4790,3725,3656,4791	DUSP6,SAA1,NFKBIA,RIPK2,NOD2,MAP3K8,NFKB1,JUN,IRAK2,NFKB2
R-HSA-173736	Alternative complement activation	0.0124421010874193	-4.3866693082302	4	2	0.00413223140495868	484	10287	718,629	C3,CFB
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.0124421010874193	-4.3866693082302	4	2	0.00413223140495868	484	10287	9353,6092	SLIT2,ROBO2
R-HSA-447115	Interleukin-12 signaling	0.0124421010874193	-4.3866693082302	4	2	0.00413223140495868	484	10287	3592,3593	IL12A,IL12B
R-HSA-372790	Signaling by GPCR	0.0126521536640657	-4.36992782817575	1299	78	0.161157024793388	484	10287	8111,623,134864,5999,2921,90226,1848,6364,3561,26575,5996,1437,57007,1236,5142,6288,9034,4283,6373,1850,718,9283,2247,6752,6004,4233,10887,2069,9162,2919,2642,283365,2914,1839,26281,643,5698,1844,8503,9340,1910,135,147,6352,64108,3710,10125,11343,6374,3627,2920,7852,1604,2918,7474,150,5021,5699,2151,719,53831,3559,11211,6376,3576,9628,6363,2847,6372,6708,1847,26230,2863,6346,5880,4314,2668,5721	GPR68,BDKRB1,TAAR1,RGS4,CXCL3,UCN2,DUSP6,CCL20,IL2RG,RGS17,RGS1,CSF2,ACKR3,CCR7,PDE4B,SAA1,CCRL2,CXCL9,CXCL11,DUSP8,C3,GPR37L1,FGF2,SSTR2,RGS16,MET,PROKR1,EREG,DGKI,CXCL1,GCGR,OR6C6,GRM4,HBEGF,FGF20,CXCR5,PSMB9,DUSP2,PIK3R3,GLP2R,EDNRB,ADORA2A,ADRA1B,CCL5,RTP4,ITPR3,RASGRP1,MGLL,CXCL5,CXCL10,CXCL2,CXCR4,CD55,GRM8,WNT5A,ADRA2A,OXTR,PSMB10,F2RL2,C3AR1,GPR84,IL2RA,FZD10,CX3CL1,CXCL8,RGS6,CCL19,MCHR1,CXCL6,SPTA1,DUSP5,TIAM2,GPR39,CCL1,RAC2,MMP3,GDNF,PSME2
R-HSA-6798695	Neutrophil degranulation	0.0134486256797611	-4.30887835809842	487	34	0.0702479338842975	484	10287	53831,154664,719,3687,3684,5329,2207,7097,5004,6616,2495,4318,718,272,6278,4033,2919,6317,8876,7133,5806,6280,79930,1520,2268,1118,5005,960,5317,4790,1604,6279,7130,3934	GPR84,ABCA13,C3AR1,ITGAX,ITGAM,PLAUR,FCER1G,TLR2,ORM1,SNAP25,FTH1,MMP9,C3,AMPD3,S100A7,LRMP,CXCL1,SERPINB3,VNN1,TNFRSF1B,PTX3,S100A9,DOK3,CTSS,FGR,CHIT1,ORM2,CD44,PKP1,NFKB1,CD55,S100A8,TNFAIP6,LCN2
R-HSA-2871796	FCERI mediated MAPK activation	0.0134810756400074	-4.30646838142867	265	21	0.0433884297520661	484	10287	1848,6708,3937,1847,3561,3725,1437,4233,2069,2668,5721,5699,1839,26281,5698,1844,1850,3559,4067,10125,2247	DUSP6,SPTA1,LCP2,DUSP5,IL2RG,JUN,CSF2,MET,EREG,GDNF,PSME2,PSMB10,HBEGF,FGF20,PSMB9,DUSP2,DUSP8,IL2RA,LYN,RASGRP1,FGF2
R-HSA-352230	Amino acid transport across the plasma membrane	0.0139280969701547	-4.27384711429503	31	5	0.0103305785123967	484	10287	9056,8140,6542,23657,124935	SLC7A7,SLC7A5,SLC7A2,SLC7A11,SLC43A2
R-HSA-162582	Signal Transduction	0.0141023981107471	-4.26141041728338	2548	141	0.291322314049587	484	10287	1437,57007,1236,1848,8828,5996,6658,8111,623,3914,3918,4233,2919,23767,10252,3624,1540,9283,2247,64321,9938,83595,284654,9034,8313,1850,116984,10046,24,5699,1604,150,4023,5021,6484,135,147,245973,6374,11343,3627,91010,4792,2642,27121,4314,6385,2668,50617,6372,6708,1847,26230,644150,23002,2863,3559,11211,4067,6376,4318,54567,9628,6363,595,5327,330,8767,658,5142,64220,4688,650,6364,3561,4790,26575,2921,195814,90226,375790,134864,5999,1080,10887,2069,9162,6752,857,6004,1030,3725,718,92737,84870,5957,6288,4283,3569,6373,7185,83478,2920,23286,7852,2918,7474,941,9340,1910,6352,64108,3710,4629,10125,2914,1839,113878,283365,26281,1645,643,7128,1844,5698,8503,23327,5880,4803,2986,5721,6461,6346,3576,2886,51176,2847,2151,719,53831,723790	CSF2,ACKR3,CCR7,DUSP6,NRP2,RGS1,SOX3,GPR68,BDKRB1,LAMB3,LAMC2,MET,CXCL1,FLRT3,SPRY1,INHBA,CYLD,GPR37L1,FGF2,SOX17,ARHGAP25,SOX7,RSPO1,CCRL2,AXIN2,DUSP8,ARAP2,MAMLD1,ABCA4,PSMB10,CD55,ADRA2A,LPL,OXTR,ST3GAL4,ADORA2A,ADRA1B,ATP6V1C2,CXCL5,MGLL,CXCL10,FMNL3,NFKBIA,GCGR,DKK4,MMP3,SDC4,GDNF,ATP6V0A4,CXCL6,SPTA1,DUSP5,TIAM2,WIPF3,DAAM1,GPR39,IL2RA,FZD10,LYN,CX3CL1,MMP9,DLL4,RGS6,CCL19,CCND1,PLAT,BIRC3,RIPK2,BMPR1B,PDE4B,STRA6,NCF2,BMP2,CCL20,IL2RG,NFKB1,RGS17,CXCL3,SDR16C5,UCN2,AGRN,TAAR1,RGS4,CFTR,PROKR1,EREG,DGKI,SSTR2,CAV1,RGS16,CDKN2B,JUN,C3,DNER,RSPO3,RCVRN,SAA1,CXCL9,IL6,CXCL11,TRAF1,ARHGAP24,CXCL2,WWC1,CXCR4,GRM8,WNT5A,CD80,GLP2R,EDNRB,CCL5,RTP4,ITPR3,MYH11,RASGRP1,GRM4,HBEGF,DTX2,OR6C6,FGF20,AKR1C1,CXCR5,TNFAIP3,DUSP2,PSMB9,PIK3R3,NEDD4L,RAC2,NGF,GUCY2F,PSME2,SHB,CCL1,CXCL8,GRB7,LEF1,MCHR1,F2RL2,C3AR1,GPR84,HIST2H2AA4
R-HSA-194068	Bile acid and bile salt metabolism	0.0146036440525205	-4.22648418877251	43	6	0.012396694214876	484	10287	9420,1645,9023,1581,8714,1646	CYP7B1,AKR1C1,CH25H,CYP7A1,ABCC3,AKR1C2
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.0153053282097918	-4.17955426220236	21	4	0.00826446280991736	484	10287	6288,4792,4791,4790	SAA1,NFKBIA,NFKB2,NFKB1
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	0.0153053282097918	-4.17955426220236	21	4	0.00826446280991736	484	10287	8626,5366,27113,637	TP63,PMAIP1,BBC3,BID
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.0153053282097918	-4.17955426220236	21	4	0.00826446280991736	484	10287	4312,3484,5069,60676	MMP1,IGFBP1,PAPPA,PAPPA2
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.0156023351133782	-4.16033468917358	97	10	0.0206611570247934	484	10287	1848,6288,4792,8767,64127,1326,4790,3725,3656,4791	DUSP6,SAA1,NFKBIA,RIPK2,NOD2,MAP3K8,NFKB1,JUN,IRAK2,NFKB2
R-HSA-196071	Metabolism of steroid hormones	0.0158865100780831	-4.14228495263231	32	5	0.0103305785123967	484	10287	231,6716,441282,1586,3290	AKR1B1,SRD5A2,AKR1B15,CYP17A1,HSD11B1
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.0162584766751764	-4.11914086466473	44	6	0.012396694214876	484	10287	3620,8942,6999,259307,8140,8564	IDO1,KYNU,TDO2,IL4I1,SLC7A5,KMO
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.0165659391836893	-4.10040654796521	372	27	0.0557851239669422	484	10287	2069,2668,5699,5721,1437,4233,4790,941,3725,3937,6708,1848,1847,3561,10125,3710,2247,3559,4067,1844,8503,5698,1850,1839,4792,26281,2207	EREG,GDNF,PSMB10,PSME2,CSF2,MET,NFKB1,CD80,JUN,LCP2,SPTA1,DUSP6,DUSP5,IL2RG,RASGRP1,ITPR3,FGF2,IL2RA,LYN,DUSP2,PIK3R3,PSMB9,DUSP8,HBEGF,NFKBIA,FGF20,FCER1G
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.0169613818456161	-4.0768161751912	271	21	0.0433884297520661	484	10287	26281,1839,8503,1844,5698,1850,3055,4067,3559,10125,2247,1848,6708,1847,3561,4233,1437,2668,2069,5699,5721	FGF20,HBEGF,PIK3R3,DUSP2,PSMB9,DUSP8,HCK,LYN,IL2RA,RASGRP1,FGF2,DUSP6,SPTA1,DUSP5,IL2RG,MET,CSF2,GDNF,EREG,PSMB10,PSME2
R-HSA-196854	Metabolism of vitamins and cofactors	0.0171471509904746	-4.06592324217454	174	15	0.0309917355371901	484	10287	4023,4363,1591,1645,441024,10135,8875,952,375790,6385,6513,5743,8876,54625,1594	LPL,ABCC1,CYP24A1,AKR1C1,MTHFD2L,NAMPT,VNN2,CD38,AGRN,SDC4,SLC2A1,PTGS2,VNN1,PARP14,CYP27B1
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0180383423109315	-4.01525565820772	45	6	0.012396694214876	484	10287	9378,6385,3914,375790,3918,2247	NRXN1,SDC4,LAMB3,AGRN,LAMC2,FGF2
R-HSA-2142850	Hyaluronan biosynthesis and export	0.0200941037785174	-3.90732885130335	5	2	0.00413223140495868	484	10287	3038,3036	HAS3,HAS1
R-HSA-192105	Synthesis of bile acids and bile salts	0.0203346744876004	-3.89542774724552	34	5	0.0103305785123967	484	10287	1645,9420,1646,1581,9023	AKR1C1,CYP7B1,AKR1C2,CYP7A1,CH25H
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.0208012578823234	-3.87274181899171	13	3	0.00619834710743802	484	10287	4790,6288,4791	NFKB1,SAA1,NFKB2
R-HSA-2029481	FCGR activation	0.0208012578823234	-3.87274181899171	13	3	0.00619834710743802	484	10287	3055,4067,2268	HCK,LYN,FGR
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.0243259516460472	-3.71621152953566	24	4	0.00826446280991736	484	10287	1645,9420,1646,1581	AKR1C1,CYP7B1,AKR1C2,CYP7A1
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.0243259516460472	-3.71621152953566	24	4	0.00826446280991736	484	10287	4790,7097,4792,4791	NFKB1,TLR2,NFKBIA,NFKB2
R-HSA-5260271	Diseases of Immune System	0.0243259516460472	-3.71621152953566	24	4	0.00826446280991736	484	10287	4792,4791,4790,7097	NFKBIA,NFKB2,NFKB1,TLR2
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.0255265746840699	-3.66803522499999	36	5	0.0103305785123967	484	10287	9636,23586,1540,7128,64135	ISG15,DDX58,CYLD,TNFAIP3,IFIH1
R-HSA-209560	NF-kB is activated and signals survival	0.0255682761308547	-3.66640290959525	14	3	0.00619834710743802	484	10287	4790,4792,4803	NFKB1,NFKBIA,NGF
R-HSA-187706	Signalling to p38 via RIT and RIN	0.0258266395564692	-3.65634877880989	249	19	0.0392561983471074	484	10287	5698,1844,1850,1839,26281,10125,2247,3559,6708,1848,1847,3561,2069,2668,5699,5721,1437,4233,4803	PSMB9,DUSP2,DUSP8,HBEGF,FGF20,RASGRP1,FGF2,IL2RA,SPTA1,DUSP6,DUSP5,IL2RG,EREG,GDNF,PSMB10,PSME2,CSF2,MET,NGF
R-HSA-170984	ARMS-mediated activation	0.0258266395564692	-3.65634877880989	249	19	0.0392561983471074	484	10287	6708,1848,3561,1847,1437,4233,4803,2069,2668,5699,5721,1839,26281,1844,5698,1850,3559,10125,2247	SPTA1,DUSP6,IL2RG,DUSP5,CSF2,MET,NGF,EREG,GDNF,PSMB10,PSME2,HBEGF,FGF20,DUSP2,PSMB9,DUSP8,IL2RA,RASGRP1,FGF2
R-HSA-422475	Axon guidance	0.0266668605074583	-3.6243336639731	549	36	0.0743801652892562	484	10287	1437,5699,80031,3561,1848,8828,286,375790,9353,4629,10125,26281,1943,1839,5698,8503,1844,4233,5880,5721,2668,2069,1847,6461,6708,2048,27289,4067,6092,214,137970,3559,2247,2886,4318,1850	CSF2,PSMB10,SEMA6D,IL2RG,DUSP6,NRP2,ANK1,AGRN,SLIT2,MYH11,RASGRP1,FGF20,EFNA2,HBEGF,PSMB9,PIK3R3,DUSP2,MET,RAC2,PSME2,GDNF,EREG,DUSP5,SHB,SPTA1,EPHB2,RND1,LYN,ROBO2,ALCAM,UNC5D,IL2RA,FGF2,GRB7,MMP9,DUSP8
R-HSA-170968	Frs2-mediated activation	0.0267790986377587	-3.62013359732294	250	19	0.0392561983471074	484	10287	5698,1844,1850,1839,26281,10125,2247,3559,1848,6708,3561,1847,2069,2668,5699,5721,1437,4233,4803	PSMB9,DUSP2,DUSP8,HBEGF,FGF20,RASGRP1,FGF2,IL2RA,DUSP6,SPTA1,IL2RG,DUSP5,EREG,GDNF,PSMB10,PSME2,CSF2,MET,NGF
R-HSA-5684996	MAPK1/MAPK3 signaling	0.0277579057505741	-3.58423458745111	251	19	0.0392561983471074	484	10287	1437,4233,2069,2668,5699,5721,1848,6708,1847,3561,3559,10125,2247,1839,26281,5698,1844,3569,1850	CSF2,MET,EREG,GDNF,PSMB10,PSME2,DUSP6,SPTA1,DUSP5,IL2RG,IL2RA,RASGRP1,FGF2,HBEGF,FGF20,PSMB9,DUSP2,IL6,DUSP8
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.0279141886987281	-3.57862016391538	25	4	0.00826446280991736	484	10287	4790,4791,6288,4792	NFKB1,NFKB2,SAA1,NFKBIA
R-HSA-977068	Termination of O-glycan biosynthesis	0.0279141886987281	-3.57862016391538	25	4	0.00826446280991736	484	10287	4586,6484,10071,6482	MUC5AC,ST3GAL4,MUC12,ST3GAL1
R-HSA-169893	Prolonged ERK activation events	0.0287634740657557	-3.54864895837033	252	19	0.0392561983471074	484	10287	2069,2668,5721,5699,1437,4233,4803,1848,6708,3561,1847,10125,2247,3559,1844,5698,1850,1839,26281	EREG,GDNF,PSME2,PSMB10,CSF2,MET,NGF,DUSP6,SPTA1,IL2RG,DUSP5,RASGRP1,FGF2,IL2RA,DUSP2,PSMB9,DUSP8,HBEGF,FGF20
R-HSA-211916	Vitamins	0.0292107185389262	-3.53321956381191	6	2	0.00413223140495868	484	10287	1591,1594	CYP24A1,CYP27B1
R-HSA-5660668	CLEC7A/inflammasome pathway	0.0292107185389262	-3.53321956381191	6	2	0.00413223140495868	484	10287	3553,4790	IL1B,NFKB1
R-HSA-187015	Activation of TRKA receptors	0.0292107185389262	-3.53321956381191	6	2	0.00413223140495868	484	10287	135,4803	ADORA2A,NGF
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.0292107185389262	-3.53321956381191	6	2	0.00413223140495868	484	10287	247,5743	ALOX15B,PTGS2
R-HSA-5336415	Uptake and function of diphtheria toxin	0.0292107185389262	-3.53321956381191	6	2	0.00413223140495868	484	10287	7296,1839	TXNRD1,HBEGF
R-HSA-8853659	RET signaling	0.029818017378333	-3.5126424581626	270	20	0.0413223140495868	484	10287	3561,1847,6708,1848,4233,1437,5721,5699,2668,2069,26281,1839,1850,1844,5698,8503,3559,2247,2886,10125	IL2RG,DUSP5,SPTA1,DUSP6,MET,CSF2,PSME2,PSMB10,GDNF,EREG,FGF20,HBEGF,DUSP8,DUSP2,PSMB9,PIK3R3,IL2RA,FGF2,GRB7,RASGRP1
R-HSA-450294	MAP kinase activation in TLR cascade	0.0300128710433131	-3.50612895455198	64	7	0.0144628099173554	484	10287	3725,4790,1326,8767,64127,1848,3656	JUN,NFKB1,MAP3K8,RIPK2,NOD2,DUSP6,IRAK2
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.031801005778403	-3.4482573614445	26	4	0.00826446280991736	484	10287	1540,330,7128,7185	CYLD,BIRC3,TNFAIP3,TRAF1
R-HSA-912526	Interleukin receptor SHC signaling	0.031944829632434	-3.44374493809484	255	19	0.0392561983471074	484	10287	6708,1848,3561,1847,1437,4233,2069,2668,5699,5721,1839,26281,1844,8503,5698,1850,3559,10125,2247	SPTA1,DUSP6,IL2RG,DUSP5,CSF2,MET,EREG,GDNF,PSMB10,PSME2,HBEGF,FGF20,DUSP2,PIK3R3,PSMB9,DUSP8,IL2RA,RASGRP1,FGF2
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.0323280156187354	-3.43182106807272	65	7	0.0144628099173554	484	10287	1839,4233,26281,2247,2069,941,8503	HBEGF,MET,FGF20,FGF2,EREG,CD80,PIK3R3
R-HSA-167044	Signalling to RAS	0.0330615079782321	-3.40938557425287	256	19	0.0392561983471074	484	10287	1839,26281,5698,1844,1850,3559,10125,2247,6708,1848,3561,1847,1437,4233,4803,2069,2668,5721,5699	HBEGF,FGF20,PSMB9,DUSP2,DUSP8,IL2RA,RASGRP1,FGF2,SPTA1,DUSP6,IL2RG,DUSP5,CSF2,MET,NGF,EREG,GDNF,PSME2,PSMB10
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.035381578535979	-3.34156397462682	258	19	0.0392561983471074	484	10287	1848,6708,1847,3561,2069,2668,5721,5699,1437,4233,1844,5698,1850,1839,26281,10125,3710,2247,3559	DUSP6,SPTA1,DUSP5,IL2RG,EREG,GDNF,PSME2,PSMB10,CSF2,MET,DUSP2,PSMB9,DUSP8,HBEGF,FGF20,RASGRP1,ITPR3,FGF2,IL2RA
R-HSA-400685	Sema4D in semaphorin signaling	0.0359892614547124	-3.32453467794887	27	4	0.00826446280991736	484	10287	4629,4233,27289,5880	MYH11,MET,RND1,RAC2
R-HSA-114508	Effects of PIP2 hydrolysis	0.0359892614547124	-3.32453467794887	27	4	0.00826446280991736	484	10287	11343,10125,3710,9162	MGLL,RASGRP1,ITPR3,DGKI
R-HSA-977606	Regulation of Complement cascade	0.0359892614547124	-3.32453467794887	27	4	0.00826446280991736	484	10287	1604,629,718,719	CD55,CFB,C3,C3AR1
R-HSA-380994	ATF4 activates genes	0.0359892614547124	-3.32453467794887	27	4	0.00826446280991736	484	10287	6347,467,3484,3576	CCL2,ATF3,IGFBP1,CXCL8
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.0366996537464002	-3.30498795866911	16	3	0.00619834710743802	484	10287	8091,3159,3008	HMGA2,HMGA1,HIST1H1E
R-HSA-5686938	Regulation of TLR by endogenous ligand	0.0366996537464002	-3.30498795866911	16	3	0.00619834710743802	484	10287	6279,6280,7097	S100A8,S100A9,TLR2
R-HSA-6806667	Metabolism of fat-soluble vitamins	0.0372128374657101	-3.29110148406974	53	6	0.012396694214876	484	10287	4023,375790,6385,1591,1645,1594	LPL,AGRN,SDC4,CYP24A1,AKR1C1,CYP27B1
R-HSA-416476	G alpha (q) signalling events	0.0372205242363648	-3.2908949430643	192	15	0.0309917355371901	484	10287	8111,8503,623,5021,2642,6288,2151,10125,3710,9162,11343,2847,147,1910,10887	GPR68,PIK3R3,BDKRB1,OXTR,GCGR,SAA1,F2RL2,RASGRP1,ITPR3,DGKI,MGLL,MCHR1,ADRA1B,EDNRB,PROKR1
R-HSA-447038	NrCAM interactions	0.0396377635397654	-3.22797299039136	7	2	0.00413223140495868	484	10287	286,8828	ANK1,NRP2
R-HSA-196791	Vitamin D (calciferol) metabolism	0.0396377635397654	-3.22797299039136	7	2	0.00413223140495868	484	10287	1591,1594	CYP24A1,CYP27B1
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.0396377635397654	-3.22797299039136	7	2	0.00413223140495868	484	10287	8313,51176	AXIN2,LEF1
R-HSA-174577	Activation of C3 and C5	0.0396377635397654	-3.22797299039136	7	2	0.00413223140495868	484	10287	629,718	CFB,C3
R-HSA-216083	Integrin cell surface interactions	0.0399794560468959	-3.21938955563286	68	7	0.0144628099173554	484	10287	375790,960,3684,3383,3687,1305,3386	AGRN,CD44,ITGAM,ICAM1,ITGAX,COL13A1,ICAM4
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.0399794560468959	-3.21938955563286	68	7	0.0144628099173554	484	10287	1594,1577,1586,1551,9420,1591,1581	CYP27B1,CYP3A5,CYP17A1,CYP3A7,CYP7B1,CYP24A1,CYP7A1
R-HSA-451927	Interleukin-2 signaling	0.0403793208485543	-3.20943748524448	262	19	0.0392561983471074	484	10287	8503,5698,1844,1850,1839,26281,10125,2247,3559,6708,1848,1847,3561,2069,2668,5699,5721,1437,4233	PIK3R3,PSMB9,DUSP2,DUSP8,HBEGF,FGF20,RASGRP1,FGF2,IL2RA,SPTA1,DUSP6,DUSP5,IL2RG,EREG,GDNF,PSMB10,PSME2,CSF2,MET
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.0404806145804473	-3.20693207179487	28	4	0.00826446280991736	484	10287	2181,2182,51703,79993	ACSL3,ACSL4,ACSL5,ELOVL7
R-HSA-179812	GRB2 events in EGFR signaling	0.0406158253070668	-3.20359750243289	245	18	0.0371900826446281	484	10287	1437,4233,5699,5721,2069,2668,1847,3561,1848,6708,3559,2247,10125,1839,26281,1850,1844,5698	CSF2,MET,PSMB10,PSME2,EREG,GDNF,DUSP5,IL2RG,DUSP6,SPTA1,IL2RA,FGF2,RASGRP1,HBEGF,FGF20,DUSP8,DUSP2,PSMB9
R-HSA-180336	SHC1 events in EGFR signaling	0.0406158253070668	-3.20359750243289	245	18	0.0371900826446281	484	10287	3559,2247,10125,1839,26281,1850,5698,1844,1437,4233,5721,5699,2069,2668,1847,3561,6708,1848	IL2RA,FGF2,RASGRP1,HBEGF,FGF20,DUSP8,PSMB9,DUSP2,CSF2,MET,PSME2,PSMB10,EREG,GDNF,DUSP5,IL2RG,SPTA1,DUSP6
R-HSA-5673001	RAF/MAP kinase cascade	0.0406158253070668	-3.20359750243289	245	18	0.0371900826446281	484	10287	1839,26281,1850,1844,5698,3559,2247,10125,1847,3561,1848,6708,1437,4233,5721,5699,2069,2668	HBEGF,FGF20,DUSP8,DUSP2,PSMB9,IL2RA,FGF2,RASGRP1,DUSP5,IL2RG,DUSP6,SPTA1,CSF2,MET,PSME2,PSMB10,EREG,GDNF
R-HSA-112412	SOS-mediated signalling	0.0406158253070668	-3.20359750243289	245	18	0.0371900826446281	484	10287	1850,5698,1844,26281,1839,2247,10125,3559,1847,3561,1848,6708,5699,5721,2668,2069,4233,1437	DUSP8,PSMB9,DUSP2,FGF20,HBEGF,FGF2,RASGRP1,IL2RA,DUSP5,IL2RG,DUSP6,SPTA1,PSMB10,PSME2,GDNF,EREG,MET,CSF2
R-HSA-187687	Signalling to ERKs	0.0417054322200561	-3.17712388959557	263	19	0.0392561983471074	484	10287	1850,5698,1844,1839,26281,2247,10125,3559,3561,1847,6708,1848,5699,5721,2069,2668,4803,1437,4233	DUSP8,PSMB9,DUSP2,HBEGF,FGF20,FGF2,RASGRP1,IL2RA,IL2RG,DUSP5,SPTA1,DUSP6,PSMB10,PSME2,EREG,GDNF,NGF,CSF2,MET
R-HSA-5173105	O-linked glycosylation	0.0419857384025976	-3.17042528020586	114	10	0.0206611570247934	484	10287	6482,9507,4586,51301,10071,56999,50614,10164,79623,6484	ST3GAL1,ADAMTS4,MUC5AC,GCNT4,MUC12,ADAMTS9,GALNT9,CHST4,GALNT14,ST3GAL4
R-HSA-2142845	Hyaluronan metabolism	0.043050762901825	-3.14537532696867	17	3	0.00619834710743802	484	10287	3036,960,3038	HAS1,CD44,HAS3
R-HSA-196807	Nicotinate metabolism	0.0452755707441906	-3.09498766912557	29	4	0.00826446280991736	484	10287	54625,10135,952,5743	PARP14,NAMPT,CD38,PTGS2
R-HSA-5688426	Deubiquitination	0.0459256408878258	-3.08073169288141	301	21	0.0433884297520661	484	10287	10318,23586,1540,5698,8313,723790,4792,7128,8767,330,5699,5721,90865,64135,1080,84101,8900,8975,79931,219333,64127	TNIP1,DDX58,CYLD,PSMB9,AXIN2,HIST2H2AA4,NFKBIA,TNFAIP3,RIPK2,BIRC3,PSMB10,PSME2,IL33,IFIH1,CFTR,USP44,CCNA1,USP13,TNIP3,USP12,NOD2
R-HSA-1433557	Signaling by SCF-KIT	0.0467482769195317	-3.06297788126291	337	23	0.0475206611570248	484	10287	4233,1437,5721,5699,2668,2069,1847,3561,6708,1848,941,4067,3559,2247,2886,10125,4318,26281,1839,1850,5698,8503,1844	MET,CSF2,PSME2,PSMB10,GDNF,EREG,DUSP5,IL2RG,SPTA1,DUSP6,CD80,LYN,IL2RA,FGF2,GRB7,RASGRP1,MMP9,FGF20,HBEGF,DUSP8,PSMB9,PIK3R3,DUSP2
R-HSA-5263617	Metabolism of ingested MeSeO2H into MeSeH	0.0470496743461074	-3.05655133441769	1	1	0.00206611570247934	484	10287	7296	TXNRD1
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.047919074330927	-3.03824164232882	101	9	0.0185950413223141	484	10287	5698,4790,4792,5971,3710,3553,5699,5721,4791	PSMB9,NFKB1,NFKBIA,RELB,ITPR3,IL1B,PSMB10,PSME2,NFKB2
R-HSA-194138	Signaling by VEGF	0.0480501280863006	-3.03551047788155	338	23	0.0475206611570248	484	10287	1839,26281,1850,5698,1844,3559,2247,10125,3710,1847,6461,3561,1848,4688,6708,857,8828,1437,4233,5699,5721,2069,2668	HBEGF,FGF20,DUSP8,PSMB9,DUSP2,IL2RA,FGF2,RASGRP1,ITPR3,DUSP5,SHB,IL2RG,DUSP6,NCF2,SPTA1,CAV1,NRP2,CSF2,MET,PSMB10,PSME2,EREG,GDNF
R-HSA-197264	Nicotinamide salvaging	0.0499115686638644	-2.99750246614351	18	3	0.00619834710743802	484	10287	5743,54625,10135	PTGS2,PARP14,NAMPT
R-HSA-912631	Regulation of signaling by CBL	0.0499115686638644	-2.99750246614351	18	3	0.00619834710743802	484	10287	4067,8503,3055	LYN,PIK3R3,HCK
R-HSA-381042	PERK regulates gene expression	0.0503735331595011	-2.98828937756105	30	4	0.00826446280991736	484	10287	3484,3576,6347,467	IGFBP1,CXCL8,CCL2,ATF3
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.0512322724298754	-2.97138562460945	8	2	0.00413223140495868	484	10287	4233,27289	MET,RND1
R-HSA-2586552	Signaling by Leptin	0.0526271709489057	-2.94452273464462	253	18	0.0371900826446281	484	10287	4233,1437,2668,2069,5699,5721,6708,1848,1847,3561,3559,10125,2247,26281,1839,5698,1844,1850	MET,CSF2,GDNF,EREG,PSMB10,PSME2,SPTA1,DUSP6,DUSP5,IL2RG,IL2RA,RASGRP1,FGF2,FGF20,HBEGF,PSMB9,DUSP2,DUSP8
R-HSA-917937	Iron uptake and transport	0.0543193612416048	-2.912874554976	44	5	0.0103305785123967	484	10287	3934,50617,245973,2495,3162	LCN2,ATP6V0A4,ATP6V1C2,FTH1,HMOX1
R-HSA-5683057	MAPK family signaling cascades	0.0556816938442347	-2.88810384236562	290	20	0.0413223140495868	484	10287	3725,1847,3561,1848,6708,5699,5721,2069,2668,1437,4233,3569,1850,5698,1844,1839,26281,2247,10125,3559	JUN,DUSP5,IL2RG,DUSP6,SPTA1,PSMB10,PSME2,EREG,GDNF,CSF2,MET,IL6,DUSP8,PSMB9,DUSP2,HBEGF,FGF20,FGF2,RASGRP1,IL2RA
R-HSA-114452	Activation of BH3-only proteins	0.0557728570395981	-2.88646796092389	31	4	0.00826446280991736	484	10287	8626,5366,637,27113	TP63,PMAIP1,BID,BBC3
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.0572684449567171	-2.86000550578739	19	3	0.00619834710743802	484	10287	8767,64127,3656	RIPK2,NOD2,IRAK2
R-HSA-166658	Complement cascade	0.058854488608304	-2.83268717616565	45	5	0.0103305785123967	484	10287	1604,629,719,718,10584	CD55,CFB,C3AR1,C3,COLEC10
R-HSA-5689880	Ub-specific processing proteases	0.0611906471242008	-2.79376092591071	223	16	0.0330578512396694	484	10287	1540,23586,4792,330,8313,5698,723790,64135,90865,1080,5721,5699,219333,84101,8900,8975	CYLD,DDX58,NFKBIA,BIRC3,AXIN2,PSMB9,HIST2H2AA4,IFIH1,IL33,CFTR,PSME2,PSMB10,USP12,USP44,CCNA1,USP13
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.0615915184896567	-2.78723110477859	106	9	0.0185950413223141	484	10287	64116,6513,64849,6580,84102,51458,6534,80736,11182	SLC39A8,SLC2A1,SLC13A3,SLC22A1,SLC41A2,RHCG,SLC6A7,SLC44A4,SLC2A6
R-HSA-375165	NCAM signaling for neurite out-growth	0.0619214499085636	-2.78188863413884	276	19	0.0392561983471074	484	10287	3561,1847,1848,6708,4233,1437,5699,5721,2668,2069,26281,1839,1850,5698,1844,3559,375790,2247,10125	IL2RG,DUSP5,DUSP6,SPTA1,MET,CSF2,PSMB10,PSME2,GDNF,EREG,FGF20,HBEGF,DUSP8,PSMB9,DUSP2,IL2RA,AGRN,FGF2,RASGRP1
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.0626155280022025	-2.77074198048229	330	22	0.0454545454545455	484	10287	1844,5698,1850,1839,26281,3710,10125,2247,3559,857,1848,4688,6708,3561,6461,1847,2069,2668,5721,5699,1437,4233	DUSP2,PSMB9,DUSP8,HBEGF,FGF20,ITPR3,RASGRP1,FGF2,IL2RA,CAV1,DUSP6,NCF2,SPTA1,IL2RG,SHB,DUSP5,EREG,GDNF,PSME2,PSMB10,CSF2,MET
R-HSA-2179392	EGFR Transactivation by Gastrin	0.0638617837624395	-2.75103415969538	9	2	0.00413223140495868	484	10287	4314,1839	MMP3,HBEGF
R-HSA-1296052	Ca2+ activated K+ channels	0.0638617837624395	-2.75103415969538	9	2	0.00413223140495868	484	10287	3783,3779	KCNN4,KCNMB1
R-HSA-194002	Glucocorticoid biosynthesis	0.0638617837624395	-2.75103415969538	9	2	0.00413223140495868	484	10287	3290,1586	HSD11B1,CYP17A1
R-HSA-390696	Adrenoceptors	0.0638617837624395	-2.75103415969538	9	2	0.00413223140495868	484	10287	150,147	ADRA2A,ADRA1B
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.0651056617665705	-2.73174376324869	20	3	0.00619834710743802	484	10287	3656,8767,64127	IRAK2,RIPK2,NOD2
R-HSA-8874081	MET activates PTK2 signaling	0.0651056617665705	-2.73174376324869	20	3	0.00619834710743802	484	10287	3914,3918,4233	LAMB3,LAMC2,MET
R-HSA-5357905	Regulation of TNFR1 signaling	0.0674641139725677	-2.69615946732773	33	4	0.00826446280991736	484	10287	7185,1540,330,7128	TRAF1,CYLD,BIRC3,TNFAIP3
R-HSA-389356	CD28 co-stimulation	0.0674641139725677	-2.69615946732773	33	4	0.00826446280991736	484	10287	4067,1326,941,8503	LYN,MAP3K8,CD80,PIK3R3
R-HSA-1222556	ROS, RNS production in phagocytes	0.0674641139725677	-2.69615946732773	33	4	0.00826446280991736	484	10287	245973,50617,4843,4688	ATP6V1C2,ATP6V0A4,NOS2,NCF2
R-HSA-2172127	DAP12 interactions	0.0704066151504654	-2.65346805502712	371	24	0.0495867768595041	484	10287	3710,10125,2247,3559,5698,8503,1844,1850,1839,26281,54210,2069,2668,5721,5699,1437,4233,941,342510,1848,3937,6708,1847,3561	ITPR3,RASGRP1,FGF2,IL2RA,PSMB9,PIK3R3,DUSP2,DUSP8,HBEGF,FGF20,TREM1,EREG,GDNF,PSME2,PSMB10,CSF2,MET,CD80,CD300E,DUSP6,LCP2,SPTA1,DUSP5,IL2RG
R-HSA-211945	Phase 1 - Functionalization of compounds	0.070879392818536	-2.64677553905191	109	9	0.0185950413223141	484	10287	874,1594,1586,54498,9420,1551,1577,1581,1591	CBR3,CYP27B1,CYP17A1,SMOX,CYP7B1,CYP3A7,CYP3A5,CYP7A1,CYP24A1
R-HSA-76002	Platelet activation, signaling and aggregation	0.0732272125852897	-2.6141881704696	282	19	0.0392561983471074	484	10287	8503,7273,2151,2207,11343,3710,5004,10125,3559,4067,5005,150,3561,3937,9162,5880,1437,5552,5341	PIK3R3,TTN,F2RL2,FCER1G,MGLL,ITPR3,ORM1,RASGRP1,IL2RA,LYN,ORM2,ADRA2A,IL2RG,LCP2,DGKI,RAC2,CSF2,SRGN,PLEK
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	0.0734057173586272	-2.61175345322587	21	3	0.00619834710743802	484	10287	7832,10769,1263	BTG2,PLK2,PLK3
R-HSA-3928663	EPHA-mediated growth cone collapse	0.0737480392345041	-2.60710087076643	34	4	0.00826446280991736	484	10287	6461,4067,1943,4629	SHB,LYN,EFNA2,MYH11
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.0738032950956624	-2.60635189937973	229	16	0.0330578512396694	484	10287	941,4790,2069,5699,5721,4233,4794,8503,5698,1839,4792,26281,10125,3710,2247,4067	CD80,NFKB1,EREG,PSMB10,PSME2,MET,NFKBIE,PIK3R3,PSMB9,HBEGF,NFKBIA,FGF20,RASGRP1,ITPR3,FGF2,LYN
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.077403672225711	-2.5587210547353	10	2	0.00413223140495868	484	10287	8626,27113	TP63,BBC3
R-HSA-425381	Bicarbonate transporters	0.077403672225711	-2.5587210547353	10	2	0.00413223140495868	484	10287	8671,23382	SLC4A4,AHCYL2
R-HSA-1250342	PI3K events in ERBB4 signaling	0.077403672225711	-2.5587210547353	10	2	0.00413223140495868	484	10287	2069,1839	EREG,HBEGF
R-HSA-2871837	FCERI mediated NF-kB activation	0.077617123078194	-2.55596721791026	79	7	0.0144628099173554	484	10287	4790,10125,5698,5699,5721,4792,4067	NFKB1,RASGRP1,PSMB9,PSMB10,PSME2,NFKBIA,LYN
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	0.0790809539648633	-2.53728321746387	49	5	0.0103305785123967	484	10287	8900,1263,7832,25946,10769	CCNA1,PLK3,BTG2,ZNF385A,PLK2
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.0811273230332236	-2.51173546913552	197	14	0.0289256198347107	484	10287	8503,5698,4790,941,26281,4792,1839,5721,5699,2247,10125,2069,4794,4233	PIK3R3,PSMB9,NFKB1,CD80,FGF20,NFKBIA,HBEGF,PSME2,PSMB10,FGF2,RASGRP1,EREG,NFKBIE,MET
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.0821496391603532	-2.49921282695704	22	3	0.00619834710743802	484	10287	3053,5270,5197	SERPIND1,SERPINE2,PF4V1
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.0821496391603532	-2.49921282695704	22	3	0.00619834710743802	484	10287	5971,4067,4790	RELB,LYN,NFKB1
R-HSA-166663	Initial triggering of complement	0.0821496391603532	-2.49921282695704	22	3	0.00619834710743802	484	10287	10584,718,629	COLEC10,C3,CFB
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.0821496391603532	-2.49921282695704	22	3	0.00619834710743802	484	10287	8503,1326,941	PIK3R3,MAP3K8,CD80
R-HSA-6803157	Antimicrobial peptides	0.0859318245333999	-2.45420103509527	97	8	0.0165289256198347	484	10287	6278,6280,6279,114770,7097,5068,5266,3934	S100A7,S100A9,S100A8,PGLYRP2,TLR2,REG3A,PI3,LCN2
R-HSA-446107	Type I hemidesmosome assembly	0.091744519371479	-2.38874752820243	11	2	0.00413223140495868	484	10287	3914,3918	LAMB3,LAMC2
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.091744519371479	-2.38874752820243	11	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-193048	Androgen biosynthesis	0.091744519371479	-2.38874752820243	11	2	0.00413223140495868	484	10287	1586,6716	CYP17A1,SRD5A2
R-HSA-190872	Transport of connexons to the plasma membrane	0.0918900357686279	-2.38716268021457	2	1	0.00206611570247934	484	10287	2706	GJB2
R-HSA-187042	TRKA activation by NGF	0.0918900357686279	-2.38716268021457	2	1	0.00206611570247934	484	10287	4803	NGF
R-HSA-5652227	Fructose biosynthesis	0.0918900357686279	-2.38716268021457	2	1	0.00206611570247934	484	10287	231	AKR1B1
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.0918900357686279	-2.38716268021457	2	1	0.00206611570247934	484	10287	637	BID
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.0918900357686279	-2.38716268021457	2	1	0.00206611570247934	484	10287	366	AQP9
R-HSA-205017	NFG and proNGF binds to p75NTR	0.0918900357686279	-2.38716268021457	2	1	0.00206611570247934	484	10287	4803	NGF
R-HSA-111452	Activation and oligomerization of BAK protein	0.0918900357686279	-2.38716268021457	2	1	0.00206611570247934	484	10287	637	BID
R-HSA-141334	PAOs oxidise polyamines to amines	0.0918900357686279	-2.38716268021457	2	1	0.00206611570247934	484	10287	54498	SMOX
R-HSA-6804754	Regulation of TP53 Expression	0.0918900357686279	-2.38716268021457	2	1	0.00206611570247934	484	10287	639	PRDM1
R-HSA-1169091	Activation of NF-kappaB in B cells	0.0996618489069525	-2.30597233415414	68	6	0.012396694214876	484	10287	5721,5699,5698,4790,4794,4792	PSME2,PSMB10,PSMB9,NFKB1,NFKBIE,NFKBIA
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.100887442022219	-2.29374981900936	24	3	0.00619834710743802	484	10287	4629,5880,27289	MYH11,RAC2,RND1
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.100887442022219	-2.29374981900936	24	3	0.00619834710743802	484	10287	4843,5152,3779	NOS2,PDE9A,KCNMB1
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.10167500137857	-2.28597381363026	38	4	0.00826446280991736	484	10287	4688,7296,6648,7295	NCF2,TXNRD1,SOD2,TXN
R-HSA-2187338	Visual phototransduction	0.102628546625415	-2.27663915272835	101	8	0.0165289256198347	484	10287	375790,6385,2986,24,1645,64220,5957,4023	AGRN,SDC4,GUCY2F,ABCA4,AKR1C1,STRA6,RCVRN,LPL
R-HSA-1236975	Antigen processing-Cross presentation	0.102628546625415	-2.27663915272835	101	8	0.0165289256198347	484	10287	5699,5721,7097,1520,6891,5698,6890,4688	PSMB10,PSME2,TLR2,CTSS,TAP2,PSMB9,TAP1,NCF2
R-HSA-388841	Costimulation by the CD28 family	0.105080011979297	-2.25303320016312	69	6	0.012396694214876	484	10287	4067,23308,941,1326,8503,29126	LYN,ICOSLG,CD80,MAP3K8,PIK3R3,CD274
R-HSA-186763	Downstream signal transduction	0.106027111211706	-2.24406045142449	352	22	0.0454545454545455	484	10287	3559,10125,2886,3710,2247,26281,1839,1844,8503,5698,1850,4233,1437,2668,2069,5721,5699,6708,1848,1847,3561,941	IL2RA,RASGRP1,GRB7,ITPR3,FGF2,FGF20,HBEGF,DUSP2,PIK3R3,PSMB9,DUSP8,MET,CSF2,GDNF,EREG,PSME2,PSMB10,SPTA1,DUSP6,DUSP5,IL2RG,CD80
R-HSA-8851680	Butyrophilin (BTN) family interactions	0.106779521572749	-2.23698911641509	12	2	0.00413223140495868	484	10287	11119,7498	BTN3A1,XDH
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.106779521572749	-2.23698911641509	12	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-2033514	FGFR3 mutant receptor activation	0.106779521572749	-2.23698911641509	12	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-190373	FGFR1c ligand binding and activation	0.106779521572749	-2.23698911641509	12	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-73621	Pyrimidine catabolism	0.106779521572749	-2.23698911641509	12	2	0.00413223140495868	484	10287	1890,51733	TYMP,UPB1
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.106779521572749	-2.23698911641509	12	2	0.00413223140495868	484	10287	375790,6385	AGRN,SDC4
R-HSA-879518	Transport of organic anions	0.106779521572749	-2.23698911641509	12	2	0.00413223140495868	484	10287	28232,28231	SLCO3A1,SLCO4A1
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.106779521572749	-2.23698911641509	12	2	0.00413223140495868	484	10287	375790,6385	AGRN,SDC4
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.109319642766172	-2.21347918570869	39	4	0.00826446280991736	484	10287	5270,2152,5197,3053	SERPINE2,F3,PF4V1,SERPIND1
R-HSA-388396	GPCR downstream signaling	0.112719746226159	-2.18285066275905	974	54	0.111570247933884	484	10287	3710,10125,64108,3627,6374,11343,9340,2921,6352,1910,147,135,134864,8503,623,8111,5999,2914,2642,283365,643,1236,5142,1437,57007,150,26575,5996,5021,7852,2920,3561,6364,2918,3576,718,2847,9628,6363,3559,719,6373,53831,2151,6288,4283,9162,2919,5880,10887,6004,26230,6372,6752	ITPR3,RASGRP1,RTP4,CXCL10,CXCL5,MGLL,GLP2R,CXCL3,CCL5,EDNRB,ADRA1B,ADORA2A,TAAR1,PIK3R3,BDKRB1,GPR68,RGS4,GRM4,GCGR,OR6C6,CXCR5,CCR7,PDE4B,CSF2,ACKR3,ADRA2A,RGS17,RGS1,OXTR,CXCR4,CXCL2,IL2RG,CCL20,GRM8,CXCL8,C3,MCHR1,RGS6,CCL19,IL2RA,C3AR1,CXCL11,GPR84,F2RL2,SAA1,CXCL9,DGKI,CXCL1,RAC2,PROKR1,RGS16,TIAM2,CXCL6,SSTR2
R-HSA-351202	Metabolism of polyamines	0.114672211825357	-2.16567755250403	87	7	0.0144628099173554	484	10287	6611,5699,5721,54498,6303,5698,6534	SMS,PSMB10,PSME2,SMOX,SAT1,PSMB9,SLC6A7
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	0.114672211825357	-2.16567755250403	87	7	0.0144628099173554	484	10287	8503,941,2069,2247,4233,26281,1839	PIK3R3,CD80,EREG,FGF2,MET,FGF20,HBEGF
R-HSA-2424491	DAP12 signaling	0.115576799209014	-2.15782004177054	356	22	0.0454545454545455	484	10287	3559,2247,3710,10125,26281,1839,1850,1844,5698,8503,4233,1437,5699,5721,2668,2069,1847,3561,6708,1848,3937,941	IL2RA,FGF2,ITPR3,RASGRP1,FGF20,HBEGF,DUSP8,DUSP2,PSMB9,PIK3R3,MET,CSF2,PSMB10,PSME2,GDNF,EREG,DUSP5,IL2RG,SPTA1,DUSP6,LCP2,CD80
R-HSA-5675221	Negative regulation of MAPK pathway	0.117213436206785	-2.14375876500768	40	4	0.00826446280991736	484	10287	1848,1847,1844,1850	DUSP6,DUSP5,DUSP2,DUSP8
R-HSA-186797	Signaling by PDGF	0.118582674715877	-2.13214488474313	376	23	0.0475206611570248	484	10287	1437,4233,2069,2668,5699,5721,6708,1848,3561,1847,941,3559,3710,10125,2886,2247,1839,26281,5327,5698,8503,1844,1850	CSF2,MET,EREG,GDNF,PSMB10,PSME2,SPTA1,DUSP6,IL2RG,DUSP5,CD80,IL2RA,ITPR3,RASGRP1,GRB7,FGF2,HBEGF,FGF20,PLAT,PSMB9,PIK3R3,DUSP2,DUSP8
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.120675331141664	-2.11465155336092	122	9	0.0185950413223141	484	10287	54625,5743,6513,8876,10135,8875,952,441024,4363	PARP14,PTGS2,SLC2A1,VNN1,NAMPT,VNN2,CD38,MTHFD2L,ABCC1
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	0.122411933153094	-2.10036342057522	13	2	0.00413223140495868	484	10287	163732,4435	CITED4,CITED1
R-HSA-190372	FGFR3c ligand binding and activation	0.122411933153094	-2.10036342057522	13	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.122411933153094	-2.10036342057522	13	2	0.00413223140495868	484	10287	4688,5880	NCF2,RAC2
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.122411933153094	-2.10036342057522	13	2	0.00413223140495868	484	10287	64135,23586	IFIH1,DDX58
R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.122411933153094	-2.10036342057522	13	2	0.00413223140495868	484	10287	1540,7128	CYLD,TNFAIP3
R-HSA-75892	Platelet Adhesion to exposed collagen	0.122411933153094	-2.10036342057522	13	2	0.00413223140495868	484	10287	2207,4067	FCER1G,LYN
R-HSA-190239	FGFR3 ligand binding and activation	0.122411933153094	-2.10036342057522	13	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.122411933153094	-2.10036342057522	13	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	0.122411933153094	-2.10036342057522	13	2	0.00413223140495868	484	10287	1839,2069	HBEGF,EREG
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	0.122411933153094	-2.10036342057522	13	2	0.00413223140495868	484	10287	25946,8900	ZNF385A,CCNA1
R-HSA-190375	FGFR2c ligand binding and activation	0.122411933153094	-2.10036342057522	13	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-74752	Signaling by Insulin receptor	0.124337723212848	-2.08475384128778	322	20	0.0413223140495868	484	10287	10125,245973,2247,3559,5698,1844,1850,1839,26281,2069,2668,5721,50617,5699,1437,4233,6708,1848,3561,1847	RASGRP1,ATP6V1C2,FGF2,IL2RA,PSMB9,DUSP2,DUSP8,HBEGF,FGF20,EREG,GDNF,PSME2,ATP6V0A4,PSMB10,CSF2,MET,SPTA1,DUSP6,IL2RG,DUSP5
R-HSA-1630316	Glycosaminoglycan metabolism	0.12968960024714	-2.04261137401151	124	9	0.0185950413223141	484	10287	960,3038,9435,6482,50515,6385,375790,3036,6484	CD44,HAS3,CHST2,ST3GAL1,CHST11,SDC4,AGRN,HAS1,ST3GAL4
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.130594717977124	-2.035656507237	90	7	0.0144628099173554	484	10287	941,2069,8503,2247,1839,4233,26281	CD80,EREG,PIK3R3,FGF2,HBEGF,MET,FGF20
R-HSA-382556	ABC-family proteins mediated transport	0.130805304703201	-2.03404528494654	107	8	0.0165289256198347	484	10287	5698,4363,8714,1080,26154,24,5699,5721	PSMB9,ABCC1,ABCC3,CFTR,ABCA12,ABCA4,PSMB10,PSME2
R-HSA-2559583	Cellular Senescence	0.13357334326535	-2.01310456424461	196	13	0.0268595041322314	484	10287	23135,8091,8900,723790,3725,1030,3569,7295,4790,3159,3576,3552,3008	KDM6B,HMGA2,CCNA1,HIST2H2AA4,JUN,CDKN2B,IL6,TXN,NFKB1,HMGA1,CXCL8,IL1A,HIST1H1E
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.134624622319792	-2.00526494893353	3	1	0.00206611570247934	484	10287	6616	SNAP25
R-HSA-190704	Oligomerization of connexins into connexons	0.134624622319792	-2.00526494893353	3	1	0.00206611570247934	484	10287	2706	GJB2
R-HSA-8875791	MET activates STAT3	0.134624622319792	-2.00526494893353	3	1	0.00206611570247934	484	10287	4233	MET
R-HSA-198745	Signalling to STAT3	0.134624622319792	-2.00526494893353	3	1	0.00206611570247934	484	10287	4803	NGF
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.134624622319792	-2.00526494893353	3	1	0.00206611570247934	484	10287	8900	CCNA1
R-HSA-177539	Autointegration results in viral DNA circles	0.134624622319792	-2.00526494893353	3	1	0.00206611570247934	484	10287	3159	HMGA1
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.134624622319792	-2.00526494893353	3	1	0.00206611570247934	484	10287	1080	CFTR
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.134624622319792	-2.00526494893353	3	1	0.00206611570247934	484	10287	51458	RHCG
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.134624622319792	-2.00526494893353	3	1	0.00206611570247934	484	10287	3159	HMGA1
R-HSA-5653890	Lactose synthesis	0.134624622319792	-2.00526494893353	3	1	0.00206611570247934	484	10287	6513	SLC2A1
R-HSA-190827	Transport of connexins along the secretory pathway	0.134624622319792	-2.00526494893353	3	1	0.00206611570247934	484	10287	2706	GJB2
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.134624622319792	-2.00526494893353	3	1	0.00206611570247934	484	10287	6616	SNAP25
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.134624622319792	-2.00526494893353	3	1	0.00206611570247934	484	10287	4121	MAN1A1
R-HSA-193681	Ceramide signalling	0.134624622319792	-2.00526494893353	3	1	0.00206611570247934	484	10287	4803	NGF
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.134624622319792	-2.00526494893353	3	1	0.00206611570247934	484	10287	150	ADRA2A
R-HSA-1280218	Adaptive Immune System	0.135461505800298	-1.9990677690583	810	45	0.0929752066115702	484	10287	3937,4688,92369,3383,941,4790,7498,221687,4794,84676,29126,5699,55008,4792,1839,26281,6890,57823,255488,5698,8503,285852,10517,6891,1520,10125,3710,117157,342510,23327,4233,127544,11119,2069,55521,5721,54210,23308,8767,1326,4067,3386,718,7097,2247	LCP2,NCF2,SPSB4,ICAM1,CD80,NFKB1,XDH,RNF182,NFKBIE,TRIM63,CD274,PSMB10,HERC6,NFKBIA,HBEGF,FGF20,TAP1,SLAMF7,RNF144B,PSMB9,PIK3R3,TREML4,FBXW10,TAP2,CTSS,RASGRP1,ITPR3,SH2D1B,CD300E,NEDD4L,MET,RNF19B,BTN3A1,EREG,TRIM36,PSME2,TREM1,ICOSLG,RIPK2,MAP3K8,LYN,ICAM4,C3,TLR2,FGF2
R-HSA-418346	Platelet homeostasis	0.136135904006404	-1.99410159804339	91	7	0.0144628099173554	484	10287	4843,6547,2268,490,3779,3710,5152	NOS2,SLC8A3,FGR,ATP2B1,KCNMB1,ITPR3,PDE9A
R-HSA-177929	Signaling by EGFR	0.136222303898633	-1.99346714024024	364	22	0.0454545454545455	484	10287	1848,6708,3561,1847,941,10252,4233,1437,2668,2069,5721,5699,26281,1839,5698,8503,1844,1850,3559,10125,3710,2247	DUSP6,SPTA1,IL2RG,DUSP5,CD80,SPRY1,MET,CSF2,GDNF,EREG,PSME2,PSMB10,FGF20,HBEGF,PSMB9,PIK3R3,DUSP2,DUSP8,IL2RA,RASGRP1,ITPR3,FGF2
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.138552542657016	-1.97650565593237	14	2	0.00413223140495868	484	10287	1839,2069	HBEGF,EREG
R-HSA-190322	FGFR4 ligand binding and activation	0.138552542657016	-1.97650565593237	14	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-162594	Early Phase of HIV Life Cycle	0.138552542657016	-1.97650565593237	14	2	0.00413223140495868	484	10287	3159,7852	HMGA1,CXCR4
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.138552542657016	-1.97650565593237	14	2	0.00413223140495868	484	10287	1645,1646	AKR1C1,AKR1C2
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.138552542657016	-1.97650565593237	14	2	0.00413223140495868	484	10287	6513,11182	SLC2A1,SLC2A6
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	0.138552542657016	-1.97650565593237	14	2	0.00413223140495868	484	10287	25946,8626	ZNF385A,TP63
R-HSA-209543	p75NTR recruits signalling complexes	0.138552542657016	-1.97650565593237	14	2	0.00413223140495868	484	10287	8767,4803	RIPK2,NGF
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.138552542657016	-1.97650565593237	14	2	0.00413223140495868	484	10287	6547,490	SLC8A3,ATP2B1
R-HSA-75893	TNF signaling	0.142299114296516	-1.94982399810447	43	4	0.00826446280991736	484	10287	7185,1540,330,7128	TRAF1,CYLD,BIRC3,TNFAIP3
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.142299114296516	-1.94982399810447	43	4	0.00826446280991736	484	10287	64321,6658,83595,51176	SOX17,SOX3,SOX7,LEF1
R-HSA-1266695	Interleukin-7 signaling	0.142749752393894	-1.94666216499117	28	3	0.00619834710743802	484	10287	8503,3561,3575	PIK3R3,IL2RG,IL7R
R-HSA-211976	Endogenous sterols	0.142749752393894	-1.94666216499117	28	3	0.00619834710743802	484	10287	1581,1586,9420	CYP7A1,CYP17A1,CYP7B1
R-HSA-2022854	Keratan sulfate biosynthesis	0.142749752393894	-1.94666216499117	28	3	0.00619834710743802	484	10287	6484,6482,9435	ST3GAL4,ST3GAL1,CHST2
R-HSA-2142753	Arachidonic acid metabolism	0.14340898836849	-1.94205467238702	59	5	0.0103305785123967	484	10287	4363,9536,247,5743,242	ABCC1,PTGES,ALOX15B,PTGS2,ALOX12B
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.146243427236558	-1.92248273585234	110	8	0.0165289256198347	484	10287	8900,3569,1030,723790,3725,4790,3552,3576	CCNA1,IL6,CDKN2B,HIST2H2AA4,JUN,NFKB1,IL1A,CXCL8
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.147131378438016	-1.91642936047218	387	23	0.0475206611570248	484	10287	1850,8503,5698,1844,26281,1839,2247,10125,3710,135,3559,941,1847,3561,6708,1848,5721,5699,2668,2069,4803,4233,1437	DUSP8,PIK3R3,PSMB9,DUSP2,FGF20,HBEGF,FGF2,RASGRP1,ITPR3,ADORA2A,IL2RA,CD80,DUSP5,IL2RG,SPTA1,DUSP6,PSME2,PSMB10,GDNF,EREG,NGF,MET,CSF2
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.150817606468335	-1.89168407645468	60	5	0.0103305785123967	484	10287	5971,4791,5721,5699,5698	RELB,NFKB2,PSME2,PSMB10,PSMB9
R-HSA-975634	Retinoid metabolism and transport	0.151097089603658	-1.88983267128102	44	4	0.00826446280991736	484	10287	1645,375790,4023,6385	AKR1C1,AGRN,LPL,SDC4
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.151097089603658	-1.88983267128102	44	4	0.00826446280991736	484	10287	27113,637,8626,5366	BBC3,BID,TP63,PMAIP1
R-HSA-112399	IRS-mediated signalling	0.152588937759514	-1.88000765450574	294	18	0.0371900826446281	484	10287	2247,10125,3559,1850,1844,5698,26281,1839,5699,5721,2668,2069,4233,1437,3561,1847,1848,6708	FGF2,RASGRP1,IL2RA,DUSP8,DUSP2,PSMB9,FGF20,HBEGF,PSMB10,PSME2,GDNF,EREG,MET,CSF2,IL2RG,DUSP5,DUSP6,SPTA1
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.15343251657691	-1.87449444004189	94	7	0.0144628099173554	484	10287	2247,8503,941,2069,26281,4233,1839	FGF2,PIK3R3,CD80,EREG,FGF20,MET,HBEGF
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.155119180423893	-1.86356155155904	15	2	0.00413223140495868	484	10287	5743,9536	PTGS2,PTGES
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.155119180423893	-1.86356155155904	15	2	0.00413223140495868	484	10287	27121,7474	DKK4,WNT5A
R-HSA-6785631	ERBB2 Regulates Cell Motility	0.155119180423893	-1.86356155155904	15	2	0.00413223140495868	484	10287	1839,2069	HBEGF,EREG
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.155119180423893	-1.86356155155904	15	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.15838363015272	-1.84273514993773	61	5	0.0103305785123967	484	10287	5698,5721,8900,5699,595	PSMB9,PSME2,CCNA1,PSMB10,CCND1
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.15838363015272	-1.84273514993773	61	5	0.0103305785123967	484	10287	5721,5699,5698,4791,5971	PSME2,PSMB10,PSMB9,NFKB2,RELB
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	0.160096367750052	-1.83197934661939	45	4	0.00826446280991736	484	10287	5366,8626,27113,637	PMAIP1,TP63,BBC3,BID
R-HSA-74751	Insulin receptor signalling cascade	0.162510470237536	-1.81701284705702	297	18	0.0371900826446281	484	10287	10125,2247,3559,5698,1844,1850,1839,26281,2069,2668,5699,5721,1437,4233,1848,6708,3561,1847	RASGRP1,FGF2,IL2RA,PSMB9,DUSP2,DUSP8,HBEGF,FGF20,EREG,GDNF,PSMB10,PSME2,CSF2,MET,DUSP6,SPTA1,IL2RG,DUSP5
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.165510466706237	-1.79872084322678	30	3	0.00619834710743802	484	10287	3710,4067,3937	ITPR3,LYN,LCP2
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.165510466706237	-1.79872084322678	30	3	0.00619834710743802	484	10287	92737,54567,113878	DNER,DLL4,DTX2
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.165510466706237	-1.79872084322678	30	3	0.00619834710743802	484	10287	10046,595,3725	MAMLD1,CCND1,JUN
R-HSA-2428924	IGF1R signaling cascade	0.165893180955797	-1.79641118597109	298	18	0.0371900826446281	484	10287	2247,10125,3559,1850,1844,5698,26281,1839,5721,5699,2668,2069,4233,1437,3561,1847,1848,6708	FGF2,RASGRP1,IL2RA,DUSP8,DUSP2,PSMB9,FGF20,HBEGF,PSME2,PSMB10,GDNF,EREG,MET,CSF2,IL2RG,DUSP5,DUSP6,SPTA1
R-HSA-2428928	IRS-related events triggered by IGF1R	0.165893180955797	-1.79641118597109	298	18	0.0371900826446281	484	10287	6708,1848,3561,1847,2668,2069,5721,5699,4233,1437,5698,1844,1850,26281,1839,10125,2247,3559	SPTA1,DUSP6,IL2RG,DUSP5,GDNF,EREG,PSME2,PSMB10,MET,CSF2,PSMB9,DUSP2,DUSP8,FGF20,HBEGF,RASGRP1,FGF2,IL2RA
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.169313184644753	-1.77600511546982	299	18	0.0371900826446281	484	10287	5721,5699,2069,2668,1437,4233,3561,1847,6708,1848,2247,10125,3559,1850,1844,5698,1839,26281	PSME2,PSMB10,EREG,GDNF,CSF2,MET,IL2RG,DUSP5,SPTA1,DUSP6,FGF2,RASGRP1,IL2RA,DUSP8,DUSP2,PSMB9,HBEGF,FGF20
R-HSA-15869	Metabolism of nucleotides	0.171690611607813	-1.7620611916196	97	7	0.0144628099173554	484	10287	1890,57089,7295,7498,7296,272,51733	TYMP,ENTPD7,TXN,XDH,TXNRD1,AMPD3,UPB1
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.172036255661628	-1.76005003565111	16	2	0.00413223140495868	484	10287	4790,1326	NFKB1,MAP3K8
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.172036255661628	-1.76005003565111	16	2	0.00413223140495868	484	10287	23586,64135	DDX58,IFIH1
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.172036255661628	-1.76005003565111	16	2	0.00413223140495868	484	10287	1839,2069	HBEGF,EREG
R-HSA-190242	FGFR1 ligand binding and activation	0.172036255661628	-1.76005003565111	16	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-1963642	PI3K events in ERBB2 signaling	0.172036255661628	-1.76005003565111	16	2	0.00413223140495868	484	10287	1839,2069	HBEGF,EREG
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.172036255661628	-1.76005003565111	16	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	8828	NRP2
R-HSA-173107	Binding and entry of HIV virion	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	7852	CXCR4
R-HSA-167060	NGF processing	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	4803	NGF
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	6506	SLC1A2
R-HSA-427975	Proton/oligopeptide cotransporters	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	51296	SLC15A3
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	6616	SNAP25
R-HSA-2408550	Metabolism of ingested H2SeO4 and H2SeO3 into H2Se	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	7296	TXNRD1
R-HSA-417973	Adenosine P1 receptors	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	135	ADORA2A
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	637	BID
R-HSA-209905	Catecholamine biosynthesis	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	1644	DDC
R-HSA-209563	Axonal growth stimulation	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	4803	NGF
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	25946	ZNF385A
R-HSA-140179	Amine Oxidase reactions	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	54498	SMOX
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	25946	ZNF385A
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	6506	SLC1A2
R-HSA-2473224	Antagonism of Activin by Follistatin	0.175352129395642	-1.74095915878197	4	1	0.00206611570247934	484	10287	3624	INHBA
R-HSA-2129379	Molecules associated with elastic fibres	0.177268067741419	-1.73009218510374	31	3	0.00619834710743802	484	10287	650,10516,27302	BMP2,FBLN5,BMP10
R-HSA-8875878	MET promotes cell motility	0.177268067741419	-1.73009218510374	31	3	0.00619834710743802	484	10287	4233,3914,3918	MET,LAMB3,LAMC2
R-HSA-5339562	Uptake and actions of bacterial toxins	0.177268067741419	-1.73009218510374	31	3	0.00619834710743802	484	10287	7296,1839,6616	TXNRD1,HBEGF,SNAP25
R-HSA-5654687	Downstream signaling of activated FGFR1	0.177268067741419	-1.73009218510374	31	3	0.00619834710743802	484	10287	23767,26281,2247	FLRT3,FGF20,FGF2
R-HSA-418360	Platelet calcium homeostasis	0.177268067741419	-1.73009218510374	31	3	0.00619834710743802	484	10287	3710,490,6547	ITPR3,ATP2B1,SLC8A3
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.178657142316592	-1.72228671592988	47	4	0.00826446280991736	484	10287	595,6484,10046,3725	CCND1,ST3GAL4,MAMLD1,JUN
R-HSA-166520	Signalling by NGF	0.182708107949431	-1.69986543809666	477	27	0.0557851239669422	484	10287	5721,5699,2668,2069,4803,4233,1437,26230,941,4790,3561,1847,6708,1848,2247,10125,3710,135,3559,1850,5698,8503,1844,8767,26281,4792,1839	PSME2,PSMB10,GDNF,EREG,NGF,MET,CSF2,TIAM2,CD80,NFKB1,IL2RG,DUSP5,SPTA1,DUSP6,FGF2,RASGRP1,ITPR3,ADORA2A,IL2RA,DUSP8,PSMB9,PIK3R3,DUSP2,RIPK2,FGF20,NFKBIA,HBEGF
R-HSA-75109	Triglyceride Biosynthesis	0.188163079593465	-1.67044624751877	82	6	0.012396694214876	484	10287	2710,51703,79993,80168,2182,2181	GK,ACSL5,ELOVL7,MOGAT2,ACSL4,ACSL3
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.188197426145438	-1.67026372809102	48	4	0.00826446280991736	484	10287	1437,3559,3561,8503	CSF2,IL2RA,IL2RG,PIK3R3
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.188197426145438	-1.67026372809102	48	4	0.00826446280991736	484	10287	2048,4067,1943,4318	EPHB2,LYN,EFNA2,MMP9
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	0.189234321368003	-1.66476923623652	17	2	0.00413223140495868	484	10287	8875,8876	VNN2,VNN1
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	0.189234321368003	-1.66476923623652	17	2	0.00413223140495868	484	10287	4586,10071	MUC5AC,MUC12
R-HSA-2033519	Activated point mutants of FGFR2	0.189234321368003	-1.66476923623652	17	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-192456	Digestion of dietary lipid	0.189234321368003	-1.66476923623652	17	2	0.00413223140495868	484	10287	119548,9388	PNLIPRP3,LIPG
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	0.189234321368003	-1.66476923623652	17	2	0.00413223140495868	484	10287	4586,10071	MUC5AC,MUC12
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	0.189234321368003	-1.66476923623652	17	2	0.00413223140495868	484	10287	10071,4586	MUC12,MUC5AC
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.190104782040205	-1.66017987441117	65	5	0.0103305785123967	484	10287	5698,5699,8900,5721,25946	PSMB9,PSMB10,CCNA1,PSME2,ZNF385A
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.190104782040205	-1.66017987441117	65	5	0.0103305785123967	484	10287	5698,5721,5699,8900,25946	PSMB9,PSME2,PSMB10,CCNA1,ZNF385A
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.201425381460831	-1.60233628150992	33	3	0.00619834710743802	484	10287	9435,6482,6484	CHST2,ST3GAL1,ST3GAL4
R-HSA-5357801	Programmed Cell Death	0.201793146074295	-1.60051213559236	175	11	0.0227272727272727	484	10287	5721,5699,3008,8626,5366,5317,5698,330,660,27113,637	PSME2,PSMB10,HIST1H1E,TP63,PMAIP1,PKP1,PSMB9,BIRC3,BMX,BBC3,BID
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.206649665455478	-1.57673035692008	18	2	0.00413223140495868	484	10287	6580,6616	SLC22A1,SNAP25
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.206649665455478	-1.57673035692008	18	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-418457	cGMP effects	0.206649665455478	-1.57673035692008	18	2	0.00413223140495868	484	10287	5152,3779	PDE9A,KCNMB1
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.206649665455478	-1.57673035692008	18	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-5654710	PI-3K cascade:FGFR3	0.206649665455478	-1.57673035692008	18	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-210993	Tie2 Signaling	0.206649665455478	-1.57673035692008	18	2	0.00413223140495868	484	10287	2888,2886	GRB14,GRB7
R-HSA-69615	G1/S DNA Damage Checkpoints	0.206753741727732	-1.57622684740543	67	5	0.0103305785123967	484	10287	25946,5698,5721,8900,5699	ZNF385A,PSMB9,PSME2,CCNA1,PSMB10
R-HSA-73887	Death Receptor Signalling	0.207744071558578	-1.57144838207455	50	4	0.00826446280991736	484	10287	330,1540,7128,7185	BIRC3,CYLD,TNFAIP3,TRAF1
R-HSA-1236974	ER-Phagosome pathway	0.210214641881149	-1.55962616606156	85	6	0.012396694214876	484	10287	7097,5699,5721,5698,6890,6891	TLR2,PSMB10,PSME2,PSMB9,TAP1,TAP2
R-HSA-3781865	Diseases of glycosylation	0.210214641881149	-1.55962616606156	85	6	0.012396694214876	484	10287	375790,6385,10071,56999,9507,4586	AGRN,SDC4,MUC12,ADAMTS9,ADAMTS4,MUC5AC
R-HSA-187024	NGF-independant TRKA activation	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	135	ADORA2A
R-HSA-426048	Arachidonate production from DAG	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	11343	MGLL
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	64849	SLC13A3
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	857	CAV1
R-HSA-8865999	MET activates PTPN11	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	4233	MET
R-HSA-112303	Electric Transmission Across Gap Junctions	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	56666	PANX2
R-HSA-3000471	Scavenging by Class B Receptors	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	6288	SAA1
R-HSA-68911	G2 Phase	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	8900	CCNA1
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	3159	HMGA1
R-HSA-209931	Serotonin and melatonin biosynthesis	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	1644	DDC
R-HSA-1614517	Sulfide oxidation to sulfate	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	58472	SQOR
R-HSA-2161517	Abacavir transmembrane transport	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	6580	SLC22A1
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	5366	PMAIP1
R-HSA-112307	Transmission across Electrical Synapses	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	56666	PANX2
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	2152	F3
R-HSA-8875513	MET interacts with TNS proteins	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	4233	MET
R-HSA-1169092	Activation of RAS in B cells	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	10125	RASGRP1
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	4121	MAN1A1
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.214166635799964	-1.54100089500556	5	1	0.00206611570247934	484	10287	2886	GRB7
R-HSA-373755	Semaphorin interactions	0.215253098306368	-1.53594074178779	68	5	0.0103305785123967	484	10287	80031,4629,27289,4233,5880	SEMA6D,MYH11,RND1,MET,RAC2
R-HSA-397795	G-protein beta:gamma signalling	0.217728828082798	-1.52450489836569	51	4	0.00826446280991736	484	10287	1437,3559,3561,8503	CSF2,IL2RA,IL2RG,PIK3R3
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.224223926686724	-1.49511005375851	19	2	0.00413223140495868	484	10287	375790,6385	AGRN,SDC4
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.224223926686724	-1.49511005375851	19	2	0.00413223140495868	484	10287	6385,375790	SDC4,AGRN
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.224223926686724	-1.49511005375851	19	2	0.00413223140495868	484	10287	6580,6534	SLC22A1,SLC6A7
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.224223926686724	-1.49511005375851	19	2	0.00413223140495868	484	10287	6385,375790	SDC4,AGRN
R-HSA-933541	TRAF6 mediated IRF7 activation	0.226293486605746	-1.48592250887906	35	3	0.00619834710743802	484	10287	23586,3659,64135	DDX58,IRF1,IFIH1
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.227840149875357	-1.47911099294907	52	4	0.00826446280991736	484	10287	5721,5699,5698,595	PSME2,PSMB10,PSMB9,CCND1
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.227840149875357	-1.47911099294907	52	4	0.00826446280991736	484	10287	5698,5699,5721,595	PSMB9,PSMB10,PSME2,CCND1
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.228700217753348	-1.47534322581854	124	8	0.0165289256198347	484	10287	718,3386,342510,285852,117157,57823,54210,3383	C3,ICAM4,CD300E,TREML4,SH2D1B,SLAMF7,TREM1,ICAM1
R-HSA-201681	TCF dependent signaling in response to WNT	0.231013443138544	-1.46527937474868	238	14	0.0289256198347107	484	10287	84870,64321,6658,83595,284654,7474,857,8313,5698,723790,27121,5721,5699,51176	RSPO3,SOX17,SOX3,SOX7,RSPO1,WNT5A,CAV1,AXIN2,PSMB9,HIST2H2AA4,DKK4,PSME2,PSMB10,LEF1
R-HSA-6806003	Regulation of TP53 Expression and Degradation	0.238941413729137	-1.43153688794053	36	3	0.00619834710743802	484	10287	6446,8900,639	SGK1,CCNA1,PRDM1
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.241372394649799	-1.42141433207815	71	5	0.0103305785123967	484	10287	595,5698,8900,5699,5721	CCND1,PSMB9,CCNA1,PSMB10,PSME2
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.241903733904364	-1.41921542575001	20	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.241903733904364	-1.41921542575001	20	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-190241	FGFR2 ligand binding and activation	0.241903733904364	-1.41921542575001	20	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-5654720	PI-3K cascade:FGFR4	0.241903733904364	-1.41921542575001	20	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-3000170	Syndecan interactions	0.241903733904364	-1.41921542575001	20	2	0.00413223140495868	484	10287	6385,2247	SDC4,FGF2
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.241903733904364	-1.41921542575001	20	2	0.00413223140495868	484	10287	857,11343	CAV1,MGLL
R-HSA-69202	Cyclin E associated events during G1/S transition	0.25026395664076	-1.38523909154969	72	5	0.0103305785123967	484	10287	595,5698,5721,5699,8900	CCND1,PSMB9,PSME2,PSMB10,CCNA1
R-HSA-388479	Vasopressin-like receptors	0.251157819253305	-1.38167377547298	6	1	0.00206611570247934	484	10287	5021	OXTR
R-HSA-8857538	PTK6 promotes HIF1A stabilization	0.251157819253305	-1.38167377547298	6	1	0.00206611570247934	484	10287	1839	HBEGF
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.251157819253305	-1.38167377547298	6	1	0.00206611570247934	484	10287	4803	NGF
R-HSA-3000484	Scavenging by Class F Receptors	0.251157819253305	-1.38167377547298	6	1	0.00206611570247934	484	10287	8578	SCARF1
R-HSA-5690714	CD22 mediated BCR regulation	0.251157819253305	-1.38167377547298	6	1	0.00206611570247934	484	10287	4067	LYN
R-HSA-189483	Heme degradation	0.251157819253305	-1.38167377547298	6	1	0.00206611570247934	484	10287	3162	HMOX1
R-HSA-5676934	Protein repair	0.251157819253305	-1.38167377547298	6	1	0.00206611570247934	484	10287	7295	TXN
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.251157819253305	-1.38167377547298	6	1	0.00206611570247934	484	10287	27121	DKK4
R-HSA-190370	FGFR1b ligand binding and activation	0.251157819253305	-1.38167377547298	6	1	0.00206611570247934	484	10287	2247	FGF2
R-HSA-193144	Estrogen biosynthesis	0.251157819253305	-1.38167377547298	6	1	0.00206611570247934	484	10287	441282	AKR1B15
R-HSA-205025	NADE modulates death signalling	0.251157819253305	-1.38167377547298	6	1	0.00206611570247934	484	10287	4803	NGF
R-HSA-8851907	MET activates PI3K/AKT signaling	0.251157819253305	-1.38167377547298	6	1	0.00206611570247934	484	10287	4233	MET
R-HSA-8849470	PTK6 Regulates Cell Cycle	0.251157819253305	-1.38167377547298	6	1	0.00206611570247934	484	10287	595	CCND1
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.251157819253305	-1.38167377547298	6	1	0.00206611570247934	484	10287	242	ALOX12B
R-HSA-6806942	MET Receptor Activation	0.251157819253305	-1.38167377547298	6	1	0.00206611570247934	484	10287	4233	MET
R-HSA-198203	PI3K/AKT activation	0.254877248187262	-1.36697322938189	128	8	0.0165289256198347	484	10287	26281,1839,8503,941,4803,4233,2247,2069	FGF20,HBEGF,PIK3R3,CD80,NGF,MET,FGF2,EREG
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.25882655413998	-1.35159711675036	55	4	0.00826446280991736	484	10287	51703,79993,2181,2182	ACSL5,ELOVL7,ACSL3,ACSL4
R-HSA-5654689	PI-3K cascade:FGFR1	0.259640367220781	-1.34845780847193	21	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-5654688	SHC-mediated cascade:FGFR1	0.259640367220781	-1.34845780847193	21	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-2024096	HS-GAG degradation	0.259640367220781	-1.34845780847193	21	2	0.00413223140495868	484	10287	6385,375790	SDC4,AGRN
R-HSA-373080	Class B/2 (Secretin family receptors)	0.264776601018763	-1.32886882355644	92	6	0.012396694214876	484	10287	1604,7474,2642,9340,11211,90226	CD55,WNT5A,GCGR,GLP2R,FZD10,UCN2
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.264776601018763	-1.32886882355644	92	6	0.012396694214876	484	10287	27076,154064,5329,8875,8876,5277	LYPD3,RAET1L,PLAUR,VNN2,VNN1,PIGA
R-HSA-4641257	Degradation of AXIN	0.269337678324665	-1.31178937686572	56	4	0.00826446280991736	484	10287	5699,5721,5698,8313	PSMB10,PSME2,PSMB9,AXIN2
R-HSA-157118	Signaling by NOTCH	0.274774386292812	-1.29180493151957	112	7	0.0144628099173554	484	10287	3725,54567,92737,113878,6484,10046,595	JUN,DLL4,DNER,DTX2,ST3GAL4,MAMLD1,CCND1
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.275095898311573	-1.29063552097165	131	8	0.0165289256198347	484	10287	26281,1839,8503,941,4067,4233,2069,2247	FGF20,HBEGF,PIK3R3,CD80,LYN,MET,EREG,FGF2
R-HSA-389513	CTLA4 inhibitory signaling	0.277389440026471	-1.28233283950274	22	2	0.00413223140495868	484	10287	4067,941	LYN,CD80
R-HSA-5655332	Signaling by FGFR3 in disease	0.277389440026471	-1.28233283950274	22	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.277389440026471	-1.28233283950274	22	2	0.00413223140495868	484	10287	5270,3053	SERPINE2,SERPIND1
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	0.277389440026471	-1.28233283950274	22	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-202131	Metabolism of nitric oxide	0.277389440026471	-1.28233283950274	22	2	0.00413223140495868	484	10287	2643,857	GCH1,CAV1
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.277389440026471	-1.28233283950274	22	2	0.00413223140495868	484	10287	1839,2069	HBEGF,EREG
R-HSA-4641263	Regulation of FZD by ubiquitination	0.277389440026471	-1.28233283950274	22	2	0.00413223140495868	484	10287	284654,84870	RSPO1,RSPO3
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.277389440026471	-1.28233283950274	22	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-203765	eNOS activation and regulation	0.277389440026471	-1.28233283950274	22	2	0.00413223140495868	484	10287	2643,857	GCH1,CAV1
R-HSA-556833	Metabolism of lipids and lipoproteins	0.282427021381234	-1.2643350931628	813	42	0.0867768595041322	484	10287	1586,11343,247,660,1645,3290,80168,79993,8714,8503,4363,80736,85441,130367,51365,25816,441282,4023,1581,9023,6716,51703,2710,1646,84879,29923,5743,231,9536,9108,7296,242,9420,9388,2181,2182,50486,3638,119548,27242,857,26230	CYP17A1,MGLL,ALOX15B,BMX,AKR1C1,HSD11B1,MOGAT2,ELOVL7,ABCC3,PIK3R3,ABCC1,SLC44A4,HELZ2,SGPP2,PLA1A,TNFAIP8,AKR1B15,LPL,CYP7A1,CH25H,SRD5A2,ACSL5,GK,AKR1C2,MFSD2A,HILPDA,PTGS2,AKR1B1,PTGES,MTMR7,TXNRD1,ALOX12B,CYP7B1,LIPG,ACSL3,ACSL4,G0S2,INSIG1,PNLIPRP3,TNFRSF21,CAV1,TIAM2
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	0.28641116188008	-1.2503268716101	7	1	0.00206611570247934	484	10287	64078	SLC28A3
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.28641116188008	-1.2503268716101	7	1	0.00206611570247934	484	10287	54567	DLL4
R-HSA-164843	2-LTR circle formation	0.28641116188008	-1.2503268716101	7	1	0.00206611570247934	484	10287	3159	HMGA1
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.28641116188008	-1.2503268716101	7	1	0.00206611570247934	484	10287	54567	DLL4
R-HSA-420597	Nectin/Necl  trans heterodimerization	0.28641116188008	-1.2503268716101	7	1	0.00206611570247934	484	10287	5818	NECTIN1
R-HSA-190371	FGFR3b ligand binding and activation	0.28641116188008	-1.2503268716101	7	1	0.00206611570247934	484	10287	26281	FGF20
R-HSA-447043	Neurofascin interactions	0.28641116188008	-1.2503268716101	7	1	0.00206611570247934	484	10287	286	ANK1
R-HSA-5652084	Fructose metabolism	0.28641116188008	-1.2503268716101	7	1	0.00206611570247934	484	10287	231	AKR1B1
R-HSA-162791	Attachment of GPI anchor to uPAR	0.28641116188008	-1.2503268716101	7	1	0.00206611570247934	484	10287	5329	PLAUR
R-HSA-2682334	EPH-Ephrin signaling	0.289200527927982	-1.24063496322208	95	6	0.012396694214876	484	10287	2048,1943,4067,6461,4318,4629	EPHB2,EFNA2,LYN,SHB,MMP9,MYH11
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.290498103369403	-1.23615823156036	40	3	0.00619834710743802	484	10287	64078,28232,28231	SLC28A3,SLCO3A1,SLCO4A1
R-HSA-6794361	Interactions of neurexins and neuroligins at synapses	0.29057155994618	-1.23590539930355	58	4	0.00826446280991736	484	10287	9456,9228,9369,9378	HOMER1,DLGAP2,NRXN3,NRXN1
R-HSA-109581	Apoptosis	0.291085873771513	-1.23413695647258	172	10	0.0206611570247934	484	10287	3008,5721,5699,5366,5317,5698,8626,660,637,27113	HIST1H1E,PSME2,PSMB10,PMAIP1,PKP1,PSMB9,TP63,BMX,BID,BBC3
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	0.295110600440777	-1.22040507615764	23	2	0.00413223140495868	484	10287	6648,3725	SOD2,JUN
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.295110600440777	-1.22040507615764	23	2	0.00413223140495868	484	10287	64220,24	STRA6,ABCA4
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.295110600440777	-1.22040507615764	23	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.295110600440777	-1.22040507615764	23	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-5654695	PI-3K cascade:FGFR2	0.295110600440777	-1.22040507615764	23	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-8863678	Neurodegenerative Diseases	0.295110600440777	-1.22040507615764	23	2	0.00413223140495868	484	10287	6648,3725	SOD2,JUN
R-HSA-4086400	PCP/CE pathway	0.297447107572599	-1.21251885947485	96	6	0.012396694214876	484	10287	7474,5880,5721,5699,5698,23002	WNT5A,RAC2,PSME2,PSMB10,PSMB9,DAAM1
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	0.301274292419385	-1.19973415869185	59	4	0.00826446280991736	484	10287	10071,9507,56999,4586	MUC12,ADAMTS4,ADAMTS9,MUC5AC
R-HSA-201451	Signaling by BMP	0.312767251203033	-1.16229597143443	24	2	0.00413223140495868	484	10287	650,658	BMP2,BMPR1B
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.312767251203033	-1.16229597143443	24	2	0.00413223140495868	484	10287	6616,6506	SNAP25,SLC1A2
R-HSA-202424	Downstream TCR signaling	0.314070925424462	-1.15813644143232	98	6	0.012396694214876	484	10287	5698,4790,5721,5699,4792,8767	PSMB9,NFKB1,PSME2,PSMB10,NFKBIA,RIPK2
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.314422448586318	-1.15701781962007	79	5	0.0103305785123967	484	10287	3008,723790,8900,3159,8091	HIST1H1E,HIST2H2AA4,CCNA1,HMGA1,HMGA2
R-HSA-1566948	Elastic fibre formation	0.316599668433422	-1.1501171788086	42	3	0.00619834710743802	484	10287	27302,650,10516	BMP10,BMP2,FBLN5
R-HSA-5576890	Phase 3 - rapid repolarisation	0.320008146074856	-1.13940882702845	8	1	0.00206611570247934	484	10287	23630	KCNE5
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.320008146074856	-1.13940882702845	8	1	0.00206611570247934	484	10287	6513	SLC2A1
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.320008146074856	-1.13940882702845	8	1	0.00206611570247934	484	10287	4688	NCF2
R-HSA-448424	Interleukin-17 signaling	0.320008146074856	-1.13940882702845	8	1	0.00206611570247934	484	10287	27189	IL17C
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	0.320008146074856	-1.13940882702845	8	1	0.00206611570247934	484	10287	57089	ENTPD7
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.320008146074856	-1.13940882702845	8	1	0.00206611570247934	484	10287	11343	MGLL
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.320008146074856	-1.13940882702845	8	1	0.00206611570247934	484	10287	6288	SAA1
R-HSA-164944	Nef and signal transduction	0.320008146074856	-1.13940882702845	8	1	0.00206611570247934	484	10287	3055	HCK
R-HSA-174430	Telomere C-strand synthesis initiation	0.320008146074856	-1.13940882702845	8	1	0.00206611570247934	484	10287	23649	POLA2
R-HSA-68952	DNA replication initiation	0.320008146074856	-1.13940882702845	8	1	0.00206611570247934	484	10287	23649	POLA2
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.320008146074856	-1.13940882702845	8	1	0.00206611570247934	484	10287	9945	GFPT2
R-HSA-422356	Regulation of insulin secretion	0.323784448580517	-1.12767726674708	80	5	0.0103305785123967	484	10287	4082,6513,150,6616,3710	MARCKS,SLC2A1,ADRA2A,SNAP25,ITPR3
R-HSA-202403	TCR signaling	0.327562708052226	-1.11607576726719	119	7	0.0144628099173554	484	10287	5721,5699,5698,4790,8767,3937,4792	PSME2,PSMB10,PSMB9,NFKB1,RIPK2,LCP2,NFKBIA
R-HSA-375280	Amine ligand-binding receptors	0.329672209994067	-1.10965642122229	43	3	0.00619834710743802	484	10287	147,150,134864	ADRA1B,ADRA2A,TAAR1
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.329672209994067	-1.10965642122229	43	3	0.00619834710743802	484	10287	2495,6288,8578	FTH1,SAA1,SCARF1
R-HSA-3000157	Laminin interactions	0.330326286943388	-1.10767436469796	25	2	0.00413223140495868	484	10287	3914,3918	LAMB3,LAMC2
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.330326286943388	-1.10767436469796	25	2	0.00413223140495868	484	10287	7296,7295	TXNRD1,TXN
R-HSA-1614635	Sulfur amino acid metabolism	0.330326286943388	-1.10767436469796	25	2	0.00413223140495868	484	10287	2730,58472	GCLM,SQOR
R-HSA-211981	Xenobiotics	0.330326286943388	-1.10767436469796	25	2	0.00413223140495868	484	10287	1577,1551	CYP3A5,CYP3A7
R-HSA-5654708	Downstream signaling of activated FGFR3	0.330326286943388	-1.10767436469796	25	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-1251985	Nuclear signaling by ERBB4	0.330326286943388	-1.10767436469796	25	2	0.00413223140495868	484	10287	1839,2069	HBEGF,EREG
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.330326286943388	-1.10767436469796	25	2	0.00413223140495868	484	10287	6890,6891	TAP1,TAP2
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.330326286943388	-1.10767436469796	25	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-425410	Metal ion SLC transporters	0.330326286943388	-1.10767436469796	25	2	0.00413223140495868	484	10287	84102,64116	SLC41A2,SLC39A8
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.333609779060758	-1.0977832951959	62	4	0.00826446280991736	484	10287	5721,5699,5698,1080	PSME2,PSMB10,PSMB9,CFTR
R-HSA-69239	Synthesis of DNA	0.339266089359022	-1.08097055513081	101	6	0.012396694214876	484	10287	23649,5721,5699,8900,5698,64785	POLA2,PSME2,PSMB10,CCNA1,PSMB9,GINS3
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.3477578477084	-1.05624888133502	26	2	0.00413223140495868	484	10287	6385,375790	SDC4,AGRN
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.3477578477084	-1.05624888133502	26	2	0.00413223140495868	484	10287	6385,375790	SDC4,AGRN
R-HSA-73848	Pyrimidine metabolism	0.3477578477084	-1.05624888133502	26	2	0.00413223140495868	484	10287	51733,1890	UPB1,TYMP
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.352026441373987	-1.04404898866548	9	1	0.00206611570247934	484	10287	9353	SLIT2
R-HSA-2453864	Retinoid cycle disease events	0.352026441373987	-1.04404898866548	9	1	0.00206611570247934	484	10287	64220	STRA6
R-HSA-447041	CHL1 interactions	0.352026441373987	-1.04404898866548	9	1	0.00206611570247934	484	10287	286	ANK1
R-HSA-428543	Inactivation of Cdc42 and Rac	0.352026441373987	-1.04404898866548	9	1	0.00206611570247934	484	10287	9353	SLIT2
R-HSA-1614558	Degradation of cysteine and homocysteine	0.352026441373987	-1.04404898866548	9	1	0.00206611570247934	484	10287	58472	SQOR
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.352026441373987	-1.04404898866548	9	1	0.00206611570247934	484	10287	81894	SLC25A28
R-HSA-2474795	Diseases associated with visual transduction	0.352026441373987	-1.04404898866548	9	1	0.00206611570247934	484	10287	64220	STRA6
R-HSA-193697	p75NTR regulates axonogenesis	0.352026441373987	-1.04404898866548	9	1	0.00206611570247934	484	10287	4803	NGF
R-HSA-162592	Integration of provirus	0.352026441373987	-1.04404898866548	9	1	0.00206611570247934	484	10287	3159	HMGA1
R-HSA-112411	MAPK1 (ERK2) activation	0.352026441373987	-1.04404898866548	9	1	0.00206611570247934	484	10287	3569	IL6
R-HSA-77387	Insulin receptor recycling	0.365035087947379	-1.00776179865729	27	2	0.00413223140495868	484	10287	50617,245973	ATP6V0A4,ATP6V1C2
R-HSA-5654716	Downstream signaling of activated FGFR4	0.365035087947379	-1.00776179865729	27	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-1257604	PIP3 activates AKT signaling	0.373958811943016	-0.983609616126802	125	7	0.0144628099173554	484	10287	1839,26281,4233,2247,941,2069,8503	HBEGF,FGF20,MET,FGF2,CD80,EREG,PIK3R3
R-HSA-1266738	Developmental Biology	0.378649438509796	-0.971144466297311	1075	53	0.109504132231405	484	10287	3561,1848,4023,8828,5317,4790,85441,4211,1437,5699,80031,3868,26281,1943,1839,9119,5698,1844,688,8503,3855,286,375790,9353,10125,1000,4629,1847,6461,6708,2048,55203,3725,3854,4233,5880,5721,2668,2069,1850,723790,5266,27289,4067,214,6092,137970,3849,3559,2312,2247,2886,4318	IL2RG,DUSP6,LPL,NRP2,PKP1,NFKB1,HELZ2,MEIS1,CSF2,PSMB10,SEMA6D,KRT16,FGF20,EFNA2,HBEGF,KRT75,PSMB9,DUSP2,KLF5,PIK3R3,KRT7,ANK1,AGRN,SLIT2,RASGRP1,CDH2,MYH11,DUSP5,SHB,SPTA1,EPHB2,LGI2,JUN,KRT6B,MET,RAC2,PSME2,GDNF,EREG,DUSP8,HIST2H2AA4,PI3,RND1,LYN,ALCAM,ROBO2,UNC5D,KRT2,IL2RA,FLG,FGF2,GRB7,MMP9
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.380383613479186	-0.966575026317646	86	5	0.0103305785123967	484	10287	3055,644150,3710,2268,4067	HCK,WIPF3,ITPR3,FGR,LYN
R-HSA-8948216	Collagen chain trimerization	0.381760066245556	-0.962962966545892	47	3	0.00619834710743802	484	10287	1294,1305,169044	COL7A1,COL13A1,COL22A1
R-HSA-1483191	Synthesis of PC	0.382133959911252	-0.961984051453613	28	2	0.00413223140495868	484	10287	84879,80736	MFSD2A,SLC44A4
R-HSA-190377	FGFR2b ligand binding and activation	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	2247	FGF2
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	3656	IRAK2
R-HSA-110056	MAPK3 (ERK1) activation	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	3569	IL6
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	64116	SLC39A8
R-HSA-8875656	MET receptor recycling	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	4233	MET
R-HSA-399997	Acetylcholine regulates insulin secretion	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	4082	MARCKS
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	9108	MTMR7
R-HSA-193692	Regulated proteolysis of p75NTR	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	4790	NFKB1
R-HSA-427601	Multifunctional anion exchangers	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	115019	SLC26A9
R-HSA-1300644	Interaction With The Zona Pellucida	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	7784	ZP3
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	6580	SLC22A1
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	117283	IP6K3
R-HSA-2161522	Abacavir transport and metabolism	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	6580	SLC22A1
R-HSA-74259	Purine catabolism	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	7498	XDH
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	3725	JUN
R-HSA-196108	Pregnenolone biosynthesis	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	231	AKR1B1
R-HSA-418886	Netrin mediated repulsion signals	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	137970	UNC5D
R-HSA-168799	Neurotoxicity of clostridium toxins	0.38254008239181	-0.96092184063887	10	1	0.00206611570247934	484	10287	6616	SNAP25
R-HSA-4608870	Asymmetric localization of PCP proteins	0.387719208766895	-0.947473890093086	67	4	0.00826446280991736	484	10287	7474,5699,5721,5698	WNT5A,PSMB10,PSME2,PSMB9
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.394664242257452	-0.929719895153916	48	3	0.00619834710743802	484	10287	56938,10135,85441	ARNTL2,NAMPT,HELZ2
R-HSA-418597	G alpha (z) signalling events	0.394664242257452	-0.929719895153916	48	3	0.00619834710743802	484	10287	5999,26575,150	RGS4,RGS17,ADRA2A
R-HSA-180292	GAB1 signalosome	0.39731758950031	-0.923019344550824	128	7	0.0144628099173554	484	10287	941,2069,8503,2247,1839,26281,4233	CD80,EREG,PIK3R3,FGF2,HBEGF,FGF20,MET
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.398498340679476	-0.920051944676531	68	4	0.00826446280991736	484	10287	4790,6288,4792,4791	NFKB1,SAA1,NFKBIA,NFKB2
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.399033010761045	-0.918711131777566	29	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-3858494	Beta-catenin independent WNT signaling	0.402801607615688	-0.909311127044185	149	8	0.0165289256198347	484	10287	7474,5698,23002,5880,3710,51176,5721,5699	WNT5A,PSMB9,DAAM1,RAC2,ITPR3,LEF1,PSME2,PSMB10
R-HSA-69306	DNA Replication	0.407151730741648	-0.89856936020821	109	6	0.012396694214876	484	10287	64785,5698,5699,8900,5721,23649	GINS3,PSMB9,PSMB10,CCNA1,PSME2,POLA2
R-HSA-5619084	ABC transporter disorders	0.409245292669731	-0.89344056513124	69	4	0.00826446280991736	484	10287	1080,5698,5721,5699	CFTR,PSMB9,PSME2,PSMB10
R-HSA-71288	Creatine metabolism	0.411619638686451	-0.887655563122448	11	1	0.00206611570247934	484	10287	6534	SLC6A7
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.411619638686451	-0.887655563122448	11	1	0.00206611570247934	484	10287	7097	TLR2
R-HSA-1059683	Interleukin-6 signaling	0.411619638686451	-0.887655563122448	11	1	0.00206611570247934	484	10287	3569	IL6
R-HSA-1980150	Signaling by NOTCH4	0.411619638686451	-0.887655563122448	11	1	0.00206611570247934	484	10287	54567	DLL4
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.411619638686451	-0.887655563122448	11	1	0.00206611570247934	484	10287	5317	PKP1
R-HSA-8851805	MET activates RAS signaling	0.411619638686451	-0.887655563122448	11	1	0.00206611570247934	484	10287	4233	MET
R-HSA-5660526	Response to metal ions	0.411619638686451	-0.887655563122448	11	1	0.00206611570247934	484	10287	4504	MT3
R-HSA-1980148	Signaling by NOTCH3	0.411619638686451	-0.887655563122448	11	1	0.00206611570247934	484	10287	54567	DLL4
R-HSA-8875555	MET activates RAP1 and RAC1	0.411619638686451	-0.887655563122448	11	1	0.00206611570247934	484	10287	4233	MET
R-HSA-5661231	Metallothioneins bind metals	0.411619638686451	-0.887655563122448	11	1	0.00206611570247934	484	10287	4504	MT3
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.411619638686451	-0.887655563122448	11	1	0.00206611570247934	484	10287	7097	TLR2
R-HSA-549127	Organic cation transport	0.411619638686451	-0.887655563122448	11	1	0.00206611570247934	484	10287	6580	SLC22A1
R-HSA-73614	Pyrimidine salvage reactions	0.411619638686451	-0.887655563122448	11	1	0.00206611570247934	484	10287	1890	TYMP
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.411619638686451	-0.887655563122448	11	1	0.00206611570247934	484	10287	259307	IL4I1
R-HSA-69242	S Phase	0.412892072737519	-0.884569045263208	130	7	0.0144628099173554	484	10287	595,23649,64785,5698,5699,5721,8900	CCND1,POLA2,GINS3,PSMB9,PSMB10,PSME2,CCNA1
R-HSA-195721	Signaling by Wnt	0.414168248185684	-0.881482991129771	336	17	0.0351239669421488	484	10287	51176,3710,284654,83595,6658,84870,64321,27121,723790,5698,8313,5880,5699,5721,7474,23002,857	LEF1,ITPR3,RSPO1,SOX7,SOX3,RSPO3,SOX17,DKK4,HIST2H2AA4,PSMB9,AXIN2,RAC2,PSMB10,PSME2,WNT5A,DAAM1,CAV1
R-HSA-917977	Transferrin endocytosis and recycling	0.415713192477347	-0.877759697654947	30	2	0.00413223140495868	484	10287	245973,50617	ATP6V1C2,ATP6V0A4
R-HSA-420092	Glucagon-type ligand receptors	0.415713192477347	-0.877759697654947	30	2	0.00413223140495868	484	10287	2642,9340	GCGR,GLP2R
R-HSA-445095	Interaction between L1 and Ankyrins	0.415713192477347	-0.877759697654947	30	2	0.00413223140495868	484	10287	286,6708	ANK1,SPTA1
R-HSA-5654696	Downstream signaling of activated FGFR2	0.415713192477347	-0.877759697654947	30	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-5683826	Surfactant metabolism	0.415713192477347	-0.877759697654947	30	2	0.00413223140495868	484	10287	135,150	ADORA2A,ADRA2A
R-HSA-8863795	Downregulation of ERBB2 signaling	0.415713192477347	-0.877759697654947	30	2	0.00413223140495868	484	10287	2069,1839	EREG,HBEGF
R-HSA-5654736	Signaling by FGFR1	0.420247091323005	-0.866912428018958	50	3	0.00619834710743802	484	10287	2247,26281,23767	FGF2,FGF20,FLRT3
R-HSA-163685	Integration of energy metabolism	0.424104710575327	-0.857774895335436	111	6	0.012396694214876	484	10287	150,6616,3710,2642,4082,6513	ADRA2A,SNAP25,ITPR3,GCGR,MARCKS,SLC2A1
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.43215768384509	-0.838964748436899	31	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-2022928	HS-GAG biosynthesis	0.43215768384509	-0.838964748436899	31	2	0.00413223140495868	484	10287	375790,6385	AGRN,SDC4
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.43215768384509	-0.838964748436899	31	2	0.00413223140495868	484	10287	1848,3725	DUSP6,JUN
R-HSA-418990	Adherens junctions interactions	0.43215768384509	-0.838964748436899	31	2	0.00413223140495868	484	10287	5818,1000	NECTIN1,CDH2
R-HSA-1839124	FGFR1 mutant receptor activation	0.43215768384509	-0.838964748436899	31	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-1227986	Signaling by ERBB2	0.432904482776798	-0.837238169363058	51	3	0.00619834710743802	484	10287	1839,2069,2886	HBEGF,EREG,GRB7
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.432904482776798	-0.837238169363058	51	3	0.00619834710743802	484	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.432904482776798	-0.837238169363058	51	3	0.00619834710743802	484	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-112310	Neurotransmitter Release Cycle	0.432904482776798	-0.837238169363058	51	3	0.00619834710743802	484	10287	6616,6506,6580	SNAP25,SLC1A2,SLC22A1
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.432904482776798	-0.837238169363058	51	3	0.00619834710743802	484	10287	6385,375790,50515	SDC4,AGRN,CHST11
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	0.439332376614757	-0.822499030250052	12	1	0.00206611570247934	484	10287	8626	TP63
R-HSA-209822	Glycoprotein hormones	0.439332376614757	-0.822499030250052	12	1	0.00206611570247934	484	10287	3624	INHBA
R-HSA-844456	The NLRP3 inflammasome	0.439332376614757	-0.822499030250052	12	1	0.00206611570247934	484	10287	7295	TXN
R-HSA-203615	eNOS activation	0.439332376614757	-0.822499030250052	12	1	0.00206611570247934	484	10287	857	CAV1
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	0.439332376614757	-0.822499030250052	12	1	0.00206611570247934	484	10287	2643	GCH1
R-HSA-176974	Unwinding of DNA	0.439332376614757	-0.822499030250052	12	1	0.00206611570247934	484	10287	64785	GINS3
R-HSA-2160916	Hyaluronan uptake and degradation	0.439332376614757	-0.822499030250052	12	1	0.00206611570247934	484	10287	960	CD44
R-HSA-389359	CD28 dependent Vav1 pathway	0.439332376614757	-0.822499030250052	12	1	0.00206611570247934	484	10287	941	CD80
R-HSA-4641265	Repression of WNT target genes	0.439332376614757	-0.822499030250052	12	1	0.00206611570247934	484	10287	51176	LEF1
R-HSA-1236977	Endosomal/Vacuolar pathway	0.439332376614757	-0.822499030250052	12	1	0.00206611570247934	484	10287	1520	CTSS
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	0.439332376614757	-0.822499030250052	12	1	0.00206611570247934	484	10287	8626	TP63
R-HSA-1475029	Reversible hydration of carbon dioxide	0.439332376614757	-0.822499030250052	12	1	0.00206611570247934	484	10287	771	CA12
R-HSA-210990	PECAM1 interactions	0.439332376614757	-0.822499030250052	12	1	0.00206611570247934	484	10287	4067	LYN
R-HSA-6794362	Protein-protein interactions at synapses	0.441223326217044	-0.818204123061453	72	4	0.00826446280991736	484	10287	9378,9369,9228,9456	NRXN1,NRXN3,DLGAP2,HOMER1
R-HSA-68949	Orc1 removal from chromatin	0.441223326217044	-0.818204123061453	72	4	0.00826446280991736	484	10287	8900,5721,5699,5698	CCNA1,PSME2,PSMB10,PSMB9
R-HSA-69052	Switching of origins to a post-replicative state	0.441223326217044	-0.818204123061453	72	4	0.00826446280991736	484	10287	5721,5699,8900,5698	PSME2,PSMB10,CCNA1,PSMB9
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.445459441930476	-0.808649075653378	52	3	0.00619834710743802	484	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.445459441930476	-0.808649075653378	52	3	0.00619834710743802	484	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-69190	DNA strand elongation	0.448351723808348	-0.802177256808717	32	2	0.00413223140495868	484	10287	23649,64785	POLA2,GINS3
R-HSA-376176	Signaling by Robo receptor	0.448351723808348	-0.802177256808717	32	2	0.00413223140495868	484	10287	6092,9353	ROBO2,SLIT2
R-HSA-1980143	Signaling by NOTCH1	0.451773253291304	-0.794574877029762	73	4	0.00826446280991736	484	10287	113878,10046,54567,92737	DTX2,MAMLD1,DLL4,DNER
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.451773253291304	-0.794574877029762	73	4	0.00826446280991736	484	10287	5699,8900,5721,5698	PSMB10,CCNA1,PSME2,PSMB9
R-HSA-73923	Lipid digestion, mobilization, and transport	0.457777616507225	-0.781371766264889	115	6	0.012396694214876	484	10287	4023,11343,857,119548,29923,9388	LPL,MGLL,CAV1,PNLIPRP3,HILPDA,LIPG
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.457902970459233	-0.781097972204874	53	3	0.00619834710743802	484	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-75153	Apoptotic execution  phase	0.457902970459233	-0.781097972204874	53	3	0.00619834710743802	484	10287	5317,3008,660	PKP1,HIST1H1E,BMX
R-HSA-180534	Vpu mediated degradation of CD4	0.457902970459233	-0.781097972204874	53	3	0.00619834710743802	484	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-69300	Removal of licensing factors from origins	0.462258285439293	-0.771631484723472	74	4	0.00826446280991736	484	10287	5698,8900,5699,5721	PSMB9,CCNA1,PSMB10,PSME2
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.462258285439293	-0.771631484723472	74	4	0.00826446280991736	484	10287	5698,8900,5721,5699	PSMB9,CCNA1,PSME2,PSMB10
R-HSA-1839126	FGFR2 mutant receptor activation	0.464282455580789	-0.767262171487369	33	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-1980145	Signaling by NOTCH2	0.464282455580789	-0.767262171487369	33	2	0.00413223140495868	484	10287	54567,10046	DLL4,MAMLD1
R-HSA-4085001	Sialic acid metabolism	0.464282455580789	-0.767262171487369	33	2	0.00413223140495868	484	10287	6482,6484	ST3GAL1,ST3GAL4
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.464282455580789	-0.767262171487369	33	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-211227	Activation of DNA fragmentation factor	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	3008	HIST1H1E
R-HSA-425561	Sodium/Calcium exchangers	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	6547	SLC8A3
R-HSA-1502540	Signaling by Activin	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	3624	INHBA
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	6288	SAA1
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	10046	MAMLD1
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	51700	CYB5R2
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	23649	POLA2
R-HSA-74217	Purine salvage	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	272	AMPD3
R-HSA-140342	Apoptosis induced DNA fragmentation	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	3008	HIST1H1E
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	7474	WNT5A
R-HSA-202670	ERKs are inactivated	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	1848	DUSP6
R-HSA-5658623	FGFRL1 modulation of FGFR1 signaling	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	2247	FGF2
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	2247	FGF2
R-HSA-350054	Notch-HLH transcription pathway	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	10046	MAMLD1
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	3710	ITPR3
R-HSA-432047	Passive transport by Aquaporins	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	366	AQP9
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.465742413563031	-0.764122558279303	13	1	0.00206611570247934	484	10287	51700	CYB5R2
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.470226696998372	-0.754540366524616	54	3	0.00619834710743802	484	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.470226696998372	-0.754540366524616	54	3	0.00619834710743802	484	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-69610	p53-Independent DNA Damage Response	0.470226696998372	-0.754540366524616	54	3	0.00619834710743802	484	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-169911	Regulation of Apoptosis	0.470226696998372	-0.754540366524616	54	3	0.00619834710743802	484	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-211859	Biological oxidations	0.474329757588939	-0.745852508052044	222	11	0.0227272727272727	484	10287	874,1594,1586,54498,27233,9420,1577,1551,2730,1581,1591	CBR3,CYP27B1,CYP17A1,SMOX,SULT1C4,CYP7B1,CYP3A5,CYP3A7,GCLM,CYP7A1,CYP24A1
R-HSA-5694530	Cargo concentration in the ER	0.479938780711763	-0.734096723397969	34	2	0.00413223140495868	484	10287	374,1294	AREG,COL7A1
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.479938780711763	-0.734096723397969	34	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-113510	E2F mediated regulation of DNA replication	0.479938780711763	-0.734096723397969	34	2	0.00413223140495868	484	10287	8900,23649	CCNA1,POLA2
R-HSA-73847	Purine metabolism	0.479938780711763	-0.734096723397969	34	2	0.00413223140495868	484	10287	7498,272	XDH,AMPD3
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.482422859088596	-0.728934248521461	55	3	0.00619834710743802	484	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-193704	p75 NTR receptor-mediated signalling	0.48299327879787	-0.727752540958746	97	5	0.0103305785123967	484	10287	4792,8767,4803,4790,26230	NFKBIA,RIPK2,NGF,NFKB1,TIAM2
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.483011217552844	-0.727715400852166	76	4	0.00826446280991736	484	10287	5699,8900,5721,5698	PSMB10,CCNA1,PSME2,PSMB9
R-HSA-5619115	Disorders of transmembrane transporters	0.483011217552844	-0.727715400852166	76	4	0.00826446280991736	484	10287	5698,5721,5699,1080	PSMB9,PSME2,PSMB10,CFTR
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.490910865168886	-0.711492705001757	14	1	0.00206611570247934	484	10287	23649	POLA2
R-HSA-69166	Removal of the Flap Intermediate	0.490910865168886	-0.711492705001757	14	1	0.00206611570247934	484	10287	23649	POLA2
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	0.490910865168886	-0.711492705001757	14	1	0.00206611570247934	484	10287	8626	TP63
R-HSA-1679131	Trafficking and processing of endosomal TLR	0.490910865168886	-0.711492705001757	14	1	0.00206611570247934	484	10287	1520	CTSS
R-HSA-69091	Polymerase switching	0.490910865168886	-0.711492705001757	14	1	0.00206611570247934	484	10287	23649	POLA2
R-HSA-177504	Retrograde neurotrophin signalling	0.490910865168886	-0.711492705001757	14	1	0.00206611570247934	484	10287	4803	NGF
R-HSA-69109	Leading Strand Synthesis	0.490910865168886	-0.711492705001757	14	1	0.00206611570247934	484	10287	23649	POLA2
R-HSA-174403	Glutathione synthesis and recycling	0.490910865168886	-0.711492705001757	14	1	0.00206611570247934	484	10287	2730	GCLM
R-HSA-428540	Activation of Rac	0.490910865168886	-0.711492705001757	14	1	0.00206611570247934	484	10287	9353	SLIT2
R-HSA-209952	Peptide hormone biosynthesis	0.490910865168886	-0.711492705001757	14	1	0.00206611570247934	484	10287	3624	INHBA
R-HSA-877312	Regulation of IFNG signaling	0.490910865168886	-0.711492705001757	14	1	0.00206611570247934	484	10287	3460	IFNGR2
R-HSA-5675482	Regulation of necroptotic cell death	0.490910865168886	-0.711492705001757	14	1	0.00206611570247934	484	10287	330	BIRC3
R-HSA-69206	G1/S Transition	0.490959904422273	-0.711392815576495	119	6	0.012396694214876	484	10287	5721,5699,8900,5698,595,23649	PSME2,PSMB10,CCNA1,PSMB9,CCND1,POLA2
R-HSA-69304	Regulation of DNA replication	0.493268599281904	-0.706701427173695	77	4	0.00826446280991736	484	10287	5699,8900,5721,5698	PSMB10,CCNA1,PSME2,PSMB9
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.493268599281904	-0.706701427173695	77	4	0.00826446280991736	484	10287	5698,8900,5721,5699	PSMB9,CCNA1,PSME2,PSMB10
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	0.494484284409285	-0.704239909194288	56	3	0.00619834710743802	484	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.494484284409285	-0.704239909194288	56	3	0.00619834710743802	484	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-5578775	Ion homeostasis	0.494484284409285	-0.704239909194288	56	3	0.00619834710743802	484	10287	6547,490,3710	SLC8A3,ATP2B1,ITPR3
R-HSA-69541	Stabilization of p53	0.494484284409285	-0.704239909194288	56	3	0.00619834710743802	484	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-6804757	Regulation of TP53 Degradation	0.495311222789515	-0.702568981075062	35	2	0.00413223140495868	484	10287	6446,8900	SGK1,CCNA1
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.495311222789515	-0.702568981075062	35	2	0.00413223140495868	484	10287	5957,2986	RCVRN,GUCY2F
R-HSA-1430728	Metabolism	0.497509976837397	-0.69813966864005	2158	102	0.210743801652893	484	10287	50486,3038,10135,259307,51700,9420,6534,9388,2181,9108,8942,1594,4504,272,29923,7295,57089,26230,669,6482,8875,6385,119548,117283,5721,8876,8140,8503,80736,4363,5698,8714,80168,2642,660,1645,3290,4082,3710,54498,11343,6484,1586,51733,1118,81894,150,960,3620,1646,2710,6611,9435,6716,4023,1581,952,1577,3162,5699,3099,130367,1591,1890,2182,2730,50515,242,441024,7296,9536,6616,231,2643,54625,5743,874,84879,857,8564,27242,3638,6303,79993,1551,771,247,27233,375790,3036,6999,7498,1644,51703,9023,441282,25816,6580,51365,58472,6513,85441	G0S2,HAS3,NAMPT,IL4I1,CYB5R2,CYP7B1,SLC6A7,LIPG,ACSL3,MTMR7,KYNU,CYP27B1,MT3,AMPD3,HILPDA,TXN,ENTPD7,TIAM2,BPGM,ST3GAL1,VNN2,SDC4,PNLIPRP3,IP6K3,PSME2,VNN1,SLC7A5,PIK3R3,SLC44A4,ABCC1,PSMB9,ABCC3,MOGAT2,GCGR,BMX,AKR1C1,HSD11B1,MARCKS,ITPR3,SMOX,MGLL,ST3GAL4,CYP17A1,UPB1,CHIT1,SLC25A28,ADRA2A,CD44,IDO1,AKR1C2,GK,SMS,CHST2,SRD5A2,LPL,CYP7A1,CD38,CYP3A5,HMOX1,PSMB10,HK2,SGPP2,CYP24A1,TYMP,ACSL4,GCLM,CHST11,ALOX12B,MTHFD2L,TXNRD1,PTGES,SNAP25,AKR1B1,GCH1,PARP14,PTGS2,CBR3,MFSD2A,CAV1,KMO,TNFRSF21,INSIG1,SAT1,ELOVL7,CYP3A7,CA12,ALOX15B,SULT1C4,AGRN,HAS1,TDO2,XDH,DDC,ACSL5,CH25H,AKR1B15,TNFAIP8,SLC22A1,PLA1A,SQOR,SLC2A1,HELZ2
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.506404371563416	-0.680419775560253	57	3	0.00619834710743802	484	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-3000178	ECM proteoglycans	0.506404371563416	-0.680419775560253	57	3	0.00619834710743802	484	10287	63923,3687,375790	TNN,ITGAX,AGRN
R-HSA-167021	PLC-gamma1 signalling	0.510391799793419	-0.672576613316085	36	2	0.00413223140495868	484	10287	3710,4803	ITPR3,NGF
R-HSA-2514856	The phototransduction cascade	0.510391799793419	-0.672576613316085	36	2	0.00413223140495868	484	10287	2986,5957	GUCY2F,RCVRN
R-HSA-453279	Mitotic G1-G1/S phases	0.51250389825828	-0.668446961640882	143	7	0.0144628099173554	484	10287	5698,8900,5699,5721,1030,23649,595	PSMB9,CCNA1,PSMB10,PSME2,CDKN2B,POLA2,CCND1
R-HSA-1483255	PI Metabolism	0.513520981911383	-0.666464389861375	79	4	0.00826446280991736	484	10287	8503,25816,660,9108	PIK3R3,TNFAIP8,BMX,MTMR7
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	0.514895985513238	-0.663790368594272	15	1	0.00206611570247934	484	10287	4233	MET
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.514895985513238	-0.663790368594272	15	1	0.00206611570247934	484	10287	54567	DLL4
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.514895985513238	-0.663790368594272	15	1	0.00206611570247934	484	10287	27289	RND1
R-HSA-5682910	LGI-ADAM interactions	0.514895985513238	-0.663790368594272	15	1	0.00206611570247934	484	10287	55203	LGI2
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.514895985513238	-0.663790368594272	15	1	0.00206611570247934	484	10287	637	BID
R-HSA-205043	NRIF signals cell death from the nucleus	0.514895985513238	-0.663790368594272	15	1	0.00206611570247934	484	10287	4803	NGF
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.514895985513238	-0.663790368594272	15	1	0.00206611570247934	484	10287	54567	DLL4
R-HSA-975577	N-Glycan antennae elongation	0.514895985513238	-0.663790368594272	15	1	0.00206611570247934	484	10287	6484	ST3GAL4
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.514895985513238	-0.663790368594272	15	1	0.00206611570247934	484	10287	7474	WNT5A
R-HSA-69183	Processive synthesis on the lagging strand	0.514895985513238	-0.663790368594272	15	1	0.00206611570247934	484	10287	23649	POLA2
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.51817707038077	-0.657438260422917	58	3	0.00619834710743802	484	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-373760	L1CAM interactions	0.518954811756173	-0.655938467514059	101	5	0.0103305785123967	484	10287	6708,214,2048,286,8828	SPTA1,ALCAM,EPHB2,ANK1,NRP2
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	0.525173905071109	-0.644025823486446	37	2	0.00413223140495868	484	10287	56999,9507	ADAMTS9,ADAMTS4
R-HSA-419037	NCAM1 interactions	0.525173905071109	-0.644025823486446	37	2	0.00413223140495868	484	10287	375790,2668	AGRN,GDNF
R-HSA-4641258	Degradation of DVL	0.529796862047933	-0.635261625061042	59	3	0.00619834710743802	484	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.531108326796089	-0.632789273280738	253	12	0.0247933884297521	484	10287	2181,7296,27242,2182,80168,51703,1581,79993,50486,26230,2710,85441	ACSL3,TXNRD1,TNFRSF21,ACSL4,MOGAT2,ACSL5,CYP7A1,ELOVL7,G0S2,TIAM2,GK,HELZ2
R-HSA-1989781	PPARA activates gene expression	0.531453936889552	-0.632138751203186	124	6	0.012396694214876	484	10287	26230,50486,1581,85441,7296,27242	TIAM2,G0S2,CYP7A1,HELZ2,TXNRD1,TNFRSF21
R-HSA-71387	Metabolism of carbohydrates	0.53155417828175	-0.631950151716381	296	14	0.0289256198347107	484	10287	50515,669,6482,9435,960,3038,6513,1118,3099,6484,375790,3036,6385,231	CHST11,BPGM,ST3GAL1,CHST2,CD44,HAS3,SLC2A1,CHIT1,HK2,ST3GAL4,AGRN,HAS1,SDC4,AKR1B1
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.533394408662951	-0.628494149735826	81	4	0.00826446280991736	484	10287	5698,5721,5699,8900	PSMB9,PSME2,PSMB10,CCNA1
R-HSA-71291	Metabolism of amino acids and derivatives	0.53476407759316	-0.625929605806226	361	17	0.0351239669421488	484	10287	8140,58472,5721,5699,8564,6611,1644,3620,6999,8942,54498,7296,6534,2730,259307,6303,5698	SLC7A5,SQOR,PSME2,PSMB10,KMO,SMS,DDC,IDO1,TDO2,KYNU,SMOX,TXNRD1,SLC6A7,GCLM,IL4I1,SAT1,PSMB9
R-HSA-5218859	Regulated Necrosis	0.537753300830564	-0.620355372628007	16	1	0.00206611570247934	484	10287	330	BIRC3
R-HSA-1433559	Regulation of KIT signaling	0.537753300830564	-0.620355372628007	16	1	0.00206611570247934	484	10287	4067	LYN
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.537753300830564	-0.620355372628007	16	1	0.00206611570247934	484	10287	5277	PIGA
R-HSA-392517	Rap1 signalling	0.537753300830564	-0.620355372628007	16	1	0.00206611570247934	484	10287	10125	RASGRP1
R-HSA-159418	Recycling of bile acids and salts	0.537753300830564	-0.620355372628007	16	1	0.00206611570247934	484	10287	8714	ABCC3
R-HSA-549132	Organic cation/anion/zwitterion transport	0.537753300830564	-0.620355372628007	16	1	0.00206611570247934	484	10287	6580	SLC22A1
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.537753300830564	-0.620355372628007	16	1	0.00206611570247934	484	10287	135	ADORA2A
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.537753300830564	-0.620355372628007	16	1	0.00206611570247934	484	10287	330	BIRC3
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.537753300830564	-0.620355372628007	16	1	0.00206611570247934	484	10287	3656	IRAK2
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.539652196032893	-0.616830428353931	38	2	0.00413223140495868	484	10287	150,10125	ADRA2A,RASGRP1
R-HSA-5655302	Signaling by FGFR1 in disease	0.539652196032893	-0.616830428353931	38	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.541258739069652	-0.613857853708667	60	3	0.00619834710743802	484	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.541258739069652	-0.613857853708667	60	3	0.00619834710743802	484	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.543179086712316	-0.610316203640222	82	4	0.00826446280991736	484	10287	7295,54541,8626,7296	TXN,DDIT4,TP63,TXNRD1
R-HSA-2672351	Stimuli-sensing channels	0.545216771526808	-0.606571817478085	104	5	0.0103305785123967	484	10287	23327,6446,6338,8989,266675	NEDD4L,SGK1,SCNN1B,TRPA1,BEST4
R-HSA-4086398	Ca2+ pathway	0.552558185117792	-0.593196538704801	61	3	0.00619834710743802	484	10287	7474,51176,3710	WNT5A,LEF1,ITPR3
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	0.552558185117792	-0.593196538704801	61	3	0.00619834710743802	484	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.552558185117792	-0.593196538704801	61	3	0.00619834710743802	484	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.552558185117792	-0.593196538704801	61	3	0.00619834710743802	484	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.552558185117792	-0.593196538704801	61	3	0.00619834710743802	484	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.552857627912833	-0.592654764652294	83	4	0.00826446280991736	484	10287	5699,51176,5721,5698	PSMB10,LEF1,PSME2,PSMB9
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.553822490219308	-0.590911058345225	39	2	0.00413223140495868	484	10287	56999,9507	ADAMTS9,ADAMTS4
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	0.553822490219308	-0.590911058345225	39	2	0.00413223140495868	484	10287	2918,2914	GRM8,GRM4
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.553822490219308	-0.590911058345225	39	2	0.00413223140495868	484	10287	4067,3710	LYN,ITPR3
R-HSA-69231	Cyclin D associated events in G1	0.553822490219308	-0.590911058345225	39	2	0.00413223140495868	484	10287	595,1030	CCND1,CDKN2B
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.553822490219308	-0.590911058345225	39	2	0.00413223140495868	484	10287	660,5317	BMX,PKP1
R-HSA-69236	G1 Phase	0.553822490219308	-0.590911058345225	39	2	0.00413223140495868	484	10287	595,1030	CCND1,CDKN2B
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.555099880476634	-0.588607216604664	127	6	0.012396694214876	484	10287	1581,26230,50486,27242,85441,7296	CYP7A1,TIAM2,G0S2,TNFRSF21,HELZ2,TXNRD1
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.559535737065484	-0.580647880051942	17	1	0.00206611570247934	484	10287	80852	GRIP2
R-HSA-5625900	RHO GTPases activate CIT	0.559535737065484	-0.580647880051942	17	1	0.00206611570247934	484	10287	4629	MYH11
R-HSA-189445	Metabolism of porphyrins	0.559535737065484	-0.580647880051942	17	1	0.00206611570247934	484	10287	3162	HMOX1
R-HSA-5627117	RHO GTPases Activate ROCKs	0.559535737065484	-0.580647880051942	17	1	0.00206611570247934	484	10287	4629	MYH11
R-HSA-432142	Platelet sensitization by LDL	0.559535737065484	-0.580647880051942	17	1	0.00206611570247934	484	10287	2268	FGR
R-HSA-622312	Inflammasomes	0.559535737065484	-0.580647880051942	17	1	0.00206611570247934	484	10287	7295	TXN
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.559535737065484	-0.580647880051942	17	1	0.00206611570247934	484	10287	3656	IRAK2
R-HSA-435354	Zinc transporters	0.559535737065484	-0.580647880051942	17	1	0.00206611570247934	484	10287	64116	SLC39A8
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.559535737065484	-0.580647880051942	17	1	0.00206611570247934	484	10287	3710	ITPR3
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.559535737065484	-0.580647880051942	17	1	0.00206611570247934	484	10287	6616	SNAP25
R-HSA-5654741	Signaling by FGFR3	0.567681668480271	-0.566194460184188	40	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	0.567681668480271	-0.566194460184188	40	2	0.00413223140495868	484	10287	4435,163732	CITED1,CITED4
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.57465405431604	-0.553987063913322	63	3	0.00619834710743802	484	10287	9945,6482,6484	GFPT2,ST3GAL1,ST3GAL4
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.580293741269747	-0.544220853179344	18	1	0.00206611570247934	484	10287	6484	ST3GAL4
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.580293741269747	-0.544220853179344	18	1	0.00206611570247934	484	10287	330	BIRC3
R-HSA-196757	Metabolism of folate and pterines	0.580293741269747	-0.544220853179344	18	1	0.00206611570247934	484	10287	441024	MTHFD2L
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.580293741269747	-0.544220853179344	18	1	0.00206611570247934	484	10287	6616	SNAP25
R-HSA-209776	Amine-derived hormones	0.580293741269747	-0.544220853179344	18	1	0.00206611570247934	484	10287	1644	DDC
R-HSA-69205	G1/S-Specific Transcription	0.580293741269747	-0.544220853179344	18	1	0.00206611570247934	484	10287	8900	CCNA1
R-HSA-1369062	ABC transporters in lipid homeostasis	0.580293741269747	-0.544220853179344	18	1	0.00206611570247934	484	10287	26154	ABCA12
R-HSA-69002	DNA Replication Pre-Initiation	0.581224904985399	-0.542617497231273	86	4	0.00826446280991736	484	10287	5699,5721,5698,23649	PSMB10,PSME2,PSMB9,POLA2
R-HSA-68874	M/G1 Transition	0.581224904985399	-0.542617497231273	86	4	0.00826446280991736	484	10287	5698,5721,5699,23649	PSMB9,PSME2,PSMB10,POLA2
R-HSA-5654743	Signaling by FGFR4	0.581227584418892	-0.542612887264814	41	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.585443720409586	-0.535385222836677	64	3	0.00619834710743802	484	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.590292660946867	-0.527136829564149	373	17	0.0351239669421488	484	10287	92369,4688,127544,221687,23327,55008,5699,5721,55521,84676,255488,6890,5698,6891,1520,10517,7097	SPSB4,NCF2,RNF19B,RNF182,NEDD4L,HERC6,PSMB10,PSME2,TRIM36,TRIM63,RNF144B,TAP1,PSMB9,TAP2,CTSS,FBXW10,TLR2
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.590448561047392	-0.526872757981778	87	4	0.00826446280991736	484	10287	8900,5721,5699,5698	CCNA1,PSME2,PSMB10,PSMB9
R-HSA-453276	Regulation of mitotic cell cycle	0.590448561047392	-0.526872757981778	87	4	0.00826446280991736	484	10287	5699,5721,8900,5698	PSMB10,PSME2,CCNA1,PSMB9
R-HSA-3928662	EPHB-mediated forward signaling	0.594458980229198	-0.520103564005252	42	2	0.00413223140495868	484	10287	4067,2048	LYN,EPHB2
R-HSA-373752	Netrin-1 signaling	0.594458980229198	-0.520103564005252	42	2	0.00413223140495868	484	10287	137970,9353	UNC5D,SLIT2
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.599552077040683	-0.511572440829974	88	4	0.00826446280991736	484	10287	4023,688,4790,85441	LPL,KLF5,NFKB1,HELZ2
R-HSA-416482	G alpha (12/13) signalling events	0.599552077040683	-0.511572440829974	88	4	0.00826446280991736	484	10287	5880,147,26230,8503	RAC2,ADRA1B,TIAM2,PIK3R3
R-HSA-446728	Cell junction organization	0.599552077040683	-0.511572440829974	88	4	0.00826446280991736	484	10287	5818,3918,3914,1000	NECTIN1,LAMC2,LAMB3,CDH2
R-HSA-190861	Gap junction assembly	0.600075397627108	-0.510699968949041	19	1	0.00206611570247934	484	10287	2706	GJB2
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	0.600075397627108	-0.510699968949041	19	1	0.00206611570247934	484	10287	25946	ZNF385A
R-HSA-3928664	Ephrin signaling	0.600075397627108	-0.510699968949041	19	1	0.00206611570247934	484	10287	2048	EPHB2
R-HSA-156584	Cytosolic sulfonation of small molecules	0.600075397627108	-0.510699968949041	19	1	0.00206611570247934	484	10287	27233	SULT1C4
R-HSA-416700	Other semaphorin interactions	0.600075397627108	-0.510699968949041	19	1	0.00206611570247934	484	10287	80031	SEMA6D
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.600075397627108	-0.510699968949041	19	1	0.00206611570247934	484	10287	6616	SNAP25
R-HSA-8851708	Signaling by FGFR2 IIIa TM	0.600075397627108	-0.510699968949041	19	1	0.00206611570247934	484	10287	2247	FGF2
R-HSA-1236394	Signaling by ERBB4	0.607375408045244	-0.498608214438647	43	2	0.00413223140495868	484	10287	2069,1839	EREG,HBEGF
R-HSA-5655253	Signaling by FGFR2 in disease	0.607375408045244	-0.498608214438647	43	2	0.00413223140495868	484	10287	26281,2247	FGF20,FGF2
R-HSA-8848021	Signaling by PTK6	0.616747749430269	-0.483295172658746	67	3	0.00619834710743802	484	10287	1839,595,2069	HBEGF,CCND1,EREG
R-HSA-5358346	Hedgehog ligand biogenesis	0.616747749430269	-0.483295172658746	67	3	0.00619834710743802	484	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.616747749430269	-0.483295172658746	67	3	0.00619834710743802	484	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-5687128	MAPK6/MAPK4 signaling	0.617390404684674	-0.482253708523876	90	4	0.00826446280991736	484	10287	5698,3725,5699,5721	PSMB9,JUN,PSMB10,PSME2
R-HSA-8876384	Listeria monocytogenes entry into host cells	0.618926537831029	-0.479768692127131	20	1	0.00206611570247934	484	10287	4233	MET
R-HSA-69186	Lagging Strand Synthesis	0.618926537831029	-0.479768692127131	20	1	0.00206611570247934	484	10287	23649	POLA2
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.62682079908084	-0.467094586088401	68	3	0.00619834710743802	484	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-381119	Unfolded Protein Response (UPR)	0.634725383027479	-0.45456284130382	92	4	0.00826446280991736	484	10287	3576,3484,467,6347	CXCL8,IGFBP1,ATF3,CCL2
R-HSA-68867	Assembly of the pre-replicative complex	0.636710594809883	-0.451440051906175	69	3	0.00619834710743802	484	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-6806834	Signaling by MET	0.636710594809883	-0.451440051906175	69	3	0.00619834710743802	484	10287	4233,3918,3914	MET,LAMC2,LAMB3
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.636890846362662	-0.451156993881653	21	1	0.00206611570247934	484	10287	54567	DLL4
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.636890846362662	-0.451156993881653	21	1	0.00206611570247934	484	10287	50515	CHST11
R-HSA-6807004	Negative regulation of MET activity	0.636890846362662	-0.451156993881653	21	1	0.00206611570247934	484	10287	4233	MET
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	0.636890846362662	-0.451156993881653	21	1	0.00206611570247934	484	10287	4363	ABCC1
R-HSA-3000480	Scavenging by Class A Receptors	0.636890846362662	-0.451156993881653	21	1	0.00206611570247934	484	10287	2495	FTH1
R-HSA-2028269	Signaling by Hippo	0.636890846362662	-0.451156993881653	21	1	0.00206611570247934	484	10287	23286	WWC1
R-HSA-5423646	Aflatoxin activation and detoxification	0.636890846362662	-0.451156993881653	21	1	0.00206611570247934	484	10287	1577	CYP3A5
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.644241054316924	-0.439682314967992	46	2	0.00413223140495868	484	10287	1030,23327	CDKN2B,NEDD4L
R-HSA-70153	Glucose transport	0.644241054316924	-0.439682314967992	46	2	0.00413223140495868	484	10287	6513,3099	SLC2A1,HK2
R-HSA-5658442	Regulation of RAS by GAPs	0.646416161142295	-0.436311770320626	70	3	0.00619834710743802	484	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.646416161142295	-0.436311770320626	70	3	0.00619834710743802	484	10287	1294,169044,1305	COL7A1,COL22A1,COL13A1
R-HSA-1482801	Acyl chain remodelling of PS	0.654009960943109	-0.424632696841066	22	1	0.00206611570247934	484	10287	51365	PLA1A
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.654009960943109	-0.424632696841066	22	1	0.00206611570247934	484	10287	8900	CCNA1
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.654009960943109	-0.424632696841066	22	1	0.00206611570247934	484	10287	4363	ABCC1
R-HSA-198753	ERK/MAPK targets	0.654009960943109	-0.424632696841066	22	1	0.00206611570247934	484	10287	1848	DUSP6
R-HSA-400253	Circadian Clock	0.655936823888812	-0.421690799723219	71	3	0.00619834710743802	484	10287	10135,85441,56938	NAMPT,HELZ2,ARNTL2
R-HSA-6809371	Formation of the cornified envelope	0.655936823888812	-0.421690799723219	71	3	0.00619834710743802	484	10287	5317,2312,5266	PKP1,FLG,PI3
R-HSA-948021	Transport to the Golgi and subsequent modification	0.657949734631169	-0.418626741712813	164	7	0.0144628099173554	484	10287	1294,6708,4121,374,6484,286,1604	COL7A1,SPTA1,MAN1A1,AREG,ST3GAL4,ANK1,CD55
R-HSA-389948	PD-1 signaling	0.670323568246667	-0.399994745492404	23	1	0.00206611570247934	484	10287	29126	CD274
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.670323568246667	-0.399994745492404	23	1	0.00206611570247934	484	10287	23327	NEDD4L
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.670323568246667	-0.399994745492404	23	1	0.00206611570247934	484	10287	2847	MCHR1
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.670323568246667	-0.399994745492404	23	1	0.00206611570247934	484	10287	6616	SNAP25
R-HSA-5365859	RA biosynthesis pathway	0.670323568246667	-0.399994745492404	23	1	0.00206611570247934	484	10287	195814	SDR16C5
R-HSA-5627123	RHO GTPases activate PAKs	0.670323568246667	-0.399994745492404	23	1	0.00206611570247934	484	10287	4629	MYH11
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.674422147922474	-0.393899031904807	73	3	0.00619834710743802	484	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.685869495071318	-0.377067909775076	24	1	0.00206611570247934	484	10287	23649	POLA2
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.685869495071318	-0.377067909775076	24	1	0.00206611570247934	484	10287	330	BIRC3
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.689072228870888	-0.372409182010244	50	2	0.00413223140495868	484	10287	660,8503	BMX,PIK3R3
R-HSA-418555	G alpha (s) signalling events	0.690016384842066	-0.371039935524846	146	6	0.012396694214876	484	10287	134864,5142,53831,9340,2642,135	TAAR1,PDE4B,GPR84,GLP2R,GCGR,ADORA2A
R-HSA-383280	Nuclear Receptor transcription pathway	0.699528055249069	-0.357349378105378	51	2	0.00413223140495868	484	10287	4929,8013	NR4A2,NR4A3
R-HSA-982772	Growth hormone receptor signaling	0.700683795408933	-0.355698570162586	25	1	0.00206611570247934	484	10287	4067	LYN
R-HSA-182971	EGFR downregulation	0.700683795408933	-0.355698570162586	25	1	0.00206611570247934	484	10287	10252	SPRY1
R-HSA-3295583	TRP channels	0.700683795408933	-0.355698570162586	25	1	0.00206611570247934	484	10287	8989	TRPA1
R-HSA-1538133	G0 and Early G1	0.700683795408933	-0.355698570162586	25	1	0.00206611570247934	484	10287	8900	CCNA1
R-HSA-162588	Budding and maturation of HIV virion	0.700683795408933	-0.355698570162586	25	1	0.00206611570247934	484	10287	23327	NEDD4L
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.700683795408933	-0.355698570162586	25	1	0.00206611570247934	484	10287	1848	DUSP6
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.709173891427972	-0.343654519577095	77	3	0.00619834710743802	484	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-2262749	Cellular response to hypoxia	0.709173891427972	-0.343654519577095	77	3	0.00619834710743802	484	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-445717	Aquaporin-mediated transport	0.709690799773091	-0.342925897078851	52	2	0.00413223140495868	484	10287	366,4645	AQP9,MYO5B
R-HSA-2559580	Oxidative Stress Induced Senescence	0.713211570816955	-0.337977169320837	126	5	0.0103305785123967	484	10287	23135,7295,1030,3725,723790	KDM6B,TXN,CDKN2B,JUN,HIST2H2AA4
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.714800833318594	-0.335751329890893	26	1	0.00206611570247934	484	10287	7474	WNT5A
R-HSA-1474165	Reproduction	0.714800833318594	-0.335751329890893	26	1	0.00206611570247934	484	10287	7784	ZP3
R-HSA-1187000	Fertilization	0.714800833318594	-0.335751329890893	26	1	0.00206611570247934	484	10287	7784	ZP3
R-HSA-912694	Regulation of IFNA signaling	0.714800833318594	-0.335751329890893	26	1	0.00206611570247934	484	10287	3455	IFNAR2
R-HSA-2029485	Role of phospholipids in phagocytosis	0.714800833318594	-0.335751329890893	26	1	0.00206611570247934	484	10287	3710	ITPR3
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.714800833318594	-0.335751329890893	26	1	0.00206611570247934	484	10287	6484	ST3GAL4
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.717403245336842	-0.332117190146149	78	3	0.00619834710743802	484	10287	6482,9945,6484	ST3GAL1,GFPT2,ST3GAL4
R-HSA-2262752	Cellular responses to stress	0.725327292164561	-0.321132288526339	451	19	0.0392561983471074	484	10287	3008,3552,3576,3159,5698,723790,3569,8091,7296,23135,5699,5721,4790,7295,3725,1030,8900,4688,6648	HIST1H1E,IL1A,CXCL8,HMGA1,PSMB9,HIST2H2AA4,IL6,HMGA2,TXNRD1,KDM6B,PSMB10,PSME2,NFKB1,TXN,JUN,CDKN2B,CCNA1,NCF2,SOD2
R-HSA-6807878	COPI-mediated anterograde transport	0.72545122943958	-0.320961432295047	79	3	0.00619834710743802	484	10287	1604,286,6708	CD55,ANK1,SPTA1
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.728253361993501	-0.317106266615658	27	1	0.00206611570247934	484	10287	23327	NEDD4L
R-HSA-180024	DARPP-32 events	0.728253361993501	-0.317106266615658	27	1	0.00206611570247934	484	10287	5142	PDE4B
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.72915476058042	-0.315869277898639	54	2	0.00413223140495868	484	10287	6385,375790	SDC4,AGRN
R-HSA-189200	Hexose transport	0.72915476058042	-0.315869277898639	54	2	0.00413223140495868	484	10287	6513,3099	SLC2A1,HK2
R-HSA-5689603	UCH proteinases	0.734609466840033	-0.308416258611771	105	4	0.00826446280991736	484	10287	5721,5699,723790,5698	PSME2,PSMB10,HIST2H2AA4,PSMB9
R-HSA-597592	Post-translational protein modification	0.736129348081984	-0.306349431017938	1034	45	0.0929752066115702	484	10287	84101,6482,8875,219333,6708,79931,4586,64127,5721,374,4121,5277,1080,8876,8313,723790,1294,5329,330,8767,10318,154064,1540,50614,9945,8900,8975,9507,1604,124872,51301,27076,5699,64135,79623,10164,90865,5698,4792,7128,10071,23586,6484,286,56999	USP44,ST3GAL1,VNN2,USP12,SPTA1,TNIP3,MUC5AC,NOD2,PSME2,AREG,MAN1A1,PIGA,CFTR,VNN1,AXIN2,HIST2H2AA4,COL7A1,PLAUR,BIRC3,RIPK2,TNIP1,RAET1L,CYLD,GALNT9,GFPT2,CCNA1,USP13,ADAMTS4,CD55,B4GALNT2,GCNT4,LYPD3,PSMB10,IFIH1,GALNT14,CHST4,IL33,PSMB9,NFKBIA,TNFAIP3,MUC12,DDX58,ST3GAL4,ANK1,ADAMTS9
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.738465398374601	-0.303181032035801	55	2	0.00413223140495868	484	10287	3638,85441	INSIG1,HELZ2
R-HSA-1368082	RORA activates gene expression	0.741072599102821	-0.299656683987503	28	1	0.00206611570247934	484	10287	85441	HELZ2
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.741072599102821	-0.299656683987503	28	1	0.00206611570247934	484	10287	150	ADRA2A
R-HSA-5576893	Phase 2 - plateau phase	0.741072599102821	-0.299656683987503	28	1	0.00206611570247934	484	10287	23630	KCNE5
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.741072599102821	-0.299656683987503	28	1	0.00206611570247934	484	10287	10125	RASGRP1
R-HSA-190828	Gap junction trafficking	0.741072599102821	-0.299656683987503	28	1	0.00206611570247934	484	10287	2706	GJB2
R-HSA-174800	Chylomicron-mediated lipid transport	0.741072599102821	-0.299656683987503	28	1	0.00206611570247934	484	10287	4023	LPL
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.749105701321455	-0.288875182162248	156	6	0.012396694214876	484	10287	3659,10938,4602,23764,9732,55619	IRF1,EHD1,MYB,MAFF,DOCK4,DOCK10
R-HSA-114608	Platelet degranulation	0.750523392330159	-0.286984459400147	132	5	0.0103305785123967	484	10287	5004,5005,7273,5552,5341	ORM1,ORM2,TTN,SRGN,PLEK
R-HSA-3700989	Transcriptional Regulation by TP53	0.750553040124897	-0.28694495735468	367	15	0.0309917355371901	484	10287	7832,6446,10769,1263,27113,637,25946,7296,639,8900,8626,3725,54541,7295,5366	BTG2,SGK1,PLK2,PLK3,BBC3,BID,ZNF385A,TXNRD1,PRDM1,CCNA1,TP63,JUN,DDIT4,TXN,PMAIP1
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.753288298670983	-0.283307257696086	29	1	0.00206611570247934	484	10287	85441	HELZ2
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	0.753288298670983	-0.283307257696086	29	1	0.00206611570247934	484	10287	54514	DDX4
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.753288298670983	-0.283307257696086	29	1	0.00206611570247934	484	10287	3055	HCK
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.753288298670983	-0.283307257696086	29	1	0.00206611570247934	484	10287	10471	PFDN6
R-HSA-375170	CDO in myogenesis	0.753288298670983	-0.283307257696086	29	1	0.00206611570247934	484	10287	1000	CDH2
R-HSA-525793	Myogenesis	0.753288298670983	-0.283307257696086	29	1	0.00206611570247934	484	10287	1000	CDH2
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.753288298670983	-0.283307257696086	29	1	0.00206611570247934	484	10287	857	CAV1
R-HSA-199977	ER to Golgi Anterograde Transport	0.756377657968668	-0.279214479957354	133	5	0.0103305785123967	484	10287	1294,374,6708,1604,286	COL7A1,AREG,SPTA1,CD55,ANK1
R-HSA-162909	Host Interactions of HIV factors	0.762128721603415	-0.271639811573146	134	5	0.0103305785123967	484	10287	3159,3055,5699,5721,5698	HMGA1,HCK,PSMB10,PSME2,PSMB9
R-HSA-1483257	Phospholipid metabolism	0.764472219981197	-0.268569591773312	207	8	0.0165289256198347	484	10287	11343,51365,84879,8503,80736,25816,660,9108	MGLL,PLA1A,MFSD2A,PIK3R3,SLC44A4,TNFAIP8,BMX,MTMR7
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.764772192902304	-0.268177276558783	58	2	0.00413223140495868	484	10287	10046,54567	MAMLD1,DLL4
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.764772192902304	-0.268177276558783	58	2	0.00413223140495868	484	10287	54567,10046	DLL4,MAMLD1
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.764772192902304	-0.268177276558783	58	2	0.00413223140495868	484	10287	10046,54567	MAMLD1,DLL4
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.764772192902304	-0.268177276558783	58	2	0.00413223140495868	484	10287	54567,10046	DLL4,MAMLD1
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.764772192902304	-0.268177276558783	58	2	0.00413223140495868	484	10287	10046,54567	MAMLD1,DLL4
R-HSA-157858	Gap junction trafficking and regulation	0.764928819581535	-0.267972495783324	30	1	0.00206611570247934	484	10287	2706	GJB2
R-HSA-983712	Ion channel transport	0.773580494877541	-0.256725548607735	209	8	0.0165289256198347	484	10287	8989,23327,6338,6446,50617,490,266675,245973	TRPA1,NEDD4L,SCNN1B,SGK1,ATP6V0A4,ATP2B1,BEST4,ATP6V1C2
R-HSA-180786	Extension of Telomeres	0.7760211907731	-0.253575451474472	31	1	0.00206611570247934	484	10287	23649	POLA2
R-HSA-5632684	Hedgehog 'on' state	0.776839282134962	-0.252521794108829	86	3	0.00619834710743802	484	10287	5721,5699,5698	PSME2,PSMB10,PSMB9
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.778767838104264	-0.250042303069923	137	5	0.0103305785123967	484	10287	5004,5005,5341,5552,7273	ORM1,ORM2,PLEK,SRGN,TTN
R-HSA-5633007	Regulation of TP53 Activity	0.780422416931491	-0.247919945720706	162	6	0.012396694214876	484	10287	1263,8626,639,8900,6446,25946	PLK3,TP63,PRDM1,CCNA1,SGK1,ZNF385A
R-HSA-193648	NRAGE signals death through JNK	0.781008603482791	-0.247169113220039	60	2	0.00413223140495868	484	10287	4803,26230	NGF,TIAM2
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.78659117358624	-0.240046640015805	32	1	0.00206611570247934	484	10287	857	CAV1
R-HSA-399719	Trafficking of AMPA receptors	0.78659117358624	-0.240046640015805	32	1	0.00206611570247934	484	10287	80852	GRIP2
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.78659117358624	-0.240046640015805	32	1	0.00206611570247934	484	10287	80852	GRIP2
R-HSA-2559585	Oncogene Induced Senescence	0.78659117358624	-0.240046640015805	32	1	0.00206611570247934	484	10287	1030	CDKN2B
R-HSA-70171	Glycolysis	0.78659117358624	-0.240046640015805	32	1	0.00206611570247934	484	10287	3099	HK2
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.78659117358624	-0.240046640015805	32	1	0.00206611570247934	484	10287	2151	F2RL2
R-HSA-68962	Activation of the pre-replicative complex	0.78659117358624	-0.240046640015805	32	1	0.00206611570247934	484	10287	23649	POLA2
R-HSA-421270	Cell-cell junction organization	0.788752685474647	-0.237302460410295	61	2	0.00413223140495868	484	10287	1000,5818	CDH2,NECTIN1
R-HSA-6805567	Keratinization	0.795229684487469	-0.229124294749647	214	8	0.0165289256198347	484	10287	3868,2312,3849,5266,3855,5317,3854,9119	KRT16,FLG,KRT2,PI3,KRT7,PKP1,KRT6B,KRT75
R-HSA-190236	Signaling by FGFR	0.796318057678375	-0.22775660299686	89	3	0.00619834710743802	484	10287	23767,26281,2247	FLRT3,FGF20,FGF2
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.796663321036499	-0.227323122269284	33	1	0.00206611570247934	484	10287	3159	HMGA1
R-HSA-163359	Glucagon signaling in metabolic regulation	0.796663321036499	-0.227323122269284	33	1	0.00206611570247934	484	10287	2642	GCGR
R-HSA-202433	Generation of second messenger molecules	0.796663321036499	-0.227323122269284	33	1	0.00206611570247934	484	10287	3937	LCP2
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.800085397811524	-0.223036809746888	311	12	0.0247933884297521	484	10287	127544,10517,23327,221687,55521,5699,55008,5721,84676,92369,255488,5698	RNF19B,FBXW10,NEDD4L,RNF182,TRIM36,PSMB10,HERC6,PSME2,TRIM63,SPSB4,RNF144B,PSMB9
R-HSA-1226099	Signaling by FGFR in disease	0.803520332631404	-0.218752789045206	63	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-5656169	Termination of translesion DNA synthesis	0.806261034365217	-0.215347724931429	34	1	0.00206611570247934	484	10287	9636	ISG15
R-HSA-1489509	DAG and IP3 signaling	0.806261034365217	-0.215347724931429	34	1	0.00206611570247934	484	10287	3710	ITPR3
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.806261034365217	-0.215347724931429	34	1	0.00206611570247934	484	10287	23327	NEDD4L
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.806261034365217	-0.215347724931429	34	1	0.00206611570247934	484	10287	10471	PFDN6
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.806261034365217	-0.215347724931429	34	1	0.00206611570247934	484	10287	1030	CDKN2B
R-HSA-390522	Striated Muscle Contraction	0.806261034365217	-0.215347724931429	34	1	0.00206611570247934	484	10287	7273	TTN
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.808500467092036	-0.212574022238443	91	3	0.00619834710743802	484	10287	51176,723790,8313	LEF1,HIST2H2AA4,AXIN2
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.808500467092036	-0.212574022238443	91	3	0.00619834710743802	484	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-194840	Rho GTPase cycle	0.809342242511134	-0.211533407486388	143	5	0.0103305785123967	484	10287	26230,116984,5880,9938,83478	TIAM2,ARAP2,RAC2,ARHGAP25,ARHGAP24
R-HSA-4791275	Signaling by WNT in cancer	0.815406617069914	-0.204068373508604	35	1	0.00206611570247934	484	10287	27121	DKK4
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.82412132613763	-0.193437519453189	36	1	0.00206611570247934	484	10287	3710	ITPR3
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.82412132613763	-0.193437519453189	36	1	0.00206611570247934	484	10287	3159	HMGA1
R-HSA-445355	Smooth Muscle Contraction	0.82412132613763	-0.193437519453189	36	1	0.00206611570247934	484	10287	4629	MYH11
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.82412132613763	-0.193437519453189	36	1	0.00206611570247934	484	10287	2247	FGF2
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.82412132613763	-0.193437519453189	36	1	0.00206611570247934	484	10287	644150	WIPF3
R-HSA-5663202	Diseases of signal transduction	0.835800308033993	-0.179365560418506	370	14	0.0289256198347107	484	10287	5698,8503,941,27121,64220,26281,1839,54567,2069,2247,5699,5721,4233,10046	PSMB9,PIK3R3,CD80,DKK4,STRA6,FGF20,HBEGF,DLL4,EREG,FGF2,PSMB10,PSME2,MET,MAMLD1
R-HSA-5689901	Metalloprotease DUBs	0.840338211042171	-0.173950835986307	38	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-156590	Glutathione conjugation	0.840338211042171	-0.173950835986307	38	1	0.00206611570247934	484	10287	2730	GCLM
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.842460546530463	-0.171428446896095	69	2	0.00413223140495868	484	10287	374,1294	AREG,COL7A1
R-HSA-390466	Chaperonin-mediated protein folding	0.851243703568143	-0.161056818235177	99	3	0.00619834710743802	484	10287	9628,10471,10517	RGS6,PFDN6,FBXW10
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	0.855062622268653	-0.156580570307994	40	1	0.00206611570247934	484	10287	10517	FBXW10
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.855062622268653	-0.156580570307994	40	1	0.00206611570247934	484	10287	9636	ISG15
R-HSA-1296071	Potassium Channels	0.855956991648081	-0.155535147504411	100	3	0.00619834710743802	484	10287	3783,131096,3779	KCNN4,KCNH8,KCNMB1
R-HSA-5610787	Hedgehog 'off' state	0.860539379991494	-0.150195900296927	101	3	0.00619834710743802	484	10287	5698,5721,5699	PSMB9,PSME2,PSMB10
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.861908498209357	-0.148606164522006	41	1	0.00206611570247934	484	10287	9636	ISG15
R-HSA-1483206	Glycerophospholipid biosynthesis	0.862828584484891	-0.147539235107608	129	4	0.00826446280991736	484	10287	51365,84879,80736,11343	PLA1A,MFSD2A,SLC44A4,MGLL
R-HSA-3214841	PKMTs methylate histone lysines	0.864391321966557	-0.145729693772133	73	2	0.00413223140495868	484	10287	4790,4791	NFKB1,NFKB2
R-HSA-446203	Asparagine N-linked glycosylation	0.866468362603975	-0.143329682202249	284	10	0.0206611570247934	484	10287	6708,1604,124872,9945,6482,1294,4121,6484,374,286	SPTA1,CD55,B4GALNT2,GFPT2,ST3GAL1,COL7A1,MAN1A1,ST3GAL4,AREG,ANK1
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.868431657199905	-0.14106638701336	42	1	0.00206611570247934	484	10287	3710	ITPR3
R-HSA-1461957	Beta defensins	0.868431657199905	-0.14106638701336	42	1	0.00206611570247934	484	10287	7097	TLR2
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.868431657199905	-0.14106638701336	42	1	0.00206611570247934	484	10287	85441	HELZ2
R-HSA-168253	Host Interactions with Influenza Factors	0.868431657199905	-0.14106638701336	42	1	0.00206611570247934	484	10287	9636	ISG15
R-HSA-5654738	Signaling by FGFR2	0.874275461938552	-0.134359779140707	75	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	0.874647282175431	-0.133934579978844	43	1	0.00206611570247934	484	10287	9628	RGS6
R-HSA-5362517	Signaling by Retinoic Acid	0.874647282175431	-0.133934579978844	43	1	0.00206611570247934	484	10287	195814	SDR16C5
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.874647282175431	-0.133934579978844	43	1	0.00206611570247934	484	10287	4645	MYO5B
R-HSA-391251	Protein folding	0.877614095215036	-0.130548309057301	105	3	0.00619834710743802	484	10287	10517,10471,9628	FBXW10,PFDN6,RGS6
R-HSA-1500931	Cell-Cell communication	0.878036616313624	-0.130066981986977	133	4	0.00826446280991736	484	10287	3918,1000,3914,5818	LAMC2,CDH2,LAMB3,NECTIN1
R-HSA-1169408	ISG15 antiviral mechanism	0.878965015054231	-0.129010182937464	76	2	0.00413223140495868	484	10287	9636,23586	ISG15,DDX58
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.878965015054231	-0.129010182937464	76	2	0.00413223140495868	484	10287	4803,26230	NGF,TIAM2
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.878965015054231	-0.129010182937464	76	2	0.00413223140495868	484	10287	9636,23586	ISG15,DDX58
R-HSA-1643685	Disease	0.879591156393591	-0.128298074474868	859	34	0.0702479338842975	484	10287	1839,4792,26281,9636,27121,3055,5698,8503,56999,375790,10071,9507,6648,64220,7852,4790,941,4791,10046,5699,7296,3159,7097,2247,54567,6616,4586,3725,1080,23327,4233,5721,2069,6385	HBEGF,NFKBIA,FGF20,ISG15,DKK4,HCK,PSMB9,PIK3R3,ADAMTS9,AGRN,MUC12,ADAMTS4,SOD2,STRA6,CXCR4,NFKB1,CD80,NFKB2,MAMLD1,PSMB10,TXNRD1,HMGA1,TLR2,FGF2,DLL4,SNAP25,MUC5AC,JUN,CFTR,NEDD4L,MET,PSME2,EREG,SDC4
R-HSA-1296072	Voltage gated Potassium channels	0.880569843225712	-0.127186031959223	44	1	0.00206611570247934	484	10287	131096	KCNH8
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.880569843225712	-0.127186031959223	44	1	0.00206611570247934	484	10287	130367	SGPP2
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.88349277833892	-0.123872161178916	77	2	0.00413223140495868	484	10287	1030,23327	CDKN2B,NEDD4L
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.886213130914482	-0.120797803225999	45	1	0.00206611570247934	484	10287	85441	HELZ2
R-HSA-6811438	Intra-Golgi traffic	0.886213130914482	-0.120797803225999	45	1	0.00206611570247934	484	10287	4121	MAN1A1
R-HSA-3214858	RMTs methylate histone arginines	0.892082057513614	-0.114197157904932	79	2	0.00413223140495868	484	10287	595,723790	CCND1,HIST2H2AA4
R-HSA-109704	PI3K Cascade	0.892082057513614	-0.114197157904932	79	2	0.00413223140495868	484	10287	2247,26281	FGF2,FGF20
R-HSA-1483249	Inositol phosphate metabolism	0.896713840615903	-0.10901848608593	47	1	0.00206611570247934	484	10287	117283	IP6K3
R-HSA-112043	PLC beta mediated events	0.896713840615903	-0.10901848608593	47	1	0.00206611570247934	484	10287	3710	ITPR3
R-HSA-70326	Glucose metabolism	0.900080604358478	-0.105270959269811	81	2	0.00413223140495868	484	10287	3099,669	HK2,BPGM
R-HSA-112040	G-protein mediated events	0.901595725499554	-0.103589057284275	48	1	0.00206611570247934	484	10287	3710	ITPR3
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.901595725499554	-0.103589057284275	48	1	0.00206611570247934	484	10287	10046	MAMLD1
R-HSA-112316	Neuronal System	0.902046604822214	-0.103089091936964	349	12	0.0247933884297521	484	10287	9378,9369,9228,80852,3779,3783,131096,56666,6616,9456,6580,6506	NRXN1,NRXN3,DLGAP2,GRIP2,KCNMB1,KCNN4,KCNH8,PANX2,SNAP25,HOMER1,SLC22A1,SLC1A2
R-HSA-157579	Telomere Maintenance	0.903869591720243	-0.101070185942629	82	2	0.00413223140495868	484	10287	723790,23649	HIST2H2AA4,POLA2
R-HSA-5576891	Cardiac conduction	0.907009242346697	-0.0976026389005089	142	4	0.00826446280991736	484	10287	23630,3710,490,6547	KCNE5,ITPR3,ATP2B1,SLC8A3
R-HSA-73893	DNA Damage Bypass	0.91067946398779	-0.0935642943630738	50	1	0.00206611570247934	484	10287	9636	ISG15
R-HSA-111885	Opioid Signalling	0.91444700283066	-0.089435764901952	85	2	0.00413223140495868	484	10287	5142,3710	PDE4B,ITPR3
R-HSA-1461973	Defensins	0.914902492169453	-0.0889377853201929	51	1	0.00206611570247934	484	10287	7097	TLR2
R-HSA-171306	Packaging Of Telomere Ends	0.914902492169453	-0.0889377853201929	51	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-3214842	HDMs demethylate histones	0.91892625083456	-0.0845494092105193	52	1	0.00206611570247934	484	10287	23135	KDM6B
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.922760124274337	-0.0803859652824907	53	1	0.00206611570247934	484	10287	2847	MCHR1
R-HSA-397014	Muscle contraction	0.923160038647312	-0.0799526698591403	204	6	0.012396694214876	484	10287	7273,6547,23630,490,3710,4629	TTN,SLC8A3,KCNE5,ATP2B1,ITPR3,MYH11
R-HSA-1592230	Mitochondrial biogenesis	0.92641305566459	-0.076435079360519	54	1	0.00206611570247934	484	10287	85441	HELZ2
R-HSA-162906	HIV Infection	0.932505082282785	-0.069880677309812	236	7	0.0144628099173554	484	10287	23327,3159,7852,5698,3055,5721,5699	NEDD4L,HMGA1,CXCR4,PSMB9,HCK,PSME2,PSMB10
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.93636944135902	-0.0657451780723644	57	1	0.00206611570247934	484	10287	2495	FTH1
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	0.937559244642924	-0.0644753288484605	93	2	0.00413223140495868	484	10287	1263,8900	PLK3,CCNA1
R-HSA-5625740	RHO GTPases activate PKNs	0.937559244642924	-0.0644753288484605	93	2	0.00413223140495868	484	10287	4629,723790	MYH11,HIST2H2AA4
R-HSA-936837	Ion transport by P-type ATPases	0.939379919406764	-0.0625352815951827	58	1	0.00206611570247934	484	10287	490	ATP2B1
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	0.940168893756999	-0.0616957456479918	126	3	0.00619834710743802	484	10287	4211,723790,3725	MEIS1,HIST2H2AA4,JUN
R-HSA-5619507	Activation of HOX genes during differentiation	0.940168893756999	-0.0616957456479918	126	3	0.00619834710743802	484	10287	723790,3725,4211	HIST2H2AA4,JUN,MEIS1
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.947584929190181	-0.0538387110133201	61	1	0.00206611570247934	484	10287	644150	WIPF3
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.950868141282237	-0.0503798787499872	99	2	0.00413223140495868	484	10287	1080,7474	CFTR,WNT5A
R-HSA-73728	RNA Polymerase I Promoter Opening	0.952429387816636	-0.0487393082551477	63	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-977225	Amyloid fiber formation	0.954669057541798	-0.0463905351645384	101	2	0.00413223140495868	484	10287	723790,6288	HIST2H2AA4,SAA1
R-HSA-5334118	DNA methylation	0.956826937026165	-0.0441327429356554	65	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-5663205	Infectious disease	0.957750508043149	-0.0431679649466519	388	12	0.0247933884297521	484	10287	1839,7852,7296,5698,9636,3055,23327,3159,4233,6616,5721,5699	HBEGF,CXCR4,TXNRD1,PSMB9,ISG15,HCK,NEDD4L,HMGA1,MET,SNAP25,PSME2,PSMB10
R-HSA-2467813	Separation of Sister Chromatids	0.959451479259374	-0.0413935335890819	168	4	0.00826446280991736	484	10287	5721,5699,9700,5698	PSME2,PSMB10,ESPL1,PSMB9
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.960818727475228	-0.0399695168625787	67	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-5358351	Signaling by Hedgehog	0.961011017901135	-0.0397694050399659	138	3	0.00619834710743802	484	10287	5699,5721,5698	PSMB10,PSME2,PSMB9
R-HSA-156580	Phase II conjugation	0.962980706188909	-0.0377219024948843	106	2	0.00413223140495868	484	10287	2730,27233	GCLM,SULT1C4
R-HSA-69620	Cell Cycle Checkpoints	0.963277873663179	-0.0374133587928747	201	5	0.0103305785123967	484	10287	5698,5721,5699,8900,25946	PSMB9,PSME2,PSMB10,CCNA1,ZNF385A
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	0.964442127939989	-0.036205450572387	69	1	0.00206611570247934	484	10287	3725	JUN
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	0.964442127939989	-0.036205450572387	69	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-73886	Chromosome Maintenance	0.967243891192244	-0.0333046010665928	109	2	0.00413223140495868	484	10287	723790,23649	HIST2H2AA4,POLA2
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.969259866270472	-0.0312225231994694	72	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-774815	Nucleosome assembly	0.969259866270472	-0.0312225231994694	72	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-195258	RHO GTPase Effectors	0.970099927538932	-0.0303561947093334	294	8	0.0165289256198347	484	10287	91010,4629,1080,5880,723790,644150,23002,4688	FMNL3,MYH11,CFTR,RAC2,HIST2H2AA4,WIPF3,DAAM1,NCF2
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	0.970716373829265	-0.0297209503426946	73	1	0.00206611570247934	484	10287	5452	POU2F2
R-HSA-421837	Clathrin derived vesicle budding	0.970716373829265	-0.0297209503426946	73	1	0.00206611570247934	484	10287	2495	FTH1
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.970716373829265	-0.0297209503426946	73	1	0.00206611570247934	484	10287	2495	FTH1
R-HSA-68882	Mitotic Anaphase	0.971965163409523	-0.0284353152776299	179	4	0.00826446280991736	484	10287	5721,5699,9700,5698	PSME2,PSMB10,ESPL1,PSMB9
R-HSA-2299718	Condensation of Prophase Chromosomes	0.972104006011225	-0.0282924781768493	74	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-174824	Lipoprotein metabolism	0.972104006011225	-0.0282924781768493	74	1	0.00206611570247934	484	10287	4023	LPL
R-HSA-212300	PRC2 methylates histones and DNA	0.972104006011225	-0.0282924781768493	74	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.97290282971242	-0.0274710684713018	180	4	0.00826446280991736	484	10287	5698,9700,5699,5721	PSMB9,ESPL1,PSMB10,PSME2
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	0.974685493354918	-0.0256404309395123	76	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-69275	G2/M Transition	0.974690816172129	-0.0256349698931407	182	4	0.00826446280991736	484	10287	5698,8900,5699,5721	PSMB9,CCNA1,PSMB10,PSME2
R-HSA-453274	Mitotic G2-G2/M phases	0.976367806975684	-0.0239159121501898	184	4	0.00826446280991736	484	10287	5721,8900,5699,5698	PSME2,CCNA1,PSMB10,PSMB9
R-HSA-5663220	RHO GTPases Activate Formins	0.976428454161128	-0.0238537989777407	117	2	0.00413223140495868	484	10287	23002,91010	DAAM1,FMNL3
R-HSA-162587	HIV Life Cycle	0.976688248624921	-0.0235877683151032	152	3	0.00619834710743802	484	10287	7852,23327,3159	CXCR4,NEDD4L,HMGA1
R-HSA-1221632	Meiotic synapsis	0.978117595753565	-0.0221253751188809	79	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-194315	Signaling by Rho GTPases	0.983441262451919	-0.0166973659137163	427	12	0.0247933884297521	484	10287	4629,91010,5880,1080,83478,26230,644150,23002,723790,116984,4688,9938	MYH11,FMNL3,RAC2,CFTR,ARHGAP24,TIAM2,WIPF3,DAAM1,HIST2H2AA4,ARAP2,NCF2,ARHGAP25
R-HSA-392499	Metabolism of proteins	0.985549232832379	-0.0145561964252295	1619	60	0.12396694214876	484	10287	8876,5277,1080,4121,374,5721,64127,79931,4586,6708,8875,219333,10471,6482,4312,3624,84101,7295,50614,1540,9628,154064,10318,3576,8767,6347,330,5329,467,6288,1294,3484,723790,8313,90865,64135,79623,10164,5699,27076,51301,1604,124872,9507,8900,8975,150,9945,5069,56999,10517,135,286,6484,23586,10071,7128,60676,4792,5698	VNN1,PIGA,CFTR,MAN1A1,AREG,PSME2,NOD2,TNIP3,MUC5AC,SPTA1,VNN2,USP12,PFDN6,ST3GAL1,MMP1,INHBA,USP44,TXN,GALNT9,CYLD,RGS6,RAET1L,TNIP1,CXCL8,RIPK2,CCL2,BIRC3,PLAUR,ATF3,SAA1,COL7A1,IGFBP1,HIST2H2AA4,AXIN2,IL33,IFIH1,GALNT14,CHST4,PSMB10,LYPD3,GCNT4,CD55,B4GALNT2,ADAMTS4,CCNA1,USP13,ADRA2A,GFPT2,PAPPA,ADAMTS9,FBXW10,ADORA2A,ANK1,ST3GAL4,DDX58,MUC12,TNFAIP3,PAPPA2,NFKBIA,PSMB9
R-HSA-912446	Meiotic recombination	0.98586950552763	-0.0142312804732439	88	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	0.98654007709097	-0.0135513288089596	89	1	0.00206611570247934	484	10287	23258	DENND5A
R-HSA-428157	Sphingolipid metabolism	0.987178888890357	-0.0129040108952102	90	1	0.00206611570247934	484	10287	130367	SGPP2
R-HSA-69481	G2/M Checkpoints	0.987742154597735	-0.0123335924225246	169	3	0.00619834710743802	484	10287	5698,5699,5721	PSMB9,PSMB10,PSME2
R-HSA-73777	RNA Polymerase I Chain Elongation	0.987787442171563	-0.012287743882558	91	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-2980736	Peptide hormone metabolism	0.987787442171563	-0.012287743882558	91	1	0.00206611570247934	484	10287	3624	INHBA
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	0.988919427383578	-0.0111424194511096	93	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-3214815	HDACs deacetylate histones	0.989445520883641	-0.0106105726723599	94	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-211000	Gene Silencing by RNA	0.989804492382817	-0.0102478377973251	137	2	0.00413223140495868	484	10287	54514,723790	DDX4,HIST2H2AA4
R-HSA-8856828	Clathrin-mediated endocytosis	0.989804492382817	-0.0102478377973251	137	2	0.00413223140495868	484	10287	7474,1080	WNT5A,CFTR
R-HSA-5693607	Processing of DNA double-strand break ends	0.991312116961063	-0.00872584271418268	98	1	0.00206611570247934	484	10287	8900	CCNA1
R-HSA-112315	Transmission across Chemical Synapses	0.992664013077927	-0.00736302760201381	217	4	0.00826446280991736	484	10287	6506,6580,80852,6616	SLC1A2,SLC22A1,GRIP2,SNAP25
R-HSA-2132295	MHC class II antigen presentation	0.993188973192803	-0.00683432771261268	103	1	0.00206611570247934	484	10287	1520	CTSS
R-HSA-5578749	Transcriptional regulation by small RNAs	0.99411473211936	-0.00590265431911343	106	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-427413	NoRC negatively regulates rRNA expression	0.994394515008388	-0.00562125468139136	107	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	0.994661023349508	-0.005353279918922	108	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.995156700895531	-0.00485506588631334	110	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.995156700895531	-0.00485506588631334	110	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-73864	RNA Polymerase I Transcription	0.995606445324776	-0.00440323470011737	112	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-2408522	Selenoamino acid metabolism	0.997166998319062	-0.00283702222546877	121	1	0.00206611570247934	484	10287	7296	TXNRD1
R-HSA-1500620	Meiosis	0.997166998319062	-0.00283702222546877	121	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-3247509	Chromatin modifying enzymes	0.997356507029638	-0.00264699316776319	279	5	0.0103305785123967	484	10287	4791,23135,595,723790,4790	NFKB2,KDM6B,CCND1,HIST2H2AA4,NFKB1
R-HSA-4839726	Chromatin organization	0.997356507029638	-0.00264699316776319	279	5	0.0103305785123967	484	10287	4790,723790,595,23135,4791	NFKB1,HIST2H2AA4,CCND1,KDM6B,NFKB2
R-HSA-212436	Generic Transcription Pathway	0.998042349289341	-0.00195956941332059	865	25	0.0516528925619835	484	10287	7295,3725,1030,8626,8900,8013,27113,1263,10308,10046,23327,6446,163732,85441,4435,7832,5366,54541,639,7296,25946,637,4929,10769,90874	TXN,JUN,CDKN2B,TP63,CCNA1,NR4A3,BBC3,PLK3,ZNF267,MAMLD1,NEDD4L,SGK1,CITED4,HELZ2,CITED1,BTG2,PMAIP1,DDIT4,PRDM1,TXNRD1,ZNF385A,BID,NR4A2,PLK2,ZNF697
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.998343871654312	-0.00165750124224151	132	1	0.00206611570247934	484	10287	8900	CCNA1
R-HSA-5693538	Homology Directed Repair	0.998764591427167	-0.00123617231909471	138	1	0.00206611570247934	484	10287	8900	CCNA1
R-HSA-162599	Late Phase of HIV Life Cycle	0.998823507355076	-0.0011771852556833	139	1	0.00206611570247934	484	10287	23327	NEDD4L
R-HSA-68875	Mitotic Prophase	0.998933059991221	-0.00106750959444854	141	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-3214847	HATs acetylate histones	0.999032430425691	-0.000968037971912075	143	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-68886	M Phase	0.999085281779124	-0.00091513683088106	308	5	0.0103305785123967	484	10287	5698,9700,5699,5721,723790	PSMB9,ESPL1,PSMB10,PSME2,HIST2H2AA4
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.999164436562312	-0.000835912715393401	146	1	0.00206611570247934	484	10287	80852	GRIP2
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.999278465122751	-0.000721795308819903	149	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-212165	Epigenetic regulation of gene expression	0.999345717667455	-0.00065449646863917	151	1	0.00206611570247934	484	10287	723790	HIST2H2AA4
R-HSA-168254	Influenza Infection	0.999512205135071	-0.000487913875547155	157	1	0.00206611570247934	484	10287	9636	ISG15
R-HSA-5693532	DNA Double-Strand Break Repair	0.999701105118934	-0.000298939559043503	167	1	0.00206611570247934	484	10287	8900	CCNA1
R-HSA-69278	Cell Cycle, Mitotic	0.999772686901505	-0.000227338938033635	514	10	0.0206611570247934	484	10287	5699,5721,9700,64785,8900,1030,723790,5698,595,23649	PSMB10,PSME2,ESPL1,GINS3,CCNA1,CDKN2B,HIST2H2AA4,PSMB9,CCND1,POLA2
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	0.99983405222981	-0.000165961541044307	179	1	0.00206611570247934	484	10287	4121	MAN1A1
R-HSA-5617833	Cilium Assembly	0.999912344807149	-8.76590347915969e-05	192	1	0.00206611570247934	484	10287	2847	MCHR1
R-HSA-5653656	Vesicle-mediated transport	0.9999413672367	-5.86344822680692e-05	650	13	0.0268595041322314	484	10287	6708,6288,1604,7474,1294,374,4121,8578,1080,286,2495,2706,23258	SPTA1,SAA1,CD55,WNT5A,COL7A1,AREG,MAN1A1,SCARF1,CFTR,ANK1,FTH1,GJB2,DENND5A
R-HSA-199991	Membrane Trafficking	0.999973613629469	-2.63867186570897e-05	610	11	0.0227272727272727	484	10287	4121,374,286,1080,2495,2706,23258,6708,7474,1604,1294	MAN1A1,AREG,ANK1,CFTR,FTH1,GJB2,DENND5A,SPTA1,WNT5A,CD55,COL7A1
R-HSA-1640170	Cell Cycle	0.999981968363322	-1.80317992494976e-05	621	11	0.0227272727272727	484	10287	595,23649,25946,5698,8900,1030,723790,64785,9700,5721,5699	CCND1,POLA2,ZNF385A,PSMB9,CCNA1,CDKN2B,HIST2H2AA4,GINS3,ESPL1,PSME2,PSMB10
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.999994165908677	-5.83410834147712e-06	247	1	0.00206611570247934	484	10287	9589	WTAP
R-HSA-73894	DNA Repair	0.999996736132729	-3.26387259760785e-06	316	2	0.00413223140495868	484	10287	9636,8900	ISG15,CCNA1
R-HSA-1852241	Organelle biogenesis and maintenance	0.999998939470627	-1.06052993527584e-06	340	2	0.00413223140495868	484	10287	85441,2847	HELZ2,MCHR1
R-HSA-381753	Olfactory Signaling Pathway	0.999999905002604	-9.49974001714511e-08	391	2	0.00413223140495868	484	10287	283365,64108	OR6C6,RTP4
R-HSA-74160	Gene Expression	0.999999999898197	-1.01802886391017e-10	1821	32	0.0661157024793388	484	10287	5721,7832,23327,5452,8626,1030,3725,7295,4929,723790,25946,7296,5699,10308,1263,85441,4435,163732,6446,10046,8900,27113,54514,8013,90874,9589,10769,639,54541,5698,5366,637	PSME2,BTG2,NEDD4L,POU2F2,TP63,CDKN2B,JUN,TXN,NR4A2,HIST2H2AA4,ZNF385A,TXNRD1,PSMB10,ZNF267,PLK3,HELZ2,CITED1,CITED4,SGK1,MAMLD1,CCNA1,BBC3,DDX4,NR4A3,ZNF697,WTAP,PLK2,PRDM1,DDIT4,PSMB9,PMAIP1,BID
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-977347	Serine biosynthesis	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-6787450	tRNA modification in the mitochondrion	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-77111	Synthesis of Ketone Bodies	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-177128	Conjugation of salicylate with glycine	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-70921	Histidine catabolism	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-804914	Transport of fatty acids	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-1483115	Hydrolysis of LPC	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-5632681	Ligand-receptor interactions	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-110329	Cleavage of the damaged pyrimidine	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-196783	Coenzyme A biosynthesis	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-2142789	Ubiquinol biosynthesis	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-444821	Relaxin receptors	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-194313	VEGF ligand-receptor interactions	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-400451	Free fatty acids regulate insulin secretion	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-73942	DNA Damage Reversal	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-8937144	Aryl hydrocarbon receptor signalling	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-72731	Recycling of eIF2:GDP	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-73928	Depyrimidination	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-1483148	Synthesis of PG	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-1253288	Downregulation of ERBB4 signaling	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.999999999955581	-4.44189326420803e-11	8	0	0	484	10287
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-77108	Utilization of Ketone Bodies	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-163282	Mitochondrial transcription initiation	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-110331	Cleavage of the damaged purine	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-5357572	Lysosomal glycogen catabolism	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-1307965	betaKlotho-mediated ligand binding	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-111458	Formation of apoptosome	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-8849472	PTK6 Down-Regulation	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-1296067	Potassium transport channels	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-844615	The AIM2 inflammasome	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-8853336	Signaling by plasma membrane FGFR1 fusions	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-977442	GABA A (rho) receptor activation	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-265473	Trafficking of dietary sterols	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-73927	Depurination	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-5602571	TRAF3 deficiency - HSE	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-191650	Regulation of gap junction activity	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-844455	The NLRP1 inflammasome	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-6806664	Metabolism of vitamin K	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-352238	Breakdown of the nuclear lamina	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-217271	FMO oxidises nucleophiles	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-3249367	STAT6-mediated induction of chemokines	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-5658034	HHAT G278V abrogates palmitoylation of Hh-Np	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.999999999963871	-3.61292038089179e-11	3	0	0	484	10287
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-6807062	Cholesterol biosynthesis via lathosterol	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-428776	Class II GLUTs	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-165158	Activation of AKT2	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-8866906	TFAP2 (AP-2) family regulates transcription of other transcription factors	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-6803544	Ion influx/efflux at host-pathogen interface	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-1296061	HCN channels	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-390650	Histamine receptors	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-6807047	Cholesterol biosynthesis via desmosterol	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-3000497	Scavenging by Class H Receptors	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-442745	Activation of CaMK IV	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-5083630	Defective LFNG causes SCDO3	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-6783984	Glycine degradation	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-399710	Activation of AMPA receptors	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-888593	Reuptake of GABA	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-1296053	Classical Kir channels	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-8849474	PTK6 Activates STAT3	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-8848584	Wax biosynthesis	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-8847453	Synthesis of PIPs in the nucleus	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-8935690	Miscellaneous digestion events	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-6802953	RAS signaling downstream of NF1 loss-of-function variants	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-4551638	SUMOylation of chromatin organization proteins	0.999999999965016	-3.49844524628269e-11	4	0	0	484	10287
R-HSA-8876725	Protein methylation	0.999999999965657	-3.43432849739361e-11	19	0	0	484	10287
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999965657	-3.43432849739361e-11	19	0	0	484	10287
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999965657	-3.43432849739361e-11	19	0	0	484	10287
R-HSA-176412	Phosphorylation of the APC/C	0.999999999965657	-3.43432849739361e-11	19	0	0	484	10287
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999965657	-3.43432849739361e-11	19	0	0	484	10287
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.999999999965657	-3.43432849739361e-11	19	0	0	484	10287
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.999999999965657	-3.43432849739361e-11	19	0	0	484	10287
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.999999999965657	-3.43432849739361e-11	19	0	0	484	10287
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.999999999965657	-3.43432849739361e-11	19	0	0	484	10287
R-HSA-5576886	Phase 4 - resting membrane potential	0.999999999965657	-3.43432849739361e-11	19	0	0	484	10287
R-HSA-110320	Translesion Synthesis by POLH	0.999999999965657	-3.43432849739361e-11	19	0	0	484	10287
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.999999999965657	-3.43432849739361e-11	19	0	0	484	10287
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.999999999965657	-3.43432849739361e-11	19	0	0	484	10287
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-171007	p38MAPK events	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-2168880	Scavenging of heme from plasma	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-2995410	Nuclear Envelope Reassembly	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-977441	GABA A receptor activation	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-175474	Assembly Of The HIV Virion	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-375281	Hormone ligand-binding receptors	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-5626467	RHO GTPases activate IQGAPs	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-2408517	SeMet incorporation into proteins	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-1663150	The activation of arylsulfatases	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-5210891	Uptake and function of anthrax toxins	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.999999999967021	-3.29786598729157e-11	13	0	0	484	10287
R-HSA-202040	G-protein activation	0.999999999967226	-3.27737229187522e-11	29	0	0	484	10287
R-HSA-390918	Peroxisomal lipid metabolism	0.999999999967226	-3.27737229187522e-11	29	0	0	484	10287
R-HSA-1482839	Acyl chain remodelling of PE	0.999999999967226	-3.27737229187522e-11	29	0	0	484	10287
R-HSA-72086	mRNA Capping	0.999999999967226	-3.27737229187522e-11	29	0	0	484	10287
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.999999999967226	-3.27737229187522e-11	29	0	0	484	10287
R-HSA-1483213	Synthesis of PE	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-418885	DCC mediated attractive signaling	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-2024101	CS/DS degradation	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999968321	-3.16792196955592e-11	14	0	0	484	10287
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	0.999999999969364	-3.06360214175117e-11	30	0	0	484	10287
R-HSA-420029	Tight junction interactions	0.999999999969364	-3.06360214175117e-11	30	0	0	484	10287
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.999999999969364	-3.06360214175117e-11	30	0	0	484	10287
R-HSA-111996	Ca-dependent events	0.999999999969364	-3.06360214175117e-11	30	0	0	484	10287
R-HSA-446353	Cell-extracellular matrix interactions	0.999999999971033	-2.89669880294774e-11	16	0	0	484	10287
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.999999999971033	-2.89669880294774e-11	16	0	0	484	10287
R-HSA-163615	PKA activation	0.999999999971033	-2.89669880294774e-11	16	0	0	484	10287
R-HSA-399956	CRMPs in Sema3A signaling	0.999999999971033	-2.89669880294774e-11	16	0	0	484	10287
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.999999999971033	-2.89669880294774e-11	16	0	0	484	10287
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.999999999971033	-2.89669880294774e-11	16	0	0	484	10287
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.999999999971033	-2.89669880294774e-11	16	0	0	484	10287
R-HSA-1170546	Prolactin receptor signaling	0.999999999971033	-2.89669880294774e-11	16	0	0	484	10287
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	0.999999999971033	-2.89669880294774e-11	16	0	0	484	10287
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.999999999971033	-2.89669880294774e-11	16	0	0	484	10287
R-HSA-1295596	Spry regulation of FGF signaling	0.999999999971033	-2.89669880294774e-11	16	0	0	484	10287
R-HSA-110312	Translesion synthesis by REV1	0.999999999971033	-2.89669880294774e-11	16	0	0	484	10287
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.999999999971033	-2.89669880294774e-11	16	0	0	484	10287
R-HSA-1834941	STING mediated induction of host immune responses	0.999999999971033	-2.89669880294774e-11	16	0	0	484	10287
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999971566	-2.84335439170688e-11	22	0	0	484	10287
R-HSA-373753	Nephrin interactions	0.999999999971566	-2.84335439170688e-11	22	0	0	484	10287
R-HSA-166208	mTORC1-mediated signalling	0.999999999971566	-2.84335439170688e-11	22	0	0	484	10287
R-HSA-5620916	VxPx cargo-targeting to cilium	0.999999999971566	-2.84335439170688e-11	22	0	0	484	10287
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.999999999971566	-2.84335439170688e-11	22	0	0	484	10287
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.999999999971566	-2.84335439170688e-11	22	0	0	484	10287
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.999999999971566	-2.84335439170688e-11	22	0	0	484	10287
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.999999999971566	-2.84335439170688e-11	22	0	0	484	10287
R-HSA-70370	Galactose catabolism	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-75157	FasL/ CD95L signaling	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-111463	SMAC binds to IAPs	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-390648	Muscarinic acetylcholine receptors	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-446205	Synthesis of GDP-mannose	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-8866911	TFAP2 (AP-2) family regulates transcription of cell cycle factors	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-8866376	Reelin signalling pathway	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-1483226	Synthesis of PI	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-157881	Cyclin B2 mediated events	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-390651	Dopamine receptors	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-5662702	Melanin biosynthesis	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-8849473	PTK6 Expression	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-196819	Vitamin B1 (thiamin) metabolism	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-2161541	Abacavir metabolism	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-71262	Carnitine synthesis	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-114516	Disinhibition of SNARE formation	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-69478	G2/M DNA replication checkpoint	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-167827	The proton buffering model	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-8869496	TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-389599	Alpha-oxidation of phytanate	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-6785470	tRNA processing in the mitochondrion	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-8853383	Lysosomal oligosaccharide catabolism	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-391906	Leukotriene receptors	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-444209	Free fatty acid receptors	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-380095	Tachykinin receptors bind tachykinins	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-71032	Propionyl-CoA catabolism	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-8852405	Signaling by MST1	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-74713	IRS activation	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-167826	The fatty acid cycling model	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-5683678	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-111469	SMAC-mediated apoptotic response	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-70350	Fructose catabolism	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-561048	Organic anion transport	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-8866423	VLDL biosynthesis	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-8849468	PTK6 Regulates Proteins Involved in RNA Processing	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.999999999972411	-2.75892795060462e-11	5	0	0	484	10287
R-HSA-1296065	Inwardly rectifying K+ channels	0.99999999997248	-2.75198039910959e-11	31	0	0	484	10287
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	0.99999999997248	-2.75198039910959e-11	31	0	0	484	10287
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.99999999997248	-2.75198039910959e-11	31	0	0	484	10287
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.99999999997248	-2.75198039910959e-11	31	0	0	484	10287
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	0.99999999997248	-2.75198039910959e-11	31	0	0	484	10287
R-HSA-73772	RNA Polymerase I Promoter Escape	0.99999999997248	-2.75198039910959e-11	31	0	0	484	10287
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	0.99999999997248	-2.75198039910959e-11	31	0	0	484	10287
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	0.99999999997248	-2.75198039910959e-11	31	0	0	484	10287
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-419812	Calcitonin-like ligand receptors	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-2562578	TRIF-mediated programmed cell death	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-70635	Urea cycle	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-201688	WNT mediated activation of DVL	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-5663084	Diseases of carbohydrate metabolism	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-428643	Organic anion transporters	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-3215018	Processing and activation of SUMO	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-6811555	PI5P Regulates TP53 Acetylation	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-2046105	Linoleic acid (LA) metabolism	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-190873	Gap junction degradation	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-8868766	rRNA processing in the mitochondrion	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-74749	Signal attenuation	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-209968	Thyroxine biosynthesis	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-170660	Adenylate cyclase activating pathway	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-159740	Gamma-carboxylation of protein precursors	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-3229121	Glycogen storage diseases	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-727802	Transport of nucleotide sugars	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-430116	GP1b-IX-V activation signalling	0.999999999973244	-2.67561605928119e-11	10	0	0	484	10287
R-HSA-380287	Centrosome maturation	0.999999999975341	-2.46589731460162e-11	82	0	0	484	10287
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	0.999999999975341	-2.46589731460162e-11	82	0	0	484	10287
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.999999999975341	-2.46589731460162e-11	82	0	0	484	10287
R-HSA-156588	Glucuronidation	0.999999999977528	-2.2471829376925e-11	24	0	0	484	10287
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.999999999977528	-2.2471829376925e-11	24	0	0	484	10287
R-HSA-171052	LDL-mediated lipid transport	0.999999999977528	-2.2471829376925e-11	24	0	0	484	10287
R-HSA-70895	Branched-chain amino acid catabolism	0.999999999977528	-2.2471829376925e-11	24	0	0	484	10287
R-HSA-191273	Cholesterol biosynthesis	0.999999999977528	-2.2471829376925e-11	24	0	0	484	10287
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-5358508	Mismatch Repair	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-156581	Methylation	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-211935	Fatty acids	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-3322077	Glycogen synthesis	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-391903	Eicosanoid ligand-binding receptors	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-3371568	Attenuation phase	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.999999999978199	-2.1800807423748e-11	15	0	0	484	10287
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.999999999979691	-2.03086283945943e-11	34	0	0	484	10287
R-HSA-1483166	Synthesis of PA	0.999999999979691	-2.03086283945943e-11	34	0	0	484	10287
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.999999999979691	-2.03086283945943e-11	34	0	0	484	10287
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.999999999979691	-2.03086283945943e-11	34	0	0	484	10287
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-2470946	Cohesin Loading onto Chromatin	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-2022923	Dermatan sulfate biosynthesis	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-937039	IRAK1 recruits IKK complex	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-376172	DSCAM interactions	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-189451	Heme biosynthesis	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-5625970	RHO GTPases activate KTN1	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-69416	Dimerization of procaspase-8	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-5218900	CASP8 activity is inhibited	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-196780	Biotin transport and metabolism	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-3371378	Regulation by c-FLIP	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-174414	Processive synthesis on the C-strand of the telomere	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-211999	CYP2E1 reactions	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-5655291	Signaling by FGFR4 in disease	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-75072	mRNA Editing	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-68689	CDC6 association with the ORC:origin complex	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-2485179	Activation of the phototransduction cascade	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-418889	Ligand-independent caspase activation via DCC	0.999999999979866	-2.01335346491891e-11	11	0	0	484	10287
R-HSA-8868773	rRNA processing in the nucleus and cytosol	0.999999999980343	-1.96570772781545e-11	191	0	0	484	10287
R-HSA-111997	CaM pathway	0.999999999980419	-1.95812433143036e-11	28	0	0	484	10287
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.999999999980419	-1.95812433143036e-11	28	0	0	484	10287
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	0.999999999980419	-1.95812433143036e-11	28	0	0	484	10287
R-HSA-111933	Calmodulin induced events	0.999999999980419	-1.95812433143036e-11	28	0	0	484	10287
R-HSA-264876	Insulin processing	0.999999999980419	-1.95812433143036e-11	28	0	0	484	10287
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.999999999980419	-1.95812433143036e-11	28	0	0	484	10287
R-HSA-437239	Recycling pathway of L1	0.999999999980419	-1.95812433143036e-11	28	0	0	484	10287
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	0.999999999980419	-1.95812433143036e-11	28	0	0	484	10287
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.999999999980419	-1.95812433143036e-11	28	0	0	484	10287
R-HSA-70268	Pyruvate metabolism	0.999999999980419	-1.95812433143036e-11	28	0	0	484	10287
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	0.999999999980419	-1.95812433143036e-11	28	0	0	484	10287
R-HSA-6803529	FGFR2 alternative splicing	0.999999999980419	-1.95812433143036e-11	28	0	0	484	10287
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.999999999980419	-1.95812433143036e-11	28	0	0	484	10287
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.999999999980484	-1.95156215020112e-11	25	0	0	484	10287
R-HSA-429947	Deadenylation of mRNA	0.999999999980484	-1.95156215020112e-11	25	0	0	484	10287
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.999999999980484	-1.95156215020112e-11	25	0	0	484	10287
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.999999999980484	-1.95156215020112e-11	25	0	0	484	10287
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.999999999980484	-1.95156215020112e-11	25	0	0	484	10287
R-HSA-1296041	Activation of G protein gated Potassium channels	0.999999999980484	-1.95156215020112e-11	25	0	0	484	10287
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.999999999980484	-1.95156215020112e-11	25	0	0	484	10287
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.999999999980484	-1.95156215020112e-11	25	0	0	484	10287
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.999999999980484	-1.95156215020112e-11	25	0	0	484	10287
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.999999999980484	-1.95156215020112e-11	25	0	0	484	10287
R-HSA-1296059	G protein gated Potassium channels	0.999999999980484	-1.95156215020112e-11	25	0	0	484	10287
R-HSA-5673000	RAF activation	0.999999999980484	-1.95156215020112e-11	25	0	0	484	10287
R-HSA-6784531	tRNA processing in the nucleus	0.999999999981206	-1.87944582009034e-11	60	0	0	484	10287
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.999999999981492	-1.85077705089671e-11	32	0	0	484	10287
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.999999999981492	-1.85077705089671e-11	32	0	0	484	10287
R-HSA-70263	Gluconeogenesis	0.999999999981492	-1.85077705089671e-11	32	0	0	484	10287
R-HSA-73863	RNA Polymerase I Transcription Termination	0.999999999981492	-1.85077705089671e-11	32	0	0	484	10287
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	0.999999999982009	-1.79911665275324e-11	26	0	0	484	10287
R-HSA-379716	Cytosolic tRNA aminoacylation	0.999999999982009	-1.79911665275324e-11	26	0	0	484	10287
R-HSA-975298	Ligand-gated ion channel transport	0.999999999982009	-1.79911665275324e-11	26	0	0	484	10287
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.999999999982799	-1.72013898019888e-11	18	0	0	484	10287
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.999999999982799	-1.72013898019888e-11	18	0	0	484	10287
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.999999999982799	-1.72013898019888e-11	18	0	0	484	10287
R-HSA-73780	RNA Polymerase III Chain Elongation	0.999999999982799	-1.72013898019888e-11	18	0	0	484	10287
R-HSA-5635838	Activation of SMO	0.999999999982799	-1.72013898019888e-11	18	0	0	484	10287
R-HSA-1482925	Acyl chain remodelling of PG	0.999999999982799	-1.72013898019888e-11	18	0	0	484	10287
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	0.999999999982799	-1.72013898019888e-11	18	0	0	484	10287
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	0.999999999982799	-1.72013898019888e-11	18	0	0	484	10287
R-HSA-5626978	TNFR1-mediated ceramide production	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-6798163	Choline catabolism	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-428808	Na+-dependent glucose transporters	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-1566977	Fibronectin matrix formation	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-177135	Conjugation of benzoate with glycine	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-3323169	Defects in biotin (Btn) metabolism	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-3065679	SUMO is proteolytically processed	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-1237112	Methionine salvage pathway	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-1482798	Acyl chain remodeling of CL	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-166662	Lectin pathway of complement activation	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-6793080	rRNA modification in the mitochondrion	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-444257	RSK activation	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-176417	Phosphorylation of Emi1	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-111957	Cam-PDE 1 activation	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-173623	Classical antibody-mediated complement activation	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-6787639	GDP-fucose biosynthesis	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-947581	Molybdenum cofactor biosynthesis	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-500753	Pyrimidine biosynthesis	0.999999999982838	-1.71623769203489e-11	6	0	0	484	10287
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-351143	Agmatine biosynthesis	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-203754	NOSIP mediated eNOS trafficking	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-71737	Pyrophosphate hydrolysis	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-75896	Plasmalogen biosynthesis	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-198765	Signalling to ERK5	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-8942233	Intestinal infectious diseases	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-8854521	Interaction between PHLDA1 and AURKA	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-168277	Influenza Virus Induced Apoptosis	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-192905	vRNP Assembly	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-1483152	Hydrolysis of LPE	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-5602636	IKBKB deficiency causes SCID	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-75064	mRNA Editing: A to I Conversion	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-916853	Degradation of GABA	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-5602566	TICAM1 deficiency - HSE	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-168268	Virus Assembly and Release	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-111995	phospho-PLA2 pathway	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-5683177	Defective ABCC8 can cause hypoglycemias and hyperglycemias	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-141424	Amplification of signal from the kinetochores	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-1614603	Cysteine formation from homocysteine	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-844623	The IPAF inflammasome	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-77042	Formation of editosomes by ADAR proteins	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-8849175	Threonine catabolism	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-888568	GABA synthesis	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-380612	Metabolism of serotonin	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-75102	C6 deamination of adenosine	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-70688	Proline catabolism	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-156582	Acetylation	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-165160	PDE3B signalling	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-1483101	Synthesis of PS	0.999999999982854	-1.71458932121671e-11	2	0	0	484	10287
R-HSA-4615885	SUMOylation of DNA replication proteins	0.999999999983917	-1.60833811045001e-11	46	0	0	484	10287
R-HSA-1660662	Glycosphingolipid metabolism	0.999999999983917	-1.60833811045001e-11	46	0	0	484	10287
R-HSA-156842	Eukaryotic Translation Elongation	0.999999999983968	-1.60323862215578e-11	96	0	0	484	10287
R-HSA-72764	Eukaryotic Translation Termination	0.999999999983968	-1.60323862215578e-11	96	0	0	484	10287
R-HSA-438064	Post NMDA receptor activation events	0.999999999985167	-1.48329552411328e-11	37	0	0	484	10287
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.999999999985167	-1.48329552411328e-11	37	0	0	484	10287
R-HSA-73884	Base Excision Repair	0.999999999985167	-1.48329552411328e-11	37	0	0	484	10287
R-HSA-176187	Activation of ATR in response to replication stress	0.999999999985167	-1.48329552411328e-11	37	0	0	484	10287
R-HSA-8849932	SALM protein interactions at the synapses	0.999999999985341	-1.46588835658596e-11	21	0	0	484	10287
R-HSA-210745	Regulation of gene expression in beta cells	0.999999999985341	-1.46588835658596e-11	21	0	0	484	10287
R-HSA-1181150	Signaling by NODAL	0.999999999985341	-1.46588835658596e-11	21	0	0	484	10287
R-HSA-69618	Mitotic Spindle Checkpoint	0.999999999985341	-1.46588835658596e-11	21	0	0	484	10287
R-HSA-445144	Signal transduction by L1	0.999999999985341	-1.46588835658596e-11	21	0	0	484	10287
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.999999999985341	-1.46588835658596e-11	21	0	0	484	10287
R-HSA-500657	Presynaptic function of Kainate receptors	0.999999999985341	-1.46588835658596e-11	21	0	0	484	10287
R-HSA-73980	RNA Polymerase III Transcription Termination	0.999999999985414	-1.4586419232236e-11	23	0	0	484	10287
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.999999999985414	-1.4586419232236e-11	23	0	0	484	10287
R-HSA-5205647	Mitophagy	0.999999999985414	-1.4586419232236e-11	23	0	0	484	10287
R-HSA-3371571	HSF1-dependent transactivation	0.999999999985414	-1.4586419232236e-11	23	0	0	484	10287
R-HSA-428930	Thromboxane signalling through TP receptor	0.999999999985414	-1.4586419232236e-11	23	0	0	484	10287
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.999999999985414	-1.4586419232236e-11	23	0	0	484	10287
R-HSA-8855121	VLDL interactions	0.999999999985414	-1.4586419232236e-11	23	0	0	484	10287
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.999999999985414	-1.4586419232236e-11	23	0	0	484	10287
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.999999999985414	-1.4586419232236e-11	23	0	0	484	10287
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.999999999985414	-1.4586419232236e-11	23	0	0	484	10287
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.999999999985414	-1.4586419232236e-11	23	0	0	484	10287
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.999999999986523	-1.34767894603922e-11	78	0	0	484	10287
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.999999999987116	-1.28840638430068e-11	137	0	0	484	10287
R-HSA-165159	mTOR signalling	0.999999999987129	-1.2871449801889e-11	39	0	0	484	10287
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	0.999999999987129	-1.2871449801889e-11	39	0	0	484	10287
R-HSA-5674135	MAP2K and MAPK activation	0.999999999987129	-1.2871449801889e-11	39	0	0	484	10287
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.999999999987129	-1.2871449801889e-11	39	0	0	484	10287
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	0.999999999987129	-1.2871449801889e-11	39	0	0	484	10287
R-HSA-6783310	Fanconi Anemia Pathway	0.999999999987129	-1.2871449801889e-11	39	0	0	484	10287
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.999999999987129	-1.2871449801889e-11	39	0	0	484	10287
R-HSA-1433617	Regulation of signaling by NODAL	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-2022857	Keratan sulfate degradation	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-166786	Creation of C4 and C2 activators	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-417957	P2Y receptors	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-1296346	Tandem pore domain potassium channels	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-5689877	Josephin domain DUBs	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-8866427	VLDLR internalisation and degradation	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-71384	Ethanol oxidation	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-5578768	Physiological factors	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-3371511	HSF1 activation	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-71064	Lysine catabolism	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-211979	Eicosanoids	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-390666	Serotonin receptors	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-211958	Miscellaneous substrates	0.99999999998758	-1.24198761543204e-11	12	0	0	484	10287
R-HSA-194223	HDL-mediated lipid transport	0.999999999988919	-1.10806439746425e-11	20	0	0	484	10287
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.999999999988919	-1.10806439746425e-11	20	0	0	484	10287
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.999999999988919	-1.10806439746425e-11	20	0	0	484	10287
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.999999999988919	-1.10806439746425e-11	20	0	0	484	10287
R-HSA-6804760	Regulation of TP53 Activity through Methylation	0.999999999988919	-1.10806439746425e-11	20	0	0	484	10287
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.999999999988919	-1.10806439746425e-11	20	0	0	484	10287
R-HSA-1643713	Signaling by EGFR in Cancer	0.999999999988919	-1.10806439746425e-11	20	0	0	484	10287
R-HSA-418217	G beta:gamma signalling through PLC beta	0.999999999988919	-1.10806439746425e-11	20	0	0	484	10287
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.999999999988919	-1.10806439746425e-11	20	0	0	484	10287
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-74182	Ketone body metabolism	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-419771	Opsins	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-425986	Sodium/Proton exchangers	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-196025	Formation of annular gap junctions	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-159424	Conjugation of carboxylic acids	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-75094	Formation of the Editosome	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-2243919	Crosslinking of collagen fibrils	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-163765	ChREBP activates metabolic gene expression	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-166665	Terminal pathway of complement	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-1300642	Sperm Motility And Taxes	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-156587	Amino Acid conjugation	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-391908	Prostanoid ligand receptors	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-2428933	SHC-related events triggered by IGF1R	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-1462054	Alpha-defensins	0.999999999989215	-1.0785533649816e-11	9	0	0	484	10287
R-HSA-429593	Inositol transporters	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-3595172	Defective CHST3 causes SEDCJD	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-5619102	SLC transporter disorders	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-426496	Post-transcriptional silencing by small RNAs	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-3656225	Defective CHST6 causes MCDC1	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-3595177	Defective CHSY1 causes TPBS	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-426117	Cation-coupled Chloride cotransporters	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-111471	Apoptotic factor-mediated response	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-433692	Proton-coupled monocarboxylate transport	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-6814848	Glycerophospholipid catabolism	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-174362	Transport and synthesis of PAPS	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-75158	TRAIL  signaling	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-199920	CREB phosphorylation	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-171319	Telomere Extension By Telomerase	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-182218	Nef Mediated CD8 Down-regulation	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.999999999989226	-1.07737212837092e-11	7	0	0	484	10287
R-HSA-5389840	Mitochondrial translation elongation	0.999999999989329	-1.06712632808892e-11	88	0	0	484	10287
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.999999999989329	-1.06712632808892e-11	88	0	0	484	10287
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	0.999999999989732	-1.02679402189943e-11	27	0	0	484	10287
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	0.999999999989732	-1.02679402189943e-11	27	0	0	484	10287
R-HSA-1482788	Acyl chain remodelling of PC	0.999999999989732	-1.02679402189943e-11	27	0	0	484	10287
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.999999999989732	-1.02679402189943e-11	27	0	0	484	10287
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	0.999999999989732	-1.02679402189943e-11	27	0	0	484	10287
R-HSA-901042	Calnexin/calreticulin cycle	0.999999999989732	-1.02679402189943e-11	27	0	0	484	10287
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	0.999999999989732	-1.02679402189943e-11	27	0	0	484	10287
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.999999999990209	-9.79056279526918e-12	100	0	0	484	10287
R-HSA-1632852	Macroautophagy	0.999999999990279	-9.72149453724441e-12	67	0	0	484	10287
R-HSA-2980766	Nuclear Envelope Breakdown	0.99999999999041	-9.58990054196769e-12	52	0	0	484	10287
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.99999999999041	-9.58990054196769e-12	52	0	0	484	10287
R-HSA-8854214	TBC/RABGAPs	0.999999999990458	-9.54236982139834e-12	45	0	0	484	10287
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.999999999990458	-9.54236982139834e-12	45	0	0	484	10287
R-HSA-379724	tRNA Aminoacylation	0.999999999990458	-9.54236982139834e-12	45	0	0	484	10287
R-HSA-74158	RNA Polymerase III Transcription	0.999999999990508	-9.49225177075152e-12	41	0	0	484	10287
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.999999999990508	-9.49225177075152e-12	41	0	0	484	10287
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.999999999990508	-9.49225177075152e-12	41	0	0	484	10287
R-HSA-5696400	Dual Incision in GG-NER	0.999999999990508	-9.49225177075152e-12	41	0	0	484	10287
R-HSA-5620924	Intraflagellar transport	0.999999999990508	-9.49225177075152e-12	41	0	0	484	10287
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.999999999990548	-9.45206610158788e-12	69	0	0	484	10287
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-171286	Synthesis and processing of ENV and VPU	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-2408552	Methylation of MeSeH for excretion	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-389542	NADPH regeneration	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-162585	Uncoating of the HIV Virion	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-1300645	Acrosome Reaction	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-164525	Plus-strand DNA synthesis	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-3248023	Regulation by TREX1	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-1483076	Synthesis of CL	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-169131	Inhibition of PKR	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-164516	Minus-strand DNA synthesis	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-6809583	Retinoid metabolism disease events	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-5083628	Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-5083633	Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-163316	Mitochondrial transcription termination	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-8853333	Signaling by FGFR2 fusions	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-2033515	t(4;14) translocations of FGFR3	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-140180	COX reactions	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-5083629	Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.999999999990662	-9.33786381551727e-12	1	0	0	484	10287
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.999999999990822	-9.17825068072387e-12	104	0	0	484	10287
R-HSA-167169	HIV Transcription Elongation	0.999999999991891	-8.1093697852673e-12	50	0	0	484	10287
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.999999999991891	-8.1093697852673e-12	50	0	0	484	10287
R-HSA-6802949	Signaling by RAS mutants	0.999999999991891	-8.1093697852673e-12	50	0	0	484	10287
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.999999999991891	-8.1093697852673e-12	50	0	0	484	10287
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	0.999999999993172	-6.82773087903048e-12	99	0	0	484	10287
R-HSA-5368286	Mitochondrial translation initiation	0.999999999993772	-6.22846869961565e-12	87	0	0	484	10287
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.999999999993772	-6.22846869961565e-12	87	0	0	484	10287
R-HSA-5419276	Mitochondrial translation termination	0.999999999993772	-6.22846869961565e-12	87	0	0	484	10287
R-HSA-5693537	Resolution of D-Loop Structures	0.999999999993964	-6.03618202809312e-12	35	0	0	484	10287
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.999999999993964	-6.03618202809312e-12	35	0	0	484	10287
R-HSA-113418	Formation of the Early Elongation Complex	0.999999999993964	-6.03618202809312e-12	35	0	0	484	10287
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.999999999993964	-6.03618202809312e-12	35	0	0	484	10287
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	0.999999999993964	-6.03618202809312e-12	35	0	0	484	10287
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.999999999993964	-6.03618202809312e-12	35	0	0	484	10287
R-HSA-76046	RNA Polymerase III Transcription Initiation	0.999999999994456	-5.54446167686397e-12	36	0	0	484	10287
R-HSA-432720	Lysosome Vesicle Biogenesis	0.999999999994456	-5.54446167686397e-12	36	0	0	484	10287
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	0.999999999994456	-5.54446167686397e-12	36	0	0	484	10287
R-HSA-177243	Interactions of Rev with host cellular proteins	0.999999999994456	-5.54446167686397e-12	36	0	0	484	10287
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.999999999994776	-5.22435969744104e-12	158	0	0	484	10287
R-HSA-3371556	Cellular response to heat stress	0.999999999994876	-5.12393947500844e-12	89	0	0	484	10287
R-HSA-8873719	RAB geranylgeranylation	0.999999999995013	-4.98730211712332e-12	64	0	0	484	10287
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.999999999995367	-4.63278560342142e-12	70	0	0	484	10287
R-HSA-3232118	SUMOylation of transcription factors	0.99999999999547	-4.53039082496434e-12	17	0	0	484	10287
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.99999999999547	-4.53039082496434e-12	17	0	0	484	10287
R-HSA-156711	Polo-like kinase mediated events	0.99999999999547	-4.53039082496434e-12	17	0	0	484	10287
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.99999999999547	-4.53039082496434e-12	17	0	0	484	10287
R-HSA-196299	Beta-catenin phosphorylation cascade	0.99999999999547	-4.53039082496434e-12	17	0	0	484	10287
R-HSA-1482922	Acyl chain remodelling of PI	0.99999999999547	-4.53039082496434e-12	17	0	0	484	10287
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.99999999999547	-4.53039082496434e-12	17	0	0	484	10287
R-HSA-5655862	Translesion synthesis by POLK	0.99999999999547	-4.53039082496434e-12	17	0	0	484	10287
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	0.99999999999547	-4.53039082496434e-12	17	0	0	484	10287
R-HSA-5656121	Translesion synthesis by POLI	0.99999999999547	-4.53039082496434e-12	17	0	0	484	10287
R-HSA-164378	PKA activation in glucagon signalling	0.99999999999547	-4.53039082496434e-12	17	0	0	484	10287
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.99999999999547	-4.53039082496434e-12	17	0	0	484	10287
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.99999999999547	-4.53039082496434e-12	17	0	0	484	10287
R-HSA-140534	Ligand-dependent caspase activation	0.99999999999547	-4.53039082496434e-12	17	0	0	484	10287
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.99999999999547	-4.53039082496434e-12	17	0	0	484	10287
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	0.999999999995591	-4.4088163926519e-12	72	0	0	484	10287
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.999999999995591	-4.4088163926519e-12	72	0	0	484	10287
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.999999999995911	-4.08875092727527e-12	47	0	0	484	10287
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.999999999995911	-4.08875092727527e-12	47	0	0	484	10287
R-HSA-167161	HIV Transcription Initiation	0.999999999995911	-4.08875092727527e-12	47	0	0	484	10287
R-HSA-5576892	Phase 0 - rapid depolarisation	0.999999999995911	-4.08875092727527e-12	47	0	0	484	10287
R-HSA-73776	RNA Polymerase II Promoter Escape	0.999999999995911	-4.08875092727527e-12	47	0	0	484	10287
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.999999999995911	-4.08875092727527e-12	47	0	0	484	10287
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.999999999995911	-4.08875092727527e-12	47	0	0	484	10287
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.999999999995966	-4.03407767963744e-12	63	0	0	484	10287
R-HSA-72172	mRNA Splicing	0.999999999996079	-3.92100896195621e-12	195	0	0	484	10287
R-HSA-5668914	Diseases of metabolism	0.99999999999608	-3.91963468176213e-12	44	0	0	484	10287
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	0.99999999999608	-3.91963468176213e-12	44	0	0	484	10287
R-HSA-168255	Influenza Life Cycle	0.999999999996651	-3.34906074882066e-12	146	0	0	484	10287
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.999999999996715	-3.2853933090116e-12	103	0	0	484	10287
R-HSA-977443	GABA receptor activation	0.999999999996883	-3.11734161182948e-12	56	0	0	484	10287
R-HSA-381038	XBP1(S) activates chaperone genes	0.999999999996883	-3.11734161182948e-12	56	0	0	484	10287
R-HSA-73857	RNA Polymerase II Transcription	0.999999999996935	-3.06503229108111e-12	159	0	0	484	10287
R-HSA-191859	snRNP Assembly	0.999999999996968	-3.03242923763819e-12	53	0	0	484	10287
R-HSA-72165	mRNA Splicing - Minor Pathway	0.999999999996968	-3.03242923763819e-12	53	0	0	484	10287
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	0.999999999996968	-3.03242923763819e-12	53	0	0	484	10287
R-HSA-194441	Metabolism of non-coding RNA	0.999999999996968	-3.03242923763819e-12	53	0	0	484	10287
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.999999999997054	-2.94594436643689e-12	40	0	0	484	10287
R-HSA-977444	GABA B receptor activation	0.999999999997054	-2.94594436643689e-12	40	0	0	484	10287
R-HSA-991365	Activation of GABAB receptors	0.999999999997054	-2.94594436643689e-12	40	0	0	484	10287
R-HSA-167290	Pausing and recovery of HIV elongation	0.999999999997054	-2.94594436643689e-12	40	0	0	484	10287
R-HSA-167287	HIV elongation arrest and recovery	0.999999999997054	-2.94594436643689e-12	40	0	0	484	10287
R-HSA-109703	PKB-mediated events	0.999999999997054	-2.94594436643689e-12	40	0	0	484	10287
R-HSA-6802952	Signaling by BRAF and RAF fusions	0.999999999997102	-2.89752962356263e-12	61	0	0	484	10287
R-HSA-72702	Ribosomal scanning and start codon recognition	0.999999999997102	-2.89752962356263e-12	61	0	0	484	10287
R-HSA-72689	Formation of a pool of free 40S subunits	0.999999999997206	-2.79427408147299e-12	105	0	0	484	10287
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.999999999998067	-1.93289480550919e-12	85	0	0	484	10287
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	0.999999999998313	-1.68662562683861e-12	54	0	0	484	10287
R-HSA-167172	Transcription of the HIV genome	0.999999999998591	-1.40911478847945e-12	77	0	0	484	10287
R-HSA-168325	Viral Messenger RNA Synthesis	0.999999999998618	-1.38242442687788e-12	43	0	0	484	10287
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.999999999998618	-1.38242442687788e-12	43	0	0	484	10287
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.999999999998618	-1.38242442687788e-12	43	0	0	484	10287
R-HSA-429914	Deadenylation-dependent mRNA decay	0.999999999998642	-1.35777512367536e-12	57	0	0	484	10287
R-HSA-5368287	Mitochondrial translation	0.999999999998947	-1.05254879626871e-12	94	0	0	484	10287
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.999999999999254	-7.46376462420665e-13	90	0	0	484	10287
R-HSA-72312	rRNA processing	0.999999999999648	-3.52062833553994e-13	201	0	0	484	10287
R-HSA-6799198	Complex I biogenesis	0.9999999999999	-1.00322063554984e-13	51	0	0	484	10287
R-HSA-192823	Viral mRNA Translation	1.00000000000038	3.75580034021916e-13	92	0	0	484	10287
R-HSA-611105	Respiratory electron transport	1.00000000000038	3.75580034021916e-13	92	0	0	484	10287
R-HSA-156902	Peptide chain elongation	1.00000000000038	3.75580034021916e-13	92	0	0	484	10287
R-HSA-392518	Signal amplification	1.00000000000077	7.72054895974063e-13	33	0	0	484	10287
R-HSA-180746	Nuclear import of Rev protein	1.00000000000077	7.72054895974063e-13	33	0	0	484	10287
R-HSA-186712	Regulation of beta-cell development	1.00000000000077	7.72054895974063e-13	33	0	0	484	10287
R-HSA-4570464	SUMOylation of RNA binding proteins	1.00000000000089	8.92861815045221e-13	48	0	0	484	10287
R-HSA-73762	RNA Polymerase I Transcription Initiation	1.00000000000089	8.92861815045221e-13	48	0	0	484	10287
R-HSA-73856	RNA Polymerase II Transcription Termination	1.00000000000176	1.76272606302827e-12	71	0	0	484	10287
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	1.00000000000176	1.76272606302827e-12	71	0	0	484	10287
R-HSA-72766	Translation	1.00000000000229	2.29267021289679e-12	162	0	0	484	10287
R-HSA-8856688	Golgi-to-ER retrograde transport	1.00000000000251	2.51000001698365e-12	110	0	0	484	10287
R-HSA-2990846	SUMOylation	1.00000000000251	2.51000001698365e-12	110	0	0	484	10287
R-HSA-381070	IRE1alpha activates chaperones	1.0000000000033	3.30306054728294e-12	58	0	0	484	10287
R-HSA-69473	G2/M DNA damage checkpoint	1.00000000000392	3.91942906976396e-12	95	0	0	484	10287
R-HSA-2408557	Selenocysteine synthesis	1.00000000000392	3.91942906976396e-12	95	0	0	484	10287
R-HSA-6802957	Oncogenic MAPK signaling	1.00000000000473	4.73118438590986e-12	75	0	0	484	10287
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	1.00000000000473	4.73118438590986e-12	75	0	0	484	10287
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	1.00000000000473	4.73118438590986e-12	75	0	0	484	10287
R-HSA-8854518	AURKA Activation by TPX2	1.00000000000473	4.73118438590986e-12	75	0	0	484	10287
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	1.00000000000543	5.42925526899102e-12	65	0	0	484	10287
R-HSA-75955	RNA Polymerase II Transcription Elongation	1.00000000000543	5.42925526899102e-12	65	0	0	484	10287
R-HSA-112382	Formation of RNA Pol II elongation complex	1.00000000000543	5.42925526899102e-12	65	0	0	484	10287
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	1.00000000000544	5.44084406563744e-12	38	0	0	484	10287
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	1.00000000000544	5.44084406563744e-12	38	0	0	484	10287
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	1.00000000000544	5.44084406563744e-12	38	0	0	484	10287
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	1.00000000000583	5.83467272192521e-12	113	0	0	484	10287
R-HSA-6782315	tRNA modification in the nucleus and cytosol	1.00000000000592	5.9234515875489e-12	42	0	0	484	10287
R-HSA-983189	Kinesins	1.00000000000592	5.9234515875489e-12	42	0	0	484	10287
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	1.00000000000592	5.9234515875489e-12	42	0	0	484	10287
R-HSA-6782135	Dual incision in TC-NER	1.00000000000608	6.07949254494378e-12	66	0	0	484	10287
R-HSA-5696398	Nucleotide Excision Repair	1.00000000000621	6.20697079145205e-12	112	0	0	484	10287
R-HSA-72187	mRNA 3'-end processing	1.00000000000838	8.37544696051571e-12	62	0	0	484	10287
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	1.00000000000838	8.37544696051571e-12	62	0	0	484	10287
R-HSA-8852135	Protein ubiquitination	1.00000000000838	8.37544696051571e-12	62	0	0	484	10287
R-HSA-72649	Translation initiation complex formation	1.00000000000838	8.37544696051571e-12	62	0	0	484	10287
R-HSA-1268020	Mitochondrial protein import	1.00000000000838	8.37544696051571e-12	62	0	0	484	10287
R-HSA-6790901	rRNA modification in the nucleus and cytosol	1.00000000000838	8.37544696051571e-12	62	0	0	484	10287
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	1.00000000000841	8.40976059590186e-12	120	0	0	484	10287
R-HSA-927802	Nonsense-Mediated Decay (NMD)	1.00000000000841	8.40976059590186e-12	120	0	0	484	10287
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	1.00000000000947	9.4716096280996e-12	115	0	0	484	10287
R-HSA-72306	tRNA processing	1.00000000001087	1.0868606327376e-11	109	0	0	484	10287
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	1.00000000001256	1.25571698520709e-11	49	0	0	484	10287
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	1.00000000001256	1.25571698520709e-11	49	0	0	484	10287
R-HSA-5693606	DNA Double Strand Break Response	1.00000000001266	1.26576628050435e-11	76	0	0	484	10287
R-HSA-72613	Eukaryotic Translation Initiation	1.00000000001313	1.31249689459026e-11	125	0	0	484	10287
R-HSA-72737	Cap-dependent Translation Initiation	1.00000000001313	1.31249689459026e-11	125	0	0	484	10287
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	1.00000000001329	1.32928916417926e-11	117	0	0	484	10287
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	1.00000000001329	1.32928916417926e-11	117	0	0	484	10287
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	1.00000000001333	1.33287468439795e-11	179	0	0	484	10287
R-HSA-5685942	HDR through Homologous Recombination (HRR)	1.00000000001546	1.54592791590785e-11	68	0	0	484	10287
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1.000000000016	1.60019551363594e-11	79	0	0	484	10287
R-HSA-68877	Mitotic Prometaphase	1.00000000001667	1.66713521767489e-11	111	0	0	484	10287
R-HSA-72163	mRNA Splicing - Major Pathway	1.00000000001741	1.74089452087541e-11	187	0	0	484	10287
